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The design, synthesis, characterization, and applications of annulated 
bis(imidazolium) salts are described. New synthetic methodologies have been developed 
that allow access to a broad structural range of bis(imidazolium) salts. Initial studies 
focused on thee use of bis(imidazolium) salts as comonomers in the formation of main-
chain organometallic polymers. Two distinct polymer scaffolds were synthesized, one 
featuring metal(II)dihalides in the main-chain, and the other featuring a chelated metal 
center. Ultimately, polymerizations were conducted under ambient atmosphere, 
proceeded in excellent overall yield, and provided main-chain organometallic polymers 
comprising Ni(II), Pd(II), and Pt(II) with molecular weights up to 106 Da. 
Departing polymer studies, focus was shifted toward the study of the physical and 
photophysical properties of the bis(imidazolium) salts. In few synthetic manipulations, a 
 vii
series of highly photoluminescent bis(imidazolium) salts were prepared whose 
substituents enable emission in solution, in the solid-state, and, uniquely, as free-flowing 
liquids.  Importantly, these materials display excellent physical properties, such as low 
glass-transition temperatures (< 0 °C) and high thermal stabilities (> 300 °C).  In 
addition, the bis(imidazolium) platform enabled access to two new fluorescent ionic 
liquid crystals, demonstrating an ability to also control mesomorphic properties of these 
materials. 
Further investigations were conducted regarding the photophysical properties of 
bis(imidazolium) salts. Focus was placed upon absorption and emission wavelength 
tunability, solvatochromism, red-edge excitation, and chemical stability. Through 
functional group modulation, the λem were varied from 329 – 561 nm with Фfs up to 0.91. 
Both the absorption and emission characteristics were found to display strong solvent-
dependencies which were found to be strongly influenced by the nature of the 
bis(imidazolium) core. The red-edge effect was investigated for a series of 
bis(imidazolium) salts and was found to be similar between Br and BF4 salts, but 
distinctly different when MeSO4 anions were incorporated. The stability of an 
amphiphilic BBI was quantified in aqueous solutions of varying pH and > 85% of the 
emission intensity was retained after 2 h at pH levels of 3 – 9.  
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Main-chain conjugated organometallic polymers (COMPs) are an interesting class 
of materials with desirable electronic and mechanical properties.1 Unfortunately, access 
to these materials is often challenged by factors such as the need for inert atmospheres 
and anhydrous conditions, restrictive compatibilities of transition metals with 
contemporary polymerization protocols, and limited polymer stabilities and/or 
solubilities. Overcoming these restraints, which have prevented COMPs from reaching 
their full potential, requires development of new building blocks and polymerization 
strategies. Although a variety of binding interactions have been employed for integrating 
metals into organic polymers, Arduengo-type N-heterocyclic carbenes2 (NHCs) remain 
an untapped resource. This is surprising considering NHCs offer broad structural 
diversity and generally display high affinities toward a wide range of transition metals.3 
We sought a versatile, direct, and simple route to bis(NHC)s connected via conjugated 
arenes. With the availability of these difunctional NHCs, we envisaged a new class of 
COMPs could be readily accessed. 
 
1.2 Synthesis of annulated bis(imidazolium) salt monomers 
We targeted rigid benzimidazole-based arene spacers to inhibit intramolecular 
metal chelation4 and to ensure regio-control over metallation.5 Toward this end, 
commercially available 1,2,4,5-tetraaminobenzene (1.1), 3,3′-diaminobenzidine (1.3), and 
known dioxin-tetraamine 1.5,6 were condensed with formic acid7 to provide the 
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corresponding bis(imidazole)s. This cyclization protocol was conducted under ambient 
atmosphere and provided products in high purity (>95%) and high yields (>90%) after 
neutralization. As shown in Scheme 1.1, direct access to the respective bis(imidazolium) 
salts was accomplished via a single-step, four-fold alkylation. Thus, the bis(imidazole)s 
described above were each treated with NaH in PhCH3 followed by addition of alkyl 
bromide. After 1 h at 110 °C, DMF was introduced as a co-solvent (50% v/v) which 
facilitated dissolution of partially alkylated intermediates. After an additional 6 h at 110 
°C, introduction of excess PhCH3 precipitated the desired bis(imidazolium) bromides 
(1.2, 1.4, and 1.6) in good to excellent yields (74 – 99%).  
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1.3 Synthesis of main-chain organometallic polymers 
As shown in Scheme 1.2, polymerization and metal incorporation was carried out 
via a modified Herrmann-Schwarz-Gardiner method8 by treatment of bis(imidazolium) 
bromides 1.2, 1.4, or 1.6with Pd(OAc)2 in DMSO at 110 °C. After one hour, the reaction 
solutions were precipitated into an excess of MeOH or H2O which afforded polymers 1.7 
– 1.9 in high yields (84 – 99%). As expected, signals in the 1H NMR spectra were 
relatively broad and shifted upfield in comparison with their respective bis(imidazolium) 
salt precursors. 13C NMR spectroscopy was used to verify Pd was successfully 
incorporated into the backbones of the polymer chains. For example, the 13C NMR 
spectrum of 1.8a exhibited a resonance at 172 ppm which was diagnostic of an imidazol-
2-ylidene-Pd bond.4,9 As summarized in Table 1, absorption maxima for the polymer 
systems were clustered around 320 nm and molar absorptivities (normalized per repeat 
unit) as high as 8.4 × 104 M-1•cm-1 were observed. Analysis of the polymers by gel 
permeation chromatography10 (GPC) indicated their polydispersities were typical of step-
growth polymerizations with number-average molecular weights (Mns), ranging from 8.0 
x 103 – 1.1 x 105 Da, dependent on the N-substituent and the bis(imidazole) structure. 
Likewise, the thermal stabilities of the polymers exhibited similar dependencies and 







Scheme 1.2 Polymerization of bis(imidazolium) salts with Pd(II) and Pt(II) 
2 Br
1.8a R = Bn, M(II) = Pd(OAc)2, X = Br
1.8b R = Bu, M(II) = Pd(OAc)2, X = Br
1.7a R = Bn, M(II) = Pd(OAc)2, X = Br
1.7b R = Bu, M(II) = Pd(OAc)2, X = Br
1.7c R = Bn, M(II) = PtCl2/NaOAc, X = Cl
1.7d R = Bu, M(II) = PtCl2/NaOAc, X = Cl
1.9a R = Bn, M(II) = Pd(OAc)2, X = Br










































Copolymerization of 1.4a with PdCl2 in the presence of NaOAc (2.0 eqv) 
successfully produced a polymeric material with comparable molecular weight and yield 
as when prepared with Pd(OAc)2. No reaction was observed when 1.4a was treated with 
NaOAc in DMSO at 110 °C in the absence of metal. These results prompted us to explore 
the incorporation of other group 10 metals under similar reaction conditions. As shown in 
Scheme 1.2 and summarized in Table 1.1, copolymerizations of the bis(imidazolium) 
salts with PtCl2/NaOAc afforded materials with remarkably high molecular weights; for 
example, the Mn of 1.7c was found to be 1.8 × 106 Da. As with Pd, molecular weights 
were found to be dependent on the organic moiety, however the transition metal 
obviously played a dominant role. Unfortunately, no polymeric materials were obtained 
with Ni(OAc)2•4H2O, which may reflect the reduced affinity of NHCs for Ni.11 
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Table 1.1. Physical characteristics of polymers 1.7 – 1.9 
Polymer Yield (%)a Mn (kDa)
b Mw /Mn Td (°C)
c λmax (nm)
e Log(ε)e,f
1.7a 90 18.4 1.9 291 316 4.72
1.7b 84 103 1.8 d 314 4.72
1.7c 99 1760 1.3 294 329 4.45
1.7d 76 766 1.7 295 322 4.51
1.8a 85 26.1 2.0 284 308 4.80
1.8b 84 8.00 1.4 d 308 4.93
1.9a 98 106 1.5 299 323 4.63
1.9b 93 408 2.6 d 329 4.92  aIsolated yield. bDetermined by GPC relative to polystyrene standards in DMF. cThe 
decomposition temperature (Td) is defined as the temperature at which 10% weight loss 
occurs determined by thermogravimetric analysis under N2, rate = 10 ºC/min. dNot 
determined. eDetermined in DMF under ambient conditions. f Per repeat unit. 
 
1.4 Metal-center coordination and structural dynamicity 
 Since the metal centers in the main-chain of the polymers are coordinatively 
unsaturated, we envisioned altering the physical properties of the macromolecules via a 
post-polymerization modification.12 For example, treatment of 1.8a, which is virtually 
insoluble in THF, with two equivalents of PCy3 or PPh3 resulted in rapid dissolution. 
GPC and 1H NMR analysis of the phosphine-bound polymer confirmed the 
macromolecular structure was not compromised. Phosphine ligation to Pd was confirmed 
by 31P NMR spectroscopy (δ = 25 ppm).13  
As bulk properties of polymeric materials are intimately related to molecular 
weight, methods for its precise control are essential for tailoring or fine-tuning physical 
characteristics.14 Chain transfer agents (CTAs) have been used extensively to control 
molecular weights of polymers obtained from equilibrium polymerizations.15 Since 
coordination of NHCs to group 10 metals is dynamic,16 inclusion of monofunctional 
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NHCs as CTAs during these polymerizations should provide an effective handle for 
controlling molecular weight. As shown in Scheme 1.3, copolymerization of 1.4b with 
Pd(OAc)2 in the presence of various amounts of N,N′-dibenzylbenzimidazolium bromide 
(1.10)17 provided the corresponding end-functionalized polymers 1.11. Integration of the 
benzyl end-groups (PhCH2- δ = 6.2 ppm) with respect to the butyl groups (ArNCH2- δ = 
4.8 ppm) along the polymeric backbone indicated the molecular weights of the polymers 
were in excellent agreement with their theoretical values based on complete incorporation 
of the CTA (Table 1.2). 
 



































Table 1.2 Experimental and theoretical molecular weight data for 11 
Polymer Xn, theo
a Xn,NMR
b Mn , NMR (kDa)
b Mn ,GPC (kDa)
c
1.11a 10 8.9 6.4 4.8
1.11b 20 23 17 8.5
1.11c 40 47 34 11  aTheoretical number average of monomer units per polymer chain given by 
2[1.4b]o/[1.10]o. bDetermined by 1H NMR spectroscopy. cDetermined by GPC relative to 






In conclusion, we have developed a highly efficient route to a new class of 
organometallic polymers with metal centers linked together via conjugated, difunctional 
NHCs. The polymerizations did not require anhydrous conditions or inert atmospheres 
and the entire process, from commercial materials to polymeric products, was 
accomplished in three simple manipulations with minimal technical difficulty. The 
physical properties of the polymers were found to be dependent on both the transition 
metal and the modular structural characteristics of the NHC, and could be further 
modified through post-polymerization ligation. Control over both molecular weight and 
end-groups was also demonstrated through the inclusion of chain transfer agents during 
polymerization. Combined with the ability to prepare polymers with high molecular 
weights, these modular building blocks should open new opportunities in polymer 
synthesis, conductive polymers, non-linear optics, and electronic devices. Full 
investigation of the electronic and physical characteristics of the polymers presented 
herein will be reported in due course. 
 
1.6  Experimental Section 
General Considerations: 1H and 13C NMR spectra were recorded using a Varian 
Unity Plus 300 or 400 spectrometer. Chemical shifts (δ) are expressed in ppm downfield 
from tetramethylsilane using the residual protonated solvent as an internal standard 
(DMSO-d6, 1H 2.49 ppm and 13C 39.5 ppm). Coupling constants are expressed in hertz. 
HRMS (ESI, CI) were obtained with a VG analytical ZAB2-E instrument. UV-vis spectra 
were recorded using a Perkin Elmer Instruments Lambda 35 spectrometer. GPC data was 
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recorded using an Agilent 1100 HPLC with an Agilent PLgel 5 μm MIXED-C column. 
Molecular weight data is reported relative to polystyrene standards in DMF. Tds were 
determined using a TA Instruments TGA-Q500 under nitrogen atmosphere. PhCH3 was 
distilled from CaH2 or sodium and benzophenone under N2 atmosphere prior to use. DMF 
was used from a solvent purification column under an atmosphere of argon. DMSO for 
polymerization reactions was of reagent quality and used as obtained from commercial 
sources. 
General Procedure for formation of bis(imidazole)s via condensation of 
tetraamino arenes with formic acid: A round bottom flask was charged with a magnetic 
stir bar and the tetraamine. Formic acid (88-99%) was added and the flask was fitted with 
an air-jacketed condenser. The reaction mixture was placed in an oil bath at 100 – 110 °C 
for 2-36 h. The reaction mixture was then allowed to cool, poured into ice-cold water 
(equal volume to formic acid) and neutralized with 10% NaOH solution or saturated 
K2CO3 solution. Neutralization caused precipitation of the product which was collected 
via vacuum filtration, rinsed with cold water, and dried under vacuum over P2O5.  
 
Benzo-bis(imidazole): 1,2,4,5-Benzenetetraamine tetrahydrochloride 1.1 (284 mg, 1.00 
mmol) was treated with formic acid (10 mL) for 36 h according to the General Procedure 
to provide 152 mg (96%) of the desired product as a brown solid: mp > 300  °C; 1H NMR 
(400 MHz, DMSO-d6) δ 8.16 (s, 2H), 7.67 (s, 2H); 13C NMR (100 MHz, DMSO-d6) δ 
142.5, 135.6, 99.2; HRMS m/z calcd for C8H7N4 [M+H+] 159.0671, found 159.0665. 
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3,3’-bibenzimidazole: 3,3’-diaminobenzidine 1.3 (4.71 g, 21.98 mmol) was treated with 
formic acid (25 mL) for 2 h according to the General Procedure to provide 4.92 g (96%) 
of the desired product as a tan powder. mp 262-267 °C (dec); 1H NMR (400 MHz, 
DMSO-d6) δ 8.23 (s, 2H), 7.82 (d, J = 1.1 Hz, 2H), 7.65 (d, J = 8.3 Hz, 2H), 7.51 (dd, J = 
8.3, 1.1 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ 143.0, 138.7, 137.9, 135.9, 122.0, 
116.1, 113.5; HRMS m/z calcd for C14H11N4 [M+H+] 235.0984, found 235.0985. 
 
Dioxin-bis(imidazole): Dioxin-2,3,7,8-tetraamine tetrahydrochloride (1.5) (525 mg, 1.35 
mmol) was treated with formic acid (15 mL) according to the General Procedure 
(complete dissolution was not achieved, and the reaction mixture remained a suspension) 
to provide 303 mg (85%) of the desired product as a tan powder:  mp >300 °C (dec); 1H 
NMR (400 MHz, DMSO-d6) δ 8.13 (s, 2H), 8.11 (s, 2H), 7.21 (s, 4H); 13C NMR (100 
MHz, DMSO-d6) δ 163.2, 142.7, 138.4, 101.8; HRMS m/z calcd for C14H9N4O2 [M+H+] 
265.0726, found 265.0725. 
 
 Tetrabenzyl benzo-bis(imidazolium) bromide (1.2a): To a solution of NaH (298 mg, 
60 wt %, 7.46 mmol) in PhCH3 (30 mL) was added the corresponding bis(imidazole) 
(576 mg, 3.64 mmol) under dry nitrogen. The solution was heated to 110 °C for 1 h, 
allowed to cool to ambient, and benzylbromide (2.61 mL, 21.84 mmol) was added via 
syringe. The suspension was placed in an oil bath at 110 °C for 1 h, then dry DMF (30 
mL) was added via syringe and the reaction was maintained at 110 °C for 6 h, then 60 °C 
for 4 h. Upon completion, the suspension was allowed to cool, diluted with PhCH3 (50 
mL) and the solids were collected by vacuum filtration, rinsed with water and THF 
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successively, and dried under vacuum over P2O5 to give 2.42 g (98%) as a tan powder: 
mp  280-282 °C (dec); 1H NMR (400 MHz, DMSO-d6) δ 10.54 (s, 2H), 8.93 (s, 2H), 
7.60-7.58 (m, 8H), 7.39-7.34 (m, 12H), 5.87 (s, 8H); 13C NMR (100 MHz, DMSO-d6) δ 
146.1, 133.4, 129.9, 128.9, 128.8, 128.6, 99.8, 50.5; HRMS m/z calcd for C36H31N4 [M-
H+] 519.2549, found 519.2543. 
 
Tetrabutyl benzo-bis(imidazolium) bromide (1.2b): It should be noted that 2b is H2O-
soluble. To a solution of NaH (415 mg, 60 wt %, 10.37 mmol) in PhCH3 (20 mL) was 
added the corresponding bis(imidazole) (800 mg, 5.06 mmol) under argon and the 
resulting suspension was placed in an oil bath at 110 °C for 1 h. To the cooled suspension 
was added 1-bromobutane (3.26 mL, 30.36 mmol) via syringe and the mixture was 
heated at 110 °C for 1 h, then dry DMF (20 mL) was added via syringe and the mixture 
was stirred at 110 °C for 8 h, then 60 °C for 4 h. The cooled reaction mixture was then 
concentrated under vacuum and the residue taken up in 1:1 CH2Cl2/MeOH and the 
insoluble NaBr was removed via filtration. To the filtrate was added EtOAc until 
precipitation of the product occurred. The solids were collected via vacuum filtration and 
dried under vacuum to provide 2.66 g (97%) of the product as a tan powder: mp 194-198 
°C (dec); 1H NMR (300 MHz, DMSO-d6)  δ 10.25 (s, 2H), 9.11 (s, 2H), 4.62 (t, J = 7.4 
Hz, 8H), 1.97 (p, J = 7.4 Hz, 8 H), 1.38 (sext, J = 7.4 Hz, 8H), 0.93 (t, J = 7.4 Hz, 12H); 
13C NMR (75 MHz, DMSO-d6) δ 145.5, 130.2, 99.3, 47.1, 30.4, 19.1, 13.5; HRMS m/z 
calcd for C24H39N4 [M-H+] 383.3175, found 383.3180. 
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Tetrabenzyl bis(benzimidazolium) bromide (1.4a): In a manner analogous to 1.2a, 
3.05 g (98%) of compound 1.4a was obtained as a tan solid: mp 179-183 °C (dec); 1H 
NMR (400 MHz, DMSO-d6) δ 10.29 (s, 2H), 8.67 (s, 2H), 8.1 (d, J = 8.8 Hz, 2H), 8.04 
(d, J = 8.8 Hz, 2H), 7.66 (d, J = 7.2 Hz, 4H), 7.57 (d, J = 7.2 Hz, 4H) 6.00 (s, 4H), 5.87; 
13C NMR (100 MHz, DMSO-d6) δ 143.5, 137.7, 134.1, 134.0, 131.9, 130.8, 129.01, 
128.97, 128.7, 128.5, 128.3, 126.5, 114.7, 112.9, 50.1, 50.0; HRMS m/z calcd for 
C42H35N4 [M-H+] 595.2862, found 595.2858. 
 
Tetrabutyl bis(benzimidazolium) bromide (1.4b): It should be noted that 1.4b is H2O-
soluble. In a manner analogous to 1.2b, 1.96 g (74%) of compound 4b was obtained as a 
tan solid: mp 248-255  °C (dec); 1H NMR (400 MHz, DMSO-d6) δ 10.05 (s, 2H), 8.71 (s, 
2H), 8.28 (d, J = 8.7 Hz, 2H), 8.2 (dd, J = 8.7, 1.4 Hz, 2H), 4.66 (t, J = 7.2 Hz, 4H), 4.57 
(t, J = 7.2 Hz, 4H), 1.97-1.90 (m, 8H), 1.41-1.32 (m, 8H), 0.93 (t, J = 7.2 Hz, 12H); 13C 
NMR (100 MHz, DMSO-d6) δ 142.9, 137.5, 132.0, 130.9, 126.3, 114.3, 112.6, 46.6, 
34.2, 30.67, 30.65, 19.09, 19.07, 13.5, 13.4; HRMS m/z calcd for C30H45N4 [M+H+] 
461.3644, found 461.3643. 
 
Tetrabenzyl dioxin-bis(imidazolium) bromide (1.6): In a manner analogous to 1.2a, 
707 mg (90%) of the compound 6 was obtained as a yellow-tan powder: mp 252-258 °C 
(dec); 1H NMR (400 MHz, DMSO-d6) δ 10.09 (s, 2H), 7.77 (s, 4H), 7.56-7.55 (m, 8H), 
7.44-7.38 (m, 12H), 5.73 (s, 8H); 13C NMR (100 MHz, DMSO-d6) δ 142.8, 140.7, 133.8, 
129.0, 128.8, 128.4, 127.4, 101.2, 50.1; HRMS m/z calcd for C42H33N4O2 [M-H+] 
625.2604, found 625.2601. 
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Typical procedure for polymerization: Polymerizations were conducted on 0.1-2.0 g 
scale. Bis(imidazolium) bromide (1.0 equiv) was dissolved in DMSO (ca. 0.1-0.2 M) and 
either M(II)(OAc)2 (1.0 equiv), or a combination of M(II)Cl2 (1.0 equiv) and NaOAc (2.0 
equiv), was added in one portion. The solution was placed in a preheated oil bath at 110 
°C and stirred open-air for 1-5 h. The reaction mixtures typically darkened in color (to 
orange-brown) as the reaction progressed. The cooled reaction mixture was precipitated 
into either MeOH or H2O and the solids were collected via vacuum filtration and dried 
under vacuum. 
 
1.7a: Light brown solid. 1H NMR (400 MHz, DMSO-d6) δ 7.80-6.80 (m, 22H), 6.40-5.41 
(m, 8H); Td = 291 °C; Mn = 18.4 kDa; PDI = 1.9. 
 
1.7b: Tan solid. 1H NMR (400 MHz, DMSO-d6) δ 8.20-8.04 (m, 2H), 4.95-4.76 (m, 8H), 
2.18-2.10 (m, 8H), 1.48-1.40 (m, 8H), 1.01-0.92 (m, 12H); Mn = 103 kDa; PDI = 1.8. 
 
1.7c: Tan solid. 1H NMR (400 MHz, DMSO-d6) δ 7.60-6.45 (m, 26H), 6.40-5.20 (m, 
8H); Td = 294 °C; Mn = 1760 kDa; PDI = 1.3. 
 
1.7d: Tan powder. 1H NMR (400 MHz, DMSO-d6) δ 8.18 (br s, 2H), 4.91-4.55 (m, 8H), 




1.8a: Light green powder. 1H NMR (400 MHz, DMSO-d6) δ 7.62 (br s, 7H), 7.40-6.90 
(m, 19H), 6.13 (br s, 4H), 6.07 (br s, 4H); Td = 284 °C; Mn = 26.1 kDa; PDI = 2.0. 
 
1.8b: Yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 7.97-7.92 (m, 2H), 7.77-7.60 (m, 
4H), 4.83-4.54 (m, 8H), 2.18-2.14 (m, 8H), 1.50 (br s, 8H), 0.99 (br s, 12H); Mn = 8.00 
kDa; PDI = 1.4. 
 
1.9a: Green powder. 1H NMR (400 MHz, DMSO-d6) δ 7.80-6.90 (m, 26H), 6.20-5.90 
(m, 8H); Td = 299 °C; Mn = 106 kDa; PDI = 1.5. 
 
1.9c: Tan powder. 1H NMR (400 MHz, DMSO-d6) δ 7.80-7.00 (m, 26H), 6.40-5.40 (m, 
8H); Mn = 408 kDa; PDI = 2.6. 
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Chapter 2: Synthesis and Study of Bidentate-Benzimidazolylidene-




Since the synthesis and isolation of the first stable, crystalline N-heterocyclic 
carbene (NHC) was disclosed2 by Arduengo in the early 1990s (2.1, Figure 2.1), the 
development of new functional organometallic complexes has witnessed tremendous 
growth.2,3 During this time, an impressively broad structural range of NHCs, and their 
complexes with various transition metals, have been studied and employed in a wide 
range of synthetic reactions.3 The electronic nature of NHC systems is important in both 
synthetic and materials chemistry, and quantum chemical studies have shown that 
annulation significantly impacts this aspect of NHCs.18 Experimentally, key advances 
with annulated NHCs have been made in the areas of benzimidazolylidenes19 (e.g., 2.220 
and 2.321), fused metallocenes (e.g., 2.4),22 extended annulated systems (e.g., 2.5),23 and 
heterocycle-fused24 NHCs (e.g., 2.625). Collectively, these compounds exhibit remarkable 
structural tunability and broad metal compatibility which often results in considerable 
performance enhancement in the respective metal-catalyzed reactions. Prime examples of 
such effects have been observed in Pd mediated carbon-carbon and carbon-heteroatom 






































2.4 2.5 2.6  
In contrast, relatively little attention has been directed toward using NHCs as a 
means to construct organometallic polymeric materials.1 Considering the large amount of 
synthetic and functional diversity inherent to NHCs coupled with their high affinity 
toward a wide range of transition metals, they are ideally suited for this purpose. 
However, to obtain polymeric materials, access to multitopic NHCs capable of binding at 
least two transition metals with high fidelity is essential. Although many di-, tri-, and 
multitopic NHC-based ligands are known,8,27 they are often poised (and designed) to 
preferentially bind to one metal center in a chelating or pincer-type fashion. Notable 
exceptions (Figure 2.2) include systems from Herrmann (2.7),28 Youngs (2.8),29 and Lee 
(2.9)4a who have each shown that some pincer-type bis(carbene)s form bimetallic 
structures (with 1:1 NHC/metal stoichiometry). In particular, with Ag(I) salts, materials 
could be obtained that were polymeric in the solid-state. However, dissolution of these 
materials affords the respective discrete bimetallic complexes. In a related example, 
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Bertrand30 reported that non-chelating bis(carbene)s based on dialkylated 1,2,4-triazoles 
(2.10) also afforded solid-state polymers with Ag(I) salts. These results suggested that 
tuning the NHC-metal interaction in corresponding organometallic polymers may 
ultimately lead to new advances in responsive materials, analogous to those of Craig31 
and Rowan.32 
 
Figure 2.2 Representative examples of NHC-based bimetallic complexes and related 
solid-state polymers 
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One limitation of our initial approach to metal-containing polymers was that the 
range of compatible transition metals was confined to Pd(II) and Pt(II) salts (see Chapter 
1). Use of other metals (e.g., Ni) resulted in labile polymeric materials that rapidly 
underwent solvolysis in the presence of protic media (e.g., H2O and MeOH). To increase 
control over material, physical, and electronic properties, we desired a method for 
overcoming this constraint and expanding the scope of compliant transition metals in 
NHC-based organometallic polymers. This required the design and synthesis of a new 
ditopic NHC-based monomer that was appropriately functionalized to exhibit enhanced 
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affinities toward transition metals. In addition, we sought a design that was flexible and 
would not compromise the ability to independently tune other characteristics of the 
resulting polymeric materials (e.g., solubilities, electronics, etc.)  
An exemplary strategy for enhancing the chemical stability of metal-NHC 
interactions is to incorporate a bidentate, or chelating, scaffold into the NHC architecture. 
For example, enhanced stability of a Cu-NHC complex was demonstrated in Hoveyda’s33 
use of imidazolylidene ligands containing N-aryloxy units. Similarly, Grubbs34 utilized 
N-(2-hydroxyphenyl) substituted imidazolium salts to complex to Pd(II) species in a 
chelating-type fashion. While many other examples of mixed multidentate carbene 
ligands built on various types of imidazole-based frameworks are known,35 related 
bidentate benzimidazolylidenes have received considerably less attention. Key examples 
are depicted in Figure 2.3 and include Ir-based complexes using chelating olefinic groups 
(2.11),36 Pd-pincer complexes comprised of a difunctional pyridine bridge (2.12),37 and a 
Ru-containing complex that exhibits intramolecular chelation through metallocene 
formation (2.13).38 For the purpose of forming macromolecular materials suitable for use 
in electronic applications, benzannulated systems are particularly attractive since the 
arene linkers maintain formal conjugation within the corresponding main-chains of the 
polymeric materials and should permit electronic tuning through further derivatization.21 
However, incorporation of chelating groups into multitopic, annulated frameworks 





























2.11 2.12 2.13  
 
The formation of main-chain polymers with transition metals that prefer four 
coordinate geometries, e.g, Ni(II), requires a ditopic NHC ligand where each carbene 
“face” of the monomer is desymmetrized39 to contain only one chelating N-substituent. 
Installation of the appropriate (i.e., chelating) N-substituents in a regiospecific manner 
about the benzobis(imidazole) system, however, can be nontrivial. Aryl-amination, a 
method that has been successfully used for the synthesis of desymmetrized 
benzimidazolium compounds,19c is reluctant to give high yields of regioselective 
amination products when tetrahalobenzenes are used. Likewise, regioselective alkylation 
of benzobis(imidazole) would be expected to be challenged by similar difficulties. Thus, 
a new synthetic route to ditopic bis(bidentate) NHC systems was needed in order to 
facilitate formation of well-defined chelated metal centers at each terminus of the ditopic 
ligand. 
Synthetic methods used to prepare NHC-metal complexes typically utilize one of three 
strategies: 1) reaction of an azolium salt with an electrophilic metal species possessing 
basic counterions or coordinating anions,27d,40 2) generation of the free carbene followed 
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by introduction of an electrophilic metal species, or 3) formation of a Ag(I)-NHC 
complex followed by ligand transfer to the desired transition metal.41 While each of the 
aforementioned methods are excellent for constructing small-molecule systems, none 
seemed directly amenable to forming stable, high molecular weight polymers with metals 
other than Pd and Pt. Examples of specific challenges can be found by surveying known 
Ni-NHC complexes. For example, Herrmann demonstrated that imidazolylidene-Ni(II) 
complexes can be obtained directly from their respective imidazolium salts in 30% yield 
using Ni(OAc)2.42 While this was an outstanding synthetic achievement, this yield is too 
low for forming high polymer and the reaction must be conducted in the melt under 
vacuum using anhydrous reagents. Synthesis of benzimidazolylidene-based Ni complexes 
using this methodology was found to be challenged by the fact that the resulting 
complexes decompose at the high reaction temperatures required (150 °C).19a Recently, 
Hahn accomplished the first synthesis of benzimidazolylidene-Ni(II) complexes19a using 
an elegant adaptation of Herrmann’s procedure. By combining benzimidazolium salts 
with tetrabutylammonium salts at elevated temperatures under vacuum, the ammonium 
salts were melted to give an ionic liquid solvent system. This ultimately allowed for 
reduced reaction temperatures (120 °C) and afforded the desired Ni complexes in 28 – 
60% yield. Since reaction yields of >95% are typically necessary to obtain high 
molecular weight polymer,43 and mild polymerization reaction conditions are desirable, 
the development of a new protocol for forming benzimidazolylidene-transition metal 
complexes was needed. 
Considering alternatives to direct metallation of azolium salts, free carbene 
generation is compatible with essentially all transition metals known to form complexes 
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with NHCs. Caveats of this approach, however, include a two-step procedure under an 
inert atmosphere and the use of dry solvents to avoid destruction of the free carbene. 
When carbene dimerization can occur, the resulting enetetraamines19d,44 are extremely 
sensitive toward oxygen and often subject to rearrangement or fragmentation, depending 
on the nature of the N-substituent.45 Although benzobis(imidazolylidene)s can be 
manipulated as either their free carbenes or respective homopolymers46 en route to 
bimetallics and metallo-polymers, this imposes limitations on compatible solvents. 
Furthermore, high molecular weight materials are generally precluded by limited 
solubilities in common organic solvents (e.g., THF, benzene, PhCH3, etc.) One method 
that has been employed with a diverse array of conditions, solvents, and substrates is 
Lin’s NHC-transfer method.33,41,47 However, disposal of stoichiometric Ag salts and 
confirmation of quantitative Ag exchange is not ideal for macromolecular applications.  
With these considerations in mind, we targeted a ligand design that alleviated the 
need for strict use of inert atmospheres and allowed access to stable NHC complexes via 
direct metallation of benzimidazolium salts in a single step and in high yields. Herein, we 
report our efforts to expand the range of transition metals that can be incorporated into 
NHC-based main-chain organometallic polymers via direct metallation of bis(azolium) 
salts bearing chelating N-(o-phenol) moieties. In particular, we aimed to increase the 
binding affinity within bis(NHC)-metal systems without compromising control over 
electronic properties. Our initial efforts focused on the synthesis and study of discrete 
complexes designed to mimick the repeating metal centers in their corresponding main-
chain polymers. Building from these results, we turned our attention toward designing 
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and deploying analogous ditopic systems that were prone to polymerize. The results of 
these investigations follow. 
  
2.2 Synthesis and characterization of bidentate-benzimidazolylidene-group 10 
metal complexes 
Prior to engaging in the synthesis of polymeric materials, we first investigated the 
propensity of a phenol-substituted benzimidazolium salt to undergo metallation and 
chelation with group 10 metal(II) species. This would provide insight into the chelation 
event and allow for characterization of model complexes representative of the repeat 
units of their respective polymer chains. Thus, a benzimidazolium salt containing a 
pendant N-(o-phenol) group was synthesized as shown in Scheme 2.1. Aryl amination of 
1-fluoro-2-nitrobenzene (2.14) with 2-aminophenol under basic conditions48 provided the 
respective diarylamine 2.15 in 92% yield.49 We envisioned that reduction of the nitro 
group followed by formylative cyclization of the resulting diamino intermediate could be 
accomplished using a “one-pot” protocol. This was successfully executed by using a 
mixture of NaO2CH/HO2CH in the presence of catalytic amounts of Pd/C which 
effectively hydrogenated the nitro group in situ. Within 1-2 h, the intense red-orange 
color associated with nitroarene 2.15 had dissipated indicating complete reduction had 
been accomplished. Continued heating (up to 10 h) ultimately provided the formylatively 
cyclized product 2.16, which was obtained after removal of Pd/C via filtration and 
neutralization of the filtrate with aqueous base.50 The crude benzimidazole was collected 
and alkylated with 1-bromobutane in CH3CN followed by removal of volatiles under 
vacuum to give benzimidazolium bromide 2.17. Due to the solubilizing butyl group, this 
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hydroscopic azolium salt was soluble in polar organic solvents (e.g., CH2Cl2, CHCl3, 
THF, CH3CN, and DMSO).  
 

























2.14 2.15 2.16 2.17  
 
With 2.17 in hand, we were poised to investigate the efficiency of metal 
complexation. Given that direct metallation of azolium salts with Pd(II) species is a well-
established protocol that gives rise to stable metal complexes, we targeted a chelated 
Pd(II) model system. Benzimidazolium salt 2.17 was thus treated with 0.5 equiv 
Pd(OAc)2 in THF at 50 °C for 2 h. Analysis of the crude product mixture by 1H NMR 
spectroscopy confirmed that no residual azolium species remained (diagnostic azolium 
1H signal: δ = 10.8 ppm in DMSO-d6). However, the phenol moieties did not appear to be 
chelated to the metal center as broad singlets were observed at δ = 10.0 and 9.9 ppm in 
the 1H NMR spectrum (solvent = DMSO-d6) and a strong signal was observed at 3331 
cm-1 in the IR spectrum of this complex. Mass spectral analysis supported a palladium 
dibromide species ligated by two NHC ligands consistent with structure (2.18·Pd) shown 
in Scheme 2.2. The methylene units of the butyl groups appeared in the 1H NMR 
spectrum as complex multiplets which, in combination with the observation of two 
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distinct hydroxyl signals, suggested that isomeric structures may be present in solution 
(e.g., relative syn and anti conformations may exist from possible cis and trans isomers). 
To investigate, X-ray quality crystals were obtained as light brown prisms by diffusion of 
hexanes into a THF solution of the product mixture. Although selected crystal data are 
summarized in Table 2.1, the ORTEP diagram shown in Figure 2.4 confirmed the non-
chelated structure of this complex. The crystallized product existed in a relative trans 
confirmation about the square-planar metal center (C1-Pd-C1* and C1-Pd-Br bond angles 
= 180.0 and 88.9°, respectively) with each butyl group experiencing a π-facial interaction 
with the phenol ring of the complementary NHC ligand (nearest interatomic distance: 
C11-C16, 3.97 Å). Most notably, the phenol rings were twisted nearly perpendicular to 
the plane of the benzimidazolylidene (average dihedral angle = 68°) with essentially no 
discernible interaction between either phenol oxygen and the Pd atom (avg. distance = 
3.99 Å). The complex exhibited a 13C resonance at δ = 181 ppm and a Pd-Ccarbene bond 
length of 2.02 Å, which were each consistent with other benzimidazolylidene-Pd(II) 
complexes.4b,23,51 The complex appeared to be stable to air and moisture, and 
thermogravimetric analysis (TGA) revealed a Td = 287 °C under an atmosphere of 
nitrogen. Finally, the complex showed good solubility in most polar organic solvents 






Scheme 2.2  Synthesis of model complexes 2.18·Pd and 2.19 (yields of 2.19 represent 


































2.19·Pt, 93%  
 
Figure 2.4  ORTEP diagram of the molecular structure of 2.18·Pd (selected bond 
lengths, angles, and crystal data are summarized in Table 2.1; ellipsoids are drawn at the 

















Table 2.1 Selected bond lengths, angles, and crystal data for 2.18·Pd and 2.19. 
2.18·Pd·2 DMSO 2.19·Pd·H2O 2.19·Ni 2.19·Pt·H2O
Bond Lengths (Å)
M-C1 2.024(3) 1.937(6) 1.839(2) 1.941(11)
N1-C1 1.353(4) 1.372(7) 1.367(2) 1.376(16)
M-X (O, Br, Cl) 2.4461(4) 2.044(4) 1.895(5) 2.040(8)
Angles (°)
N1-C1-N2 106.7(3) 105.6(5) 106.2(7) 106.6(9)
C1-M-C1* 180.00(18) 99.3(3) 94.5(3) 100.9(5)
C1-M-O1 -- 86.5(2) 88.3(9) 86.7(4)
C1-M-O1* -- 173.2(2) 168.9(6) 171.9(4)
C1-N1-C8-C9 110.3(4) -34.4(8) 26.7(3) -33.6(18)
Crystal Data
emperical formula C34H36Br2N4O2Pd·2(CH3)2SO C34H34N4O2Pd·H2O C34H34N4NiO2 C34H34N4O2Pt·H2O
formula weight 955.14 655.07 589.36 743.76
cryst syst monoclinic triclinic monoclinic triclinic
space group P21/c P-1 P21/n P-1
a , Å 9.5039(3) 12.4990(4) 12.8694(2) 12.5210(5)
b , Å 10.6594(4) 13.8210(5) 10.3815(2) 13.8700(6)
c, Å 20.8233(9) 18.5590(7) 21.7249(4) 18.6940(10)
α, deg 90 90.2940(15) 90 90.248(2)
β, deg 101.660(2) 102.5920(14) 96.904(1) 102.670(2)
γ, deg 90 99.4230(14) 90 99.0040(17)
V, Å3 2065.99(14) 3083.93(19) 2881.48(9) 3125.9(2)
T , K 153(2) 153(2) 233(2) 153(2)
Z 2 4 4 4
D calc, Mg/m
3 1.535 1.411 1.359 1.580
cryst size (mm) 0.22 × 0.21 × 0.17 0.20 × 0.06 × 0.05 0.20 × 0.16 × 0.12 0.14 × 0.13 × 0.05
reflections collected 7923 12704 13775 11823
independent reflections 4689 12706 13779 6579
R 1, wR 2 {I  > 2σ(I )} 0.0401, 0.0894 0.0683, 0.1011 0.0407, 0.0891 0.0654, 0.1355
goodness of fit 1.054 1.140 1.017 1.018  
 
To facilitate chelation, crystals of 2.18·Pd were redissolved in THF and treated 
with a methanolic solution of Na2CO3 for 1 h under ambient conditions. After aqueous 
workup, spectroscopic analysis of the product suggested successful chelation and clean 
formation of complex 2.19·Pd. Signals corresponding to hydroxyl groups were not 
observed in either the 1H NMR or IR spectrum of this complex. In contrast to 2.18·Pd, 
the 1H NMR spectrum of 2.19·Pd represented a single isomer with a NCH2 triplet at δ = 
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4.9 ppm. To confirm and study its molecular structure, X-ray quality crystals of 2.19·Pd 
were obtained as yellow laths by slow evaporation of a THF/hexanes solution of the 
complex. Surprisingly, the X-ray data (represented as an ORTEP diagram in Figure 2.5) 
revealed that the relative geometry about the metal center was now cis.52 The metal 
center remained square-planar as expected with C1-Pd-O1* and C1-Pd-C1* bond angles 
of 173.2 and 99.3°, respectively. The Pd-Ccarbene bond length (1.94 Å) was slightly shorter 
than those typically observed in benzimidazolylidene-Pd(II) complexes (1.97 – 2.02 
Å).23,51 It is important to note, however, that the majority of related benzimidazolylidene-
Pd(II) complexes contain Pd-halide bonds whereas 2.19·Pd contains Pd-O bonds; thus, 
different trans influences may be expected. In addition, chelation effects may also 
contribute to the relative shortening of the Pd-Ccarbene bond. The N-C-N bond angle 
(105.6°) and 13C NMR resonance at δ = 178 ppm were consistent with other known 
benzimidazolylidene-Pd(II) complexes.23,51 The slight upfield shift of the carbenoid 
signal (relative to 2.18·Pd, δ = 181 ppm) may reflect increased electron density at the 
metal center as a result of the Pd-O bonds. Interestingly, chelation appeared 
(qualitatively) to impart greater solubility (relative to 2.18·Pd) and complex 2.19·Pd 
readily dissolved in common organic solvents such as CH2Cl2, THF, CHCl3, MeOH, 






Figure 2.5 ORTEP diagram of the molecular structure of 2.19·Pd (selected bond 
lengths, angles, and crystal data are summarized in Table 2.1; ellipsoids are drawn at the 













It was desirable to have a “one-pot” complexation/chelation sequence to afford 
chelated complexes directly from benzimidazolium salt 2.17. This was accomplished by 
simply adding exogenous base during the metallation procedure. Thus, treatment of 
benzimidazolium salt 2.17 with Pd(OAc)2 and NaOAc provided the chelated complex 
2.19·Pd in 91% yield. Reactions were routinely conducted in DMSO or THF, however 
other polar organic solvents (e.g., EtOH, CH3CN, etc.) were also found to facilitate 
efficient complexation.53 The effects of chelation on thermal stability were probed using 
TGA. Complex 2.18·Pd exhibited a Td = 287 °C whereas complex 2.19·Pd exhibited a Td 
= 311 °C (both under nitrogen) (Figure 2.6). The 24 C° increase in decomposition 
temperature is believed to be predominately due to chelation effects. 
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Figure 2.6 TGA data for complexes 2.18·Pd (- - -) and 2.19·Pd (―) taken under 

























Having confirmed chelation, and enhanced thermal stability as a result of these 
extra intramolecular interactions, we investigated the susceptibility of other transition 
metals to undergo chelation to provide stable complexes. In particular, incorporation of 
Ni(II) would expand the relatively narrow scope of synthetic methodologies for accessing 
benzimidazolylidene-Ni(II) complexes. Thus, in analogy with the synthesis of 2.19·Pd, 
benzimidazolium salt 2.17 was reacted with 0.5 equiv of Ni(OAc)2·4H2O in the presence 
of NaOAc in DMSO at 80 °C. Gratifyingly, this provided the corresponding Ni complex 
2.19·Ni in excellent yield (95%). Attempts to isolate a ligated, non-chelated Ni-complex 
in analogy to 2.18·Pd were met with limited success which can likely be ascribed to a 
more favorable cyclization geometry and/or relative greater oxophilicity of Ni. Similar to 
the Pd-complex 2.19·Pd, 2.19·Ni was found to be stable toward air and moisture, and 
exhibited similar solubilities as well. The thermal stability of 2.19·Ni was investigated 
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through TGA and revealed a Td = 286 °C (under nitrogen) which reiterates the positive 
effects of chelation. Similar to the Pd analogue 2.19·Pd, the Ni-complex appeared to be 
stable indefinitely in solution and in the solid-state under ambient conditions, and could 
be purified by chromatography on neutral alumina.  
NMR, IR, and mass spectral analyses of 2.19·Ni supported formation of a 
chelated 2:1 ligand/metal complex. The 13C NMR was unremarkable and displayed a 
single NCN resonance at δ = 173 ppm, which was intermediate with known 
benzimidazolylidene (~184 ppm) and imidazolylidene (~164 - 170 ppm)35e,54 Ni(II) 
complexes. Interestingly, and in contrast to 2.19·Pd, the butyl groups in 2.19·Ni showed 
diastereotopic signals in the 1H NMR spectrum with some signals appearing markedly 
upfield in comparison with other NHC-Ni complexes.35,42 In particular, NCH2 resonances 
typically appear between δ = 4.5 and 6.5 ppm, depending on the nature of the alkyl 
groups. In 2.19·Ni however, the diastereotopic protons associated with the NCH2 
fragment appeared at δ = 4.2 and 3.6 ppm. One plausible explanation for the observed 
diastereotopicity in the 1H NMR spectrum can be drawn from the X-ray data (see below) 
which revealed a π-facial interaction between each butyl group and the 
benzimidazolylidene moiety of its complementary ligand. Although this arrangement is 
superficially similar to that of 2.19·Pd, the distances between the methylene units and the 
complementary benzimidazolylidene moiety in 2.19·Ni are shorter than in the Pd 
analogue. For example, the interatomic distance between the NCH2 carbon and the 
nearest atom of the complimentary benzimidazolylidene moiety (i.e., C1) in 2.19·Ni is 
3.20 Å. The same interatomic measurement in 2.19·Pd is 3.54 Å.  
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Quality crystals suitable for X-ray diffraction analysis were obtained as yellow 
plates by slow diffusion of hexanes into a saturated THF solution of 2.19·Ni. As shown in 
the ORTEP diagram in Figure 2.7, the molecular structure of 2.19·Ni revealed that the 
complex adopted a cis geometry about the metal center, which to the best of our 
knowledge is the first Ni complex comprised of two benzimidazolylidenes of this relative 
configuration. The metal center displayed a distorted square-planar arrangement with C1-
Ni-C1*, C1-Ni-O1 (cis), and O1-Ni-O1* bond angles of 94.5, 89.0, and 90.5°, 
respectively. Analogous to the Pd-complex, the Ni-Ccarbene bond lengths were shortened 
(1.84 Å) relative to known bis(benzimidazolylidene)-Ni(II) halide complexes (1.89 – 
1.91 Å), again likely due to chelation in conjunction with trans effects. The N-C-N bond 
angles of complex 2.19·Ni (106.2°) were as expected for azolylidene-Ni(II) complexes.42  
 
Figure 2.7 ORTEP diagram of the molecular structure of 2.19·Ni (selected bond 
lengths, angles, and crystal data are summarized in Table 2.1; ellipsoids are drawn at the 
50% probability level, hydrogen atoms and solvent molecules have been removed for 
clarity). 
 

















To complete the series of group 10 model systems, we targeted Pt-based complex 
2.19·Pt (Scheme 2.2). Chelation to form 2.19·Pt required additional reaction periods at 
elevated temperatures, relative to its Ni- and Pd-analogues, which may ascribed to the 
reduced oxophilicity of Pt. More specifically, whereas chelation from 2.18·Pd could be 
completed within 1 h using Na2CO3 at room temperature, complete formation of 2.19·Pt 
(monitored by 1H NMR spectroscopy) in the presence of Na2CO3 in DMSO required 8 h 
at 80 °C (up to 24 h when NaOAc was used in lieu of Na2CO3).55 Upon completion, the 
desired Pt complex was isolated as a single isomer in 93% yield. Full chelation was 
confirmed through IR and NMR spectroscopy, as well as mass spectral analysis, and 
solubilities resembled those of the Ni- and Pd-analogues. Although the solid-state 
structure (see below) was isostructural with 2.19·Pd, the 1H NMR spectrum more closely 
resembled the Ni analogue with regard to chemical shifts and splitting patterns for the 
butyl groups. Specifically, diastereotopic NCH2 resonances appeared at δ = 4.0 and 3.8 
ppm in the 1H NMR spectrum of 2.19·Pt. The 13C NMR spectrum of this same complex 
showed resonances at δ = 161 and 158 ppm, either of which could reasonably be assigned 
to the carbene NCN signal.56 Considering that there are very few benzimidazolylidene-
Pt(II) complexes known,19b,57 and that the range NCN 13C NMR resonances of known 
imidazolylidene- and imidazolinylidene-Pt(II) complexes varies from 143 – 191 ppm,58 
full assignment of the 13C signals in 2.19·Pt cannot be made at this time. To confirm and 
study the structure of 2.19·Pt, X-ray quality crystals were obtained as colorless plates by 
slow evaporation of a THF solution of the complex. An ORTEP diagram of the molecular 
structure of 2.19·Pt is shown in Figure 2.8. Although N-C-N bond angle (106.7°) was 
consistent with other Pt(II)-based azolylidene complexes, the Pt-Ccarbene bond length 
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(1.94 Å) was shorter than typically observed (1.96 – 2.04 Å).19b,57-59 Similar to chelated 
complexes 2.19·Pd and 2.19·Ni, the Pt-analogue showed a Td of 314 °C by TGA.  
 
Figure 2.8 ORTEP diagram of the molecular structure of 2.19·Pt (selected bond 
lengths, angles, and crystal data are summarized in Table 2.1; ellipsoids are drawn at the 












Overall, the model systems provide a comprehensive view of chelation effects in 
group 10 metals and key characterization data are summarized in Table 2.2. Chelation 
from the phenol moieties was qualitatively observed to be progressively slower from Ni 
to Pd to Pt, a reflection of their relative oxophiliticities. The respective metal-Ccarbene 
bond lengths were generally shorter in complexes 2.19 when compared to known 
azolylidene complexes with the same metal(II) species. Chelation resulted in a change in 
the geometry of the metal center from trans (2.18·Pd) to cis (2.19·Pd), as well as 
increased thermal stability as determined using TGA. Interestingly, the cis conformation 
observed for each model system resulted in C2-symmetric planar chiral complexes. 
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Although the crystals formed as racemates, separation of these enantiomers may 
ultimately open new avenues to optically active metal species with potential application 
in asymmetric catalysis. 
 
Table 2.2 Key characterization data for complexes 2.18·Pd and 2.19 
Complex Yield (%)a Td (°C)
b λmax (nm)
c δ NC N (ppm)
2.18·Pd 93 287 285 181
2.19·Pd 91 311 315 178
2.19·Ni 95 286 359 173
2.19·Pt 93 314 314 161 or 158d  aIsolated yields based on 2.17. bThe decomposition temperature (Td) is defined as the 
temperature at which 10% weight loss occurs, as determined by thermogravimetric 
analysis under N2 with a rate = 10 °C/min. cDetermined in DMF under ambient 
conditions. dSee discussion in the text. 
 
 
2.3 Synthesis and characterization of bidentate-benzimidazolylidene-group 10 
main-chain organometallic polymers 
Having confirmed chelation and proof of structure in each of the group 10 model 
complexes, we turned our attention toward synthesizing main-chain organometallic 
polymers containing chelating benzimidazolylidenes. Considering that 
benzobis(imidazolylidene)s have a high propensity to form metal adducts at each carbene 
moiety of the ditopic ligand, installation of a single chelating N-substituent on each 
imidazole moiety should provide a monomer capable of forming chelated metal centers at 
each terminus. As shown in Scheme 2.3, the corresponding ditopic bis(bidentate) 
benzobis(imidazolium) monomer was synthesized by the same general reaction sequence 
that was used for the synthesis of 2.17: SNAr, reduction/cyclization, and alkylation. In 
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particular, treatment of readily available 1,5-dichloro-2,4-dinitrobenzene 2.20 with 2-
aminophenol (4.0 equiv) in refluxing EtOH provided 1,5-bis[(2-hydroxyphenyl)amino]-
2,4-dinitrobenzene 2.21 in nearly quantitative yield. The in situ reductive cyclization 
protocol described above was successfully applied to 2.21 and provided 
benzobis(imidazole) 2.22 in 85% yield. Finally, alkylation with 1-bromobutane provided 
bis(azolium) dibromide 2.23 in 93% yield (78% overall yield from 2.21).  
 

































As shown in Scheme 2.4, polymerizations were conducted using the conditions 
optimized for the synthesis of model complexes 2.19. Combining a stoichiometric 
amount of metal salt60 with 2.23 and NaOAc61 in DMSO at 80 °C gave polymers 
2.24·Pd, 2.24·Ni and 2.24·Pt in 99, 95, and 96% yields, respectively.62 The Pd- and Pt-
based systems 2.24·Pd and 2.24·Pt were tan powders whereas the Ni-based polymer 
2.24·Ni was a dark brown powder. Each of the polymers noted above were characterized 
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by IR spectroscopy, NMR spectroscopy, gel permeation chromatography (GPC), UV-Vis 
spectroscopy, and TGA; key information is summarized in Table 2.3. 
 



















The availability of non-chelated complex 2.18·Pd allowed for direct comparison 
of IR spectra obtained for the corresponding chelated monomer (2.19·Pd) and its 
respective polymer (2.24·Pd) (Figure 2.9). It was clear that the signal corresponding to 
the OH stretching frequency at approximately 3330 cm-1 was absent in both (small 
molecule and polymeric) chelated systems. Similar spectra were observed for polymers 
2.24·Ni and 2.24·Pt, which also supported chelated structures. This was further supported 
by 1H NMR spectroscopy as polymers 2.24 did not show any signals indicative of free 
phenol hydroxyl groups (e.g., δ ~ 10 ppm in DMSO-d6). In general, the 1H NMR spectra 
of the polymers 2.24 were broadened and shifted upfield relative to their respective 
monomer 2.23. The 1H NMR signals corresponding to the butyl groups in 2.24 were 
suggestive of diastereotopic signals for each of the metals used. Specifically, the NCH2 
signals were broad multiplets appearing between 4.1 and 5.0 ppm. Considering the NMR 
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data in combination with the rapid and exclusive formation of cis isomers in the model 
systems (2.19), the metal centers in 2.24 are assumed to be of high cis content. 
 






















Polymer 2.24·Ni was only slightly soluble in common polar solvents (e.g., 
DMSO, DMF, and NMP) which manifested in low molecular weight material as 
determined by GPC (Mn = 7.68 kDa, relative to polystyrene standards). The 
polydispersity of this polymer was also extraordinarily narrow (PDI = 1.09) which was 
believed to be due to selective fractionation of insoluble high molecular weight material. 
In contrast, the Pd- and Pt-based polymers 2.24 were highly soluble in polar solvents and 
afforded polymers with Mns of 67.5 and 363 kDa, respectively. The polydispersity 
indices (PDIs) of these materials were 1.6 and 2.2, respectively and typical of step-
growth polymerizations, as expected. Qualitatively, each of the polymers (2.24·Pd, 
2.24·Ni and 2.24·Pt) were found to be stable toward water and oxygen as no signs of 
degradation (as determined by 1H NMR spectroscopy and GPC analysis) were observed 
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upon prolonged standing in wet, aerated solvents. Quantitative thermal gravimetric 
analysis of polymers 2.24 indicated that their Tds ranged from 340 to 362 °C. This 
represented a 50 – 80 C° increase in thermal stability in comparison with their analogous 
organometallic polymers containing (non-chelating) N-alkyl substituents (e.g., 1.7, 1.8, 
and 1.9).  
 
Table 2.3 Physical characterization and absorption maxima of polymers 2.24 
Metal Yield (%)a Mn (kDa)
b Mw /Mn Td (°C)
c λmax (nm)
d
Pd 99 67.5 2.20 342 312
Ni 96 7.68e 1.09e 362 322
Pt 95 363 1.59 340 316, 372 (sh)  aIsolated yields. bDetermined by GPC relative to polystyrene standards in DMF with 0.01 
M LiBr at 40 °C. cThe decomposition temperature (Td) is defined as the temperature at 
which 10% weight loss occurs, as determined by thermogravimetric analysis under N2 
with a rate = 10 °C/min. dDetermined in DMF under ambient conditions. ePoor solubility 
of 28·Ni resulted in fractionation. 
 
After model metal complexes 2.19 and their respective polymers 2.24 were 
synthesized, it was possible to independently study and compare the electronic effects 
resulting from chelation as well as polymerization using UV/Vis spectroscopy (Figure 
2.10). The effects of chelation on the overall electronic properties were investigated by 
comparing non-chelated 2.18·Pd with chelated analogue 2.19·Pd (Figure 2.10A). The 
two spectra nearly overlap which suggested that chelation had minimal impact on the 
electronic characteristics of the chromophore. Ultimately, this may provide a general 
means to adjust physical characteristics of NHC-based metal complexes without 
compromising control over their electronic properties. Additional support was obtained 
after analyzing polymers 2.24·Pd (λmax = 312 nm) values and 2.24·Pt (λmax = 316 nm); 
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these polymer exhibit λmax values  in the same range as similar Pd- and Pt-based polymer 
that do not contain chelating N-substituents (λmax values from 314 – 329 nm).  
To determine if delocalization occurred along the main-chain of polymers 2.24, 
we compared each model complex with its corresponding polymer (Figure 2.10B-C). In 
general, the λmax values of the polymers were bathochromically shifted from their 
respective model complexes. In particular, Pd- and Pt-based polymers were red-shifted 
27 and 26 nm when compared to 2.19·Pd (Figure 2.11B) and 2.19·Pt (Figure 2.10C), 
respectively. In contrast, polymer 2.24·Ni was red-shifted by only 3 nm relative to model 
complex 2.19·Ni, which may be partially explained by fractionation and detection of only 
low-molecular weight material (see above). The Ni polymer does, however, show 
increased relative absorption intensities at longer wavelengths (> 335 nm) in comparison 
with the model system. The electronic fine structures of polymers 2.24 were also in good 
agreement with those of model complexes 2.19, as concluded by comparing the 
topologies of the corresponding spectra. For example, vibronic contributions in the Ni-
based systems were manifested in two distinguishable local maxima (Figure 2.10C) 
between 300 and 325 nm. 
The general order of absorption maxima for both the models and polymers was 
found to be: Ni > Pt ~ Pd. The increased electronic communication between the NHC 
moiety and the Ni(II) center may be due to the lower electronegativity of Ni in 
combination with better orbital overlap between the NHC and the smaller Ni center 
(relative to Pd and Pt). In both the models and the polymers, the Pd- and Pt-based 
compounds showed similar absorption maxima. This is as would be expected given their 
nearly identical electronegativities and the observation that 2.19·Pd and 2.19·Pt were 
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isostructural in the solid-state. Overall, the electronic absorption data was encouraging 
because it supported the possibility of these materials exhibiting long-range, through-
metal electron communication. 
 
Figure 2.10 Electronic absorption spectra of metal complexes and related polymers in 
DMF at room temperature 
 














    














































    















In summary, we describe the synthesis and characterization of a series of group 10 
metal-carbene complexes and organometallic polymers comprised of a new chelating 
benzimidazolylidene. The model complexes were prepared in 91 – 95% yields via direct 
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metallation of a N-(o-phenol) substituted benzimidazolium bromide using Pd(II), Ni(II), 
or Pt(II) salts. The synthesis of the requisite benzimidazolium salt was completed in three 
steps in 85% yield from commercial material. This synthesis was borne out through the 
development of a one-pot reduction/cyclization protocol which converted o-nitroanilines 
to benzimidazoles in high yields. A modular feature of this ligand design is that the final 
N-substituent (i.e., the butyl group) may be varied to control physical characteristics such 
as solubility and processability. A ligated but non-chelated Pd(II) complex (2.18·Pd) was 
also obtained which allowed for direct comparison of the effects of chelation on bonding 
geometry, thermal stability, and electronic characteristics. Interestingly, it was observed 
that the non-chelated trans Pd complex was converted into the corresponding cis isomer 
upon chelation, a geometry that was observed for each of the chelated complexes. In 
addition, chelation provided increased thermal stability which was manifested in a 24 °C 
increase in Td in going from 2.18·Pd to 2.19·Pd. The structures of the model complexes 
were supported by NMR and IR spectroscopy, and unambiguously confirmed through X-
ray crystallographic analysis. The 1H NMR spectra of the Ni- and Pt-based complexes 
displayed diastereotopic butyl groups whereas the Pd complex exhibited no 
diastereotopicity. Each of the model complexes contained shorter metal-Ccarbene bonds 
than generally observed for NHC complexes of the same metal species. 
These results formed the basis for the design of a new class of organometallic 
polymers. An annulated benzobis(imidazolium) salt bearing N-(o-phenol) substituents 
was synthesized by a short SNAr, reduction/cyclization, alkylation sequence in 78% 
overall yield without the need for chromatography. Direct metallation with Pd(II), Ni(II), 
or Pt(II) salts afforded the respective main-chain organometallic polymers in 95 – 99% 
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isolated yields. The resulting organometallic polymers contained a 
benzobis(imidazolylidene) with pendant N-(o-phenol) groups that were found to 
coordinate to transition metals in a chelating type fashion, as confirmed by 1H NMR and 
IR spectroscopies. This resulted in polymeric materials with molecular weights up to 363 
kDa (relative to polystyrene standards) and PDIs typical of step-growth polymerizations. 
The polymers showed  excellent moisture- and air-stability in both solution and solid-
state. TGA analysis of the polymers revealed Tds ranged from 340 – 362 °C (under 
nitrogen), which correspond to a 50 – 80 °C increase in thermal stability relative to 
previously reported, non-chelating polymers of similar composition.  
The electronic absorption spectra of the model complexes and their corresponding 
polymeric materials revealed several promising features. First, chelation has a minimal 
overall impact on the electronic characteristics of the complexes and polymers. This was 
confirmed through the comparison of 2.18·Pd and 2.19·Pd which displayed nearly 
overlapping electronic absorption spectra. The λmax values for the model complexes and 
polymers ranged from 285 - 319 nm and 312 - 322 nm, respectively, depending on the 
incorporated metal. In each series, λmax increased in the order of Ni > Pt ~ Pd. The 
polymers each displayed electronic absorption spectra consistent in shape with the 
corresponding model complexes. The electronic absorption spectra of the polymers were 
also bathochromically shifted by 3 – 27 nm relative to their respective model systems 
which suggested an increased delocalization character in the former. Collectively, the 
data suggested that the thermal stabilities of our previously reported materials were 
increased without a comprise in their electronic characteristics. 
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This new series of main-chain NHC-based polymers builds upon our recently 
reported procedure for preparing analogous polymers by extending the range of transition 
metals that may be incorporated into the main-chains. Importantly, the new ligand design 
facilitated the synthesis and characterization of each group 10 system, ultimately 
revealing that the greatest degree of electronic communication may in fact be in the Ni-
based materials. Future efforts will focus on exploring the utility of these materials in 
catalysis and further examining their physical characteristics with an emphasis on their 
potential in electronic applications 
 
2.5 Experimental Section  
General Considerations: 1H and 13C NMR spectra were recorded using a Varian 
Unity Plus 300 or 400 spectrometer and were routinely run using broadband decoupling. 
Chemical shifts (δ) are expressed in ppm downfield from tetramethylsilane using the 
residual protonated solvent as an internal standard (DMSO-d6, 1H: 2.49 ppm and 13C: 
39.5 ppm; CDCl3 1H: 7.26 ppm and 13C: 77.0 ppm). Coupling constants are expressed in 
hertz (Hz). HRMS (CI) were obtained with a VG analytical ZAB2-E instrument. UV-vis 
spectra were recorded using a Perkin Elmer Instruments Lambda 35 spectrometer. 
Infrared spectra were recorded a Thermo IR200. GPC data was obtained using a Waters 
HPLC system consisting of HR-1, HR-3, and HR-5E Styragel® columns arranged in 
series, a 1515 pump, and a 2414 RI detector. Molecular weight data is reported relative to 
polystyrene standards in DMF (0.01 M LiBr) at 40 °C (column temperature). 
Decomposition temperatures (Tds) were determined using a TA Instruments TGA-Q500 
under nitrogen atmosphere and were defined as the temperature at which 10% mass loss 
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occurred. All solvents and reagents were of reagent quality and used as obtained from 
commercial sources. Chromatography was performed with neutral alumina (Brockmann 
I, 60-325 mesh). 
 
2-(2-Nitro-phenylamino)-phenol (2.15): 1-Fluoro-2-nitrobenzene (2.14) (1.34 g, 9.48 
mmol), 2-aminophenol (2.59 g, 23.7 mmol), NaHCO3 (1.59 g, 18.96 mol), EtOH (10 mL) 
and a magnetic stirbar were combined in a 20 mL Schlenk flask. The mixture was stirred 
in an oil bath at 100 °C for 20 h. The cooled reaction mixture was filtered through Celite 
with the aid of 10 mL CH2Cl2 and concentrated. The crude material was taken up in 
CH2Cl2 and filtered through a plug of silica gel (eluting with CH2Cl2). Concentration of 
the resulting red-orange filtrate provided 2.00 g (92% yield) of the desired material. 
Although this compound was previously reported, complete spectral data were not 
provided.49 1H NMR (400 MHz, CDCl3): δ 9.01 (br s, 1H), 8.21 (dd, J = 8.4, 1.6 Hz, 1H), 
7.40-7.35 (m, 1H), 7.28-7.20 (m, 2H), 7.07 (dd, J = 8.0, 1.2 Hz, 1H), 6.99 (ddd, J = 7.8, 
7.6, 1.2 Hz, 1H), 6.84-6.79 (m, 1H), 6.77 (dd, J = 8.6, 1.4 Hz, 1H), 5.63 (br s, 1H). 13C 
NMR (100 MHz CDCl3): δ 152.2, 144.0, 136.1, 133.6, 128.9, 127.8, 126.5, 124.9, 121.4, 
118.1, 116.3, 116.2. HRMS m/z calcd for C12H11N2O3 [M+H+] 231.0770, found 
231.0775. 
 
N-(2-hydroxyphenyl)-benzimidazole (2.16): A 100 mL flask was charged with a 
magnetic stirbar, formic acid (88%, 60 mL), NaO2CH (1.77 g, 26.1 mmol), and 10% 
Pd/C (460 mg, 0.43 mmol Pd). After adding nitroarene 2.15 (2.00 g, 8.69 mmol) to this 
mixture, this flask was fitted with a H2O-jacketed condenser and stirred in an oil bath at 
 44
110 °C for 7 h. Upon completion, the cooled reaction mixture was filtered through Celite 
with the aid of 25 mL H2O and the volume of the filtrate was reduced to approximately 
10 mL, under reduced pressure. The acidic solution was then slowly added to a 
vigorously stirred aqueous solution of saturated Na2CO3 (250 mL). The resulting solids 
were collected by vacuum filtration, rinsed with H2O, and dried under vacuum to give 
2.12 g (93% yield) of monosubstituted benzimidazole 2.16 as a tan solid. This material 
was routinely used without additional purification. Although this compound was 
previously reported, complete spectral data were not provided. 1H NMR (400 MHz, 
DMSO-d6): δ 8.29 (s, 1H), 7.72 (br s, 1H), 7.34 (d, J = 7.6 Hz, 1H), 7.29-7.22 (m, 4H), 
7.11 (d, J = 8.4 Hz, 1H), 6.89 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ 
152.2, 144.4, 143.0, 134.3, 129.7, 127.5, 122.9, 122.9, 121.9, 119.6, 119.5, 117.0, 111.1. 
HRMS m/z calcd for C13H11N2O [M+H+] 211.0871, found 211.0873. 
 
N-Butyl-N´-(2-hydroxyphenyl)-benzimidazolium bromide (2.17): In a 20 mL screw-
cap vial, benzimidazole 2.16 (347 mg, 1.65 mmol) was dissolved in a mixture of CH3CN 
(5.0 mL) and 1-bromobutane (0.53 mL, 4.95 mmol). After adding a magnetic stirbar, the 
vial was sealed with a Teflon-lined cap, placed in an oil bath at 100 °C and then stirred 
for 12 h. After cooling to ambient temperature, the reaction mixture was transferred to a 
round-bottom flask with the aid of 3 mL MeOH. The crude material was then 
concentrated under reduced pressure to provide benzimidazolium bromide 2.17 as the 
sole detectable product in >99% yield. Recrystallization from hot CH2Cl2/hexanes gave 
colorless needles. 1H NMR (400 MHz, DMSO-d6): δ 10.75 (s, 1H), 10.11 (s, 1H), 8.21 
(d, J = 8.0 Hz, 1H), 7.76-7.69 (m, 3H), 7.58-7.51 (m, 2H), 7.22 (d, J = 0.8 Hz, 1H), 7.11 
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(ddd, J = 8.0, 7.6, 1.2 Hz, 1H) 4.59 (t, J = 7.2 Hz, 2H), 1.96 (pent, J = 7.2 Hz, 2H), 1.39 
(sext, J = 7.2 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, DMSO-d6): δ 152.2, 
143.2, 132.1, 131.7, 130.8, 127.9, 127.2, 126.7, 112.0, 119.8, 117.3, 114.0, 46.8, 30.5, 
19.1, 13.4; HRMS m/z calcd for C17H19N2O [M+] 267.1497, found 267.1494. 
 
Palladium dibromide complex 2.18·Pd: After suspending benzimidazolium bromide 
2.17 (598 mg, 1.72 mmol) in THF (15 mL), Pd(OAc)2 (193 mg, 0.86 mmol) was added. 
The resulting mixture was then vigorously stirred at 50 °C for 2 h, allowed to cool, 
filtered through a thin pad of alumina, and then concentrated under vacuum to give 639 
mg (93% yield) of complex 2.18·Pd as a tan powder. Crystals suitable for X-ray analysis 
were obtained by dilution of an NMR sample (in DMSO-d6) with THF (four-fold by 
volume) and diffusion of hexanes into this mixture. Anal. calcd for 
C34H36N4O2Br2Pd·H2O: C, 49.99; H, 4.54; N, 7.04; found: C, 49.84; H, 4.43; N, 6.53; 1H 
NMR (400 MHz, DMSO-d6): δ 7.55-7.49 (m, 4H), 7.38 (d, J = 8.0 Hz, 2H), 7.33 (dd, J = 
8.2, 1.4 Hz, 2H), 7.31-7.27 (m, 2H), 7.23-7.18 (m, 4H), 7.01-6.98 (m, 2H), 4.40-4.29 (m, 
4H), 1.85-1.79 (m, 4H), 1.29-1.23 (m, 4H), 0.94 (t, J = 7.4 Hz, 6H); 13C NMR (75 MHz 
DMSO-d6): δ 181.2, 152.2, 136.2, 134.1, 131.1, 130.7, 126.2, 123.5, 121.9, 120.4, 111.3, 
110.5, 109.7, 106.7, 48.3, 44.5, 31.4, 20.3, 14.0; IR (KBr): 3331, 3061, 2958, 2931, 2872, 
1591, 1500, 1462, 1416, 1344 cm-1; HRMS m/z calcd for C34H36N4O2Br2Pd [M+] 
794.0245, found 794.0240. 
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Chelated palladium complex 2.19·Pd: Direct procedure: After dissolving 
benzimidazolium bromide 2.17 (200 mg, 0.58 mmol) in DMSO (10 mL), Pd(OAc)2 (58 
mg, 0.26 mmol) and NaOAc (48 mg, 0.58 mmol) were added. The reaction mixture was 
then placed in an oil bath thermostatted at 80 °C and stirred for 2 h at which time NMR 
spectroscopy revealed complete consumption of 2.17. The solution was then allowed to 
cool to ambient temperature and poured into H2O (25 mL). The resulting precipitates 
were collected via vacuum filtration and dried under vacuum to give 151 mg (91% yield) 
of the chelated complex. Step-wise procedure: After dissolving benzimidazolium 
bromide 2.17 (200 mg, 0.58 mmol) in THF (10 mL), Pd(OAc)2 (58 mg, 0.26 mmol) was 
added. The reaction mixture was placed in an oil bath thermostatted at 50 °C and stirred 
for 2 h. After allowing the mixture to cool to ambient temperature, Na2CO3 (256 mg, 2.32 
mmol) and MeOH (10 mL) were added. The resulting slurry was stirred for 1 h, poured 
into H2O (25 mL), and extracted with EtOAc (3 × 10 mL). The organic extracts were 
washed with brine (50 mL), dried over Na2SO4, filtered through a thin pad of alumina, 
and concentrated. Flash chromatography on neutral alumina (eluent = Et2O) provided the 
desired complex in 88% yield as a yellow-gold powder. Crystals suitable for X-ray 
analysis were obtained by slow evaporation of a THF/hexanes mixture of the crude 
product mixture. Anal. calcd for C34H34N4O2Pd·0.5H2O: C, 63.21; H, 5.46; N, 8.55; 
found: C, 63.81; H, 5.42; N, 8.74; 1H NMR (400 MHz, CDCl3): δ 7.89 (dd, J = 7.4, 1.0 
Hz, 2H), 7.59 (dd, J = 8.0, 1.6 Hz, 2H), 7.54 (dd, J = 7.4, 1.4 Hz, 2H), 7.39-7.31 (m, 4H), 
7.07-6.99 (m, 6H), 6.76 (ddd appearing as td, J = 7.4, 1.8 Hz, 2H), 4.86 (t, J = 7.6 Hz, 
4H), 2.20-2.13 (m, 4H), 1.68-1.58 (m, 4H), 1.03 (t, J = 7.6 Hz, 6H); 13C NMR (75 MHz 
CDCl3): δ 177.7, 160.6, 135.4, 131.6, 130.6, 127.6, 123.5, 122.0, 121.5, 115.1, 112.9, 
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111, 46.0, 32.8, 20.4, 14.0; IR (KBr): 3057, 3022, 2960, 2929, 2860, 1585, 1473, 1288, 
1115, 1084, 1018 cm-1; HRMS m/z calcd for C34H34N4O2Pd [M+] 636.1717, found 
636.1721. 
 
Nickel complex 2.19·Ni: The complex was synthesized in analogy to 2.19·Pd from 
azolium salt 2.17 (347 mg, 1.0 mmol), Ni(OAc)2·4H2O (124 mg, 0.50 mmol), and 
NaOAc (82 mg, 1.0 mmol) in DMSO (4.0 mL). Recrystallization of the crude material 
from CH2Cl2/hexanes gave 280 mg (95% yield) of the desired product as a yellow solid. 
Alternatively, the crude material could be purified by flash chromatography on neutral 
alumina (eluent = Et2O). Crystals suitable for X-ray analysis were obtained by slow 
diffusion of hexanes into a THF solution of the crude product mixture. Anal. calcd for 
C34H34N4O2Ni·H2O: C, 67.23; H, 5.97; N, 9.22; found: C, 67.23; H, 5.83; N, 9.17; 1H 
NMR (400 MHz, CDCl3): δ 7.91-7.89 (m, 2H), 7.67 (d, J = 7.2 Hz, 2H), 7.39 (d, J = 8.4 
Hz, 2H), 7.30-7.29 (m, 6H), 7.17 (t, J = 7.2 Hz, 2H), 6.80 (t, J = 7.4 Hz, 2H), 4.23-4.16 
(m, 2H), 3.64-3.57 (m, 2H), 2.32-2.28 (m, 2H), 1.32-1.24 (m, 4H), 1.11-1.04 (m, 2H), 
0.55 (t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 172.5, 158.9, 135.3, 132.2, 128.2, 
128.1, 123.72, 123.67, 122.4, 120.1, 113.9, 112.2, 109.9, 48.3, 32.1, 20.2, 13.3; IR (KBr): 
3059, 3037, 2962, 2933, 2862, 1585, 1487, 1275, 1115, 1020 cm-1; HRMS m/z calcd for 
C34H35N4O2Ni [M+H+] 589.2113, found 589.2115. 
 
Platinum complex 2.19·Pt: The complex was synthesized in analogy to 2.19·Pd from 
azolium salt 2.17 (120 mg, 0.35 mmol), PtCl2 (41 mg, 0.16 mmol), and NaOAc (62 mg, 
0.76 mmol) in DMSO (3.0 mL). Recrystallization of the crude material from 
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CH2Cl2/hexanes gave 108 mg (93% yield) of the desired product as a white solid. 
Alternatively, the crude material could be purified by flash chromatography on neutral 
alumina (eluent = 10% CH2Cl2/Et2O). Crystals suitable for X-ray analysis were obtained 
by slow evaporation of a THF solution of the purified complex. Anal. calcd for 
C34H34N4O2Pt·0.5H2O: C, 55.58; H, 4.80; N, 7.63; found: C, 55.35; H, 4.40; N, 7.20; 1H 
NMR (400 MHz, CDCl3): δ 7.93-7.91 (m, 2H), 7.59 (dd, J = 7.6, 1.6 Hz, 2H), 7.44 (dd, J 
= 8.4, 1.2 Hz, 2H), 7.39-7.30 (m, 6H), 7.23-7.19 (m, 2H), 6.79 (ddd appearing as td, J = 
8.0, 1.2 Hz, 2H), 4.05-3.98 (m, 2H), 3.84-3.76 (m, 2H), 2.19-2.01 (m, 2H), 1.56-1.45 (m, 
2H), 1.18-1.02 (m, 4H), 0.57 (t, J = 7.4 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 160.8, 
157.8, 134.6, 132.2, 128.5, 128.2, 123.9, 123.8, 122.4, 121.2, 114.8, 112.8, 110.3, 48.1, 
31.1, 20.0, 13.2; IR (KBr): 3061, 3030, 2964, 2933, 2874, 2862, 1585, 1489, 1473,  1294, 
1113, 1038, 1020 cm-1; HRMS m/z calcd for C34H35N4O2Pt [M+H+] 726.2408, found 
726.2402. 
 
1,5-Bis[(2-hydroxyphenyl)amino]-2,4-dinitrobenzene (2.21): A 500 mL flask was 
charged with 1,5-dichloro-2,4-dinitrobenzene (10.0 g, 42.2 mmol), 2-aminophenol (18.4 
g, 169 mmol), EtOH (250 mL) and a magnetic stir bar. The flask was equipped with a 
H2O-jacketed condenser and the mixture was heated under reflux for 48 h. The resulting 
red solution was allowed to cool to ambient temperature and the volume was reduced to 
approximately half its original volume under reduced pressure. The red slurry was then 
poured into H2O (200 mL) and allowed to stand for 1 h. The red solids that had formed 
were collected by vacuum filtration, rinsed with H2O, and dried under vacuum to give 
2.21 (15.9 g, 99% yield). Although this material was routinely used without additional 
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purification, recrystallization from hot MeOH/H2O affords orange-red crystals. 1H NMR 
(400 MHz, DMSO-d6): δ 9.64 (br s, 2H), 9.04 (s, 1H), 7.21 (dd, J = 7.6, 1.2 Hz, 2H), 7.03 
(t, J = 6.8 Hz, 2H), 6.92 (d, J = 7.4 Hz, 2H), 6.76 (t, J = 7.0 Hz, 2H), 6.30 (s, 1H); 13C 
NMR (100 MHz DMSO-d6): δ 150.8, 145.6, 128.3, 127.0, 125.0, 124.7, 124.6, 119.2, 
116.3, 95.5; HRMS m/z calcd for C18H14N4O6 [M-] 382.0913, found 382.0912. 
 
Benzobis(imidazole) 2.22: In an 500 mL flask, a suspension of 10% Pd/C (1.0 g, 0.94 
mmol Pd) and NaO2CH (22.6 g, 333 mmol) in formic acid (88%, 250 mL) was treated 
with dinitroarene 2.21 (10.6 g, 27.7 mmol) in several portions. The flask was then 
equipped with a H2O-jacketed condenser and the mixture was heated under reflux for 48 
h. Upon completion, the mixture was allowed to cool to ambient temperature, filtered 
through Celite and washed with 50 mL H2O. The filtrate volume was then reduced under 
vacuum to approximately 50 mL and then slowly added to a stirred aqueous solution 
saturated with Na2CO3. The resulting precipitate was collected by vacuum filtration, 
rinsed with H2O, and dried under vacuum to give benzobis(imidazole) 2.22 (8.1 g, 85% 
yield) as a tan powder. The material was routinely used without additional purification. 
1H NMR (400 MHz, DMSO-d6): δ 10.2 (br s, 2H), 8.31 (s, 2H), 8.02 (s, 1H), 7.39 (d, J = 
7.6 Hz, 2H), 7.30 (t, J = 7.6 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 6.95 (t, J = 7.2 Hz, 2H), 
6.91 (s, 1H). 13C NMR (75 MHz DMSO-d6): δ 152.2, 145.0, 140.1, 132.3, 129.6, 127.6, 




Benzobis(imidazolium) dibromide 2.23: A Schlenk flask was charged with DMF (100 
mL), benzobis(imidazole) 2.22 (11.8 g, 34.5 mmol), 1-bromobutane (22.2 mL, 207 
mmol), and a magnetic stirbar. After sealing the flask, the resulting slurry was stirred at 
110 °C for 48 h during which time the mixture became homogenous for a short period of 
time and then heterogeneous. Subsequently, the cooled mixture was poured into PhCH3 
(200 mL) and the solids were collected by vacuum filtration, rinsed with THF, and dried 
under vacuum. Recrystallization from MeOH/THF mixture (1:3 v/v) gave 19.8 g (93% 
yield) of the bis(azolium) salt as a tan powder. 1H NMR (400 MHz, DMSO-d6): δ 10.77 
(br s, 2H) 10.52 (s, 2H), 9.46 (s, 1H), 7.72 (dd, J = 8.0, 1.2 Hz, 2H), 7.53-7.49 (m, 3H), 
7.22 (d, J = 8.4 Hz, 2H), 7.09 (t, J = 8.2 Hz, 2H), 4.80 (t, J = 6.8 Hz, 4H), 2.08 (pent, J = 
7.4 Hz, 4H), 1.46 (sext, J = 7.4 Hz, 4H), 0.97 (t, J = 7.2 Hz, 6H), 13C NMR (75 MHz 
DMSO-d6): δ 152.2, 147.0, 132.5, 130.9, 130.0, 128.1, 120.0, 119.7, 117.5, 100.0, 98.9, 
47.6, 30.2, 19.1, 13.5; HRMS m/z calcd for C28H31N4O2 [M-H+] 455.2447, found 
455.2447. 
 
General polymerization procedure: After dissolving bis(azolium) dibromide 2.23 (1.0 
mmol, 1.0 equiv) in DMSO (5 mL), metal salt (1.0 mmol, 1.0 equiv) and NaOAc (2.0 
mmol, 2.0 equiv if Ni(OAc)2; 4.0 mmol, 4.0 equiv if PdCl2 or PtCl2) were then added to 
the reaction vessel. The resulting solution was then stirred at 80 °C for 24 – 48 h and 
monitored by 1H NMR spectroscopy.62  Upon completion, the mixture was allowed to 
cool and added dropwise into H2O (50 mL). The resulting precipitate was collected via 
vacuum filtration, rinsed with H2O and dried under vacuum. 
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Polymer 2.24·Pd: 1H NMR (400 MHz, DMSO-d6): δ 8.15 (br, 2H), 7.40-6.80 (br, 8H), 
4.40-5.00 (br, 4H), 2.15 (br, 4H), 1.45 (br 4H), 1.00 (br, 6H); IR (KBr): 3067, 2966, 
2954, 2882, 1594, 1486, 1421, 1381, 1301 cm-1. 
 
Polymer 2.24·Ni: 1H NMR (400 MHz, DMSO-d6): δ 8.02 (br 2H), 7.58-7.21 (br, 4H), 
7.20-6.75 (br, 4H), 4.05-4.62 (br, 4H), 2.00 (br, 4H), 1.40 (br, 4H), 0.94 (br, 6H); IR 
(KBr): 3143, 3038, 2962, 2952, 2898, 1594, 1489, 1414, 1376, 1301 cm-1. 
 
Polymer 2.24·Pt: 1H NMR (400 MHz, DMSO-d6): δ 8.05 (br, 2H), 7.55-7.25 (br, 4H), 
7.20-6.90 (br, 4H), 4.38-4.99 (br, 4H), 2.01 (br, 4H), 1.40 (br, 4H), 0.95 (br, 6H); IR 
(KBr): 3097, 3051, 2971, 2949, 2899, 2881, 1597, 1483, 1444, 1381, 1307 cm-1. 
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Chapter 3: Highly Efficient Synthesis and Solid-State Characterization 
of 1,2,4,5-Tetrakis(alkyl- and arylamino)benzenes and Cyclization to 
their Respective Benzobis(imidazolium) Salts 
 
3.1 Introduction 
 As a general class of highly electron-rich molecules, tetraaminobenzenes have 
seen a rich diversity of chemical applications. For example, 1,2,4,5-tetraaminobenzene63 
(3.1) and its oxidized derivative, 2,5-diamino-1,4-quinonediimine64 (3.2), have found 
great utility in organic, organometallic, and macromolecular chemistry. They have been 
used as ditopic ligands in coordination chemistry,65 as pH-dependent chromophores,66 as 
difunctional monomers in the synthesis of main-chain organometallic67 and 










While 3.170 is commercially available (as its tetrahydrochloride salt, i.e., 1.1), 
access to its N,N’,N’’,N’’’-tetra(alkyl and aryl) derivatives remains synthetically 
challenging due to the high propensity of these electron rich arenes to oxidize during 
isolation. For example, Braunstein obtained a variety of N,N’,N’’,N’’’-tetraalkyl 2,5-
diamino-1,4-benzoquinonediimines by reducing their respective 1,2,4,5-
tetraamidobenzenes under aerobic conditions.65h,66 Similarly, azophenines are generally 
obtained upon condensation of o-benzoquinone dioxime63,71 or N,N’-diphenylsulfonyl-
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quinonediimine72 with various arylamines. More recently, in a breakthrough report by 
Harlan,73 exhaustive Buchwald-Hartwig74 Pd-catalyzed amination of 1,2,4,5-
tetrabromobenzene with 2,6-dimethylaniline provided mixtures of the respective 
tetra(arylamino)benzene and azophenine in a promising 26% yield.75 With these 
considerations in mind, we considered the possibility that large N-substituents (desired 
for bis(azolium) compounds) could serve a dual purpose to slow down (or even 
eliminate) undesired oxidative pathways and facilitate isolation of the targeted 
tetraamines.  
 
3.2 Four-fold aryl amination 
Inspired by Harlan’s report,73 we examined the Pd-catalyzed cross coupling of 
tert-butylamine with 1,2,4,5-tetrabromobenzene (3.3) under basic conditions as shown in 
Scheme 3.1. The reaction was performed in toluene (0.2 M) using 1,3-bis(2,6-
diisopropylphenyl)imidazolylidene·HCl26b (IPr·HCl) /  Pd(OAc)276 (2:1 stoichiometry; 1 
mol % Pd relative to 3.3) as the catalyst precursor.77 Surprisingly, after less than 1 h at 
110 ºC, a colorless solid precipitated from the reaction solution which was subsequently 
isolated in 96% yield via filtration under a cone of nitrogen.78 The 1H NMR spectrum of 
this compound exhibited a single, diagnostic signal at δ = 6.53 ppm (solvent = CDCl3) 
which was indicative of highly symmetric structure consistent with the desired 1,2,4,5-
tetrakis(tert-butylamino)benzene (3.4). To confirm, a crystal suitable for X-ray 
crystallography was obtained by slow cooling of a hot saturated solution of 3.4 in 
toluene; an ORTEP diagram of the corresponding structure is shown in Figure 3.1 (left). 
Notably, the four nitrogen atoms were found to be co-planar with nearly equivalent N-C 
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(1.43-1.44 Å) and aryl C-C (1.39-1.41 Å) bond distances. In addition, the tert-butyl 
groups on the nitrogen atoms were situated above and below the plane of the arene ring 
with dihedral angles (C4-N1-C1-C2 and C8-N2-C2-N1) of 120-121º. 
 



























PhCH3, 110 °C, 2h
 
 
To compare 3.4 directly with its corresponding 2,5-diamino-1,4-quinonediimine, 
the tetramine was dissolved in CHCl3 and stirred under an atmosphere of oxygen at room 
temperature.79 The 1H NMR spectrum (solvent = CDCl3) of this compound exhibited a 
signal at  δ = 5.53 ppm which was consistent65h,66 with quinoid-derivative 3.5 (Scheme 
3.1). Crystals of azophenine 3.5 suitable for X-ray analysis were also obtained which 
allowed for direct comparison of the related species. As shown in Figure 3.1 (right), the 
ORTEP diagram of 3.5 exhibited not only co-planar tert-butyl groups (with dihedral 
angles of 175-179º), but also varied N-C (N1-C1, 1.35 Å and N2-C2, 1.29 Å) and aryl C-
C (1.51 Å, 1.37 Å, and 1.44 Å) bond lengths. This type of bonding pattern has been 
previously described65h,66 and is fully consistent with related azophenine solid-state 
structures.65h,66,73 To our knowledge, this is the first example of a crystalline 1,2,4,5-
tetrakis(alkylamino)benzene and a direct comparison with its oxidized derivative. More 
importantly, the collective data suggested that the synthetic methodology detailed above 
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was successful in preparing and isolating bona fide N,N’,N’’,N’’’-tetra(alkyl) 1,2,4,5-
tetraminobenzenes.  
 
Figure 3.1 (left) ORTEP representation of the X-ray crystal structure of 1,2,4,5-
tetra(tert-butylamino)benzene (3.4), showing non-hydrogen atoms as 50% thermal 
ellipsoids. (right) ORTEP representation of the X-ray crystal structure of N,N',N'',N'''-
tetrakis(tert-butyl) 1,4-diamino-2,5-benzoquinone-diimine (3.5), showing non-hydrogen 
atoms as 50% thermal ellipsoids. 
    
Selected bond lengths (Å) and degrees (º) for 3.4: N1-C1, 1.429(2); N2-C2, 1.441(2); C1-
C2, 1.411(2); C2-C3, 1.394(2); C1-C3_2, 1.394(2); N1-C1-C2, 121.1(1); N2-C2-C1, 
119.6(1); C2-C1-N1-C4, 109.8(1); C1-C2-N2-C8, 99.8(2). Selected bond lengths (Å) and 
degrees (º) for 3.5: N1–C1, 1.349(1); N2–C2, 1.294(1); C1–C2, 1.513(1); C1–C3, 
1.367(1); C2–C3_3, 1.437(1), N1-C1-C2, 113.0(1); N2-C2-C1, 113.9(1); C2-C1-N1-C4, 
175.1(1), C1-C2-N2-C8, 179.4(1). 
 
Prompted by these results and using the protocol described above, a variety of 
other amines were probed for their ability to couple with 3.3. As expected, the coupling 
of 1-adamantyl amine (AdNH2) with 3.3 afforded similar results as tBuNH2 (90% yield; 
Table 3.1, Entry 2). Aryl amines including aniline, relatively bulky mesitylamine,80 and 
electron-rich o-anisidine were also found to successfully couple to 3.3 in excellent yields 
 56
(Entries 3 - 5). Unfortunately, primary (i.e., 1-butylamine), secondary (i.e., 
cyclohexylamine), or electron deficient aryl amines (nitro- and chloroanilines) either 
resulted in no reaction or afforded complex product mixtures. It is noteworthy that cross-
coupling of 2,3,5,6–tetrabromo-p-xylene and 1,2,4,5-tetrachlorobenzene with tBuNH2 
afforded the corresponding tetraamines in 99 and 94% yields, respectively (Entries 6 and 
7). The former result suggested that the bulky IPr-ligated Pd catalyst was not impeded by 
the presence of steric bulk ortho to both sites of amination and was a testament to the 






























tetrahalobenzene amine product yield entry 
X R    
1 Br H tBuNH2 3.4 96% 
2 Br H AdNH2 3.6 90% 
3 Br H PhNH2 3.7 76% 
4 Br H MesNH2 3.8 94% 
5 Br H 2-MeOPhNH2 3.10 96% 
6 Br Me tBuNH2 3.11 99% 
7 Cl H tBuNH2 3.4 94% 
aGeneral reaction conditions: IPr•HCl (0.04 equiv); Pd(OAc)2 (0.02 equiv); NaOtBu (4.1 
equiv); RNH2 (4.1 equiv); solvent = toluene, temp = 110 °C. Isolated yields are indicated. 
tBuNH2 = tert-butyl amine; AdNH2 = 1-adamantyl amine;  PhNH2 = aniline; MesNH2 = 
2,4,6-trimethylaniline; 2-MeOPhNH2 = o-anisidine. 
 
After the 1,2,4,5-tetrakis(alkyl- and arylamino)-benzenes were synthesized, their 
relative susceptibilities toward oxidation were qualitatively investigated.81 The amines 
were independently dissolved in aerated CDCl3 and examined by 1H NMR spectroscopy 
periodically over time. In general, the 1,2,4,5-tetrakis(alkylamino)benzenes were found to 
oxidize slower (τ½ ~ days) than their N-aryl analogues (τ½ ~ hours). However, the 
electron-rich N-anisidyl derivative 3.10 was exceptional and was found to exhibit 
stability comparable to the N-alkyl derivatives (3.4 and 3.6). The most stable tetraamine 
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was the xylene derivative 3.11 which resisted oxidation even after dissolution in aerated 
solvents for several weeks. These results may be rationalized by examining individual 
sterics and electronic contributors which may kinetically and/or thermodynamically 
inhibit nitrogenyl formation.82 As expected, electronically rich and sterically hindered 
tetraamines show lower propensities to undergo oxidation. 
Thus far we have demonstrated that various tetrakis(aryl and alkylamino)arenes 
can be prepared via aryl amination from their corresponding tetrahaloarene. However, in 
situations when the requisite polyhalogenated arenes are not readily available (e.g., 
3,3’,4,4’-tetrachlorobiphenyl83), a complementary route to the respective 
tetrakis(amino)arenes would be desirable. As shown in Scheme 3.3, mesityl bromide was 
coupled to commericially available 3,3’-diaminobenzidine 3.12 using the catalyst system 
and conditions discussed above to afford the corresponding N,N’,N’’,N’’’-tetramesityl 
3,3’-diaminobenzidine (3.13) in 47%  yield (Scheme 3.3).84  
 


















3.3 Formylative cyclization to produce benzobis(imidazolium) salts 
With the tetraamines in hand we were poised to complete the synthesis of the 
desired N-aryl and bulky N-alkyl benzobis(imidazolium) salts (Scheme 3.4).85 Using HCl 
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in HC(OEt)3 at elevated temperatures was successful in cyclizing N-anisidyl substrate 
3.10 in high (92%) yield. Although this substrate underwent clean cyclization within 2 h, 
other compounds were sluggish apparently due to solubility limitations of monocyclized 
intermediates. Gratifyingly, switching to HBF4 in place of HCl sufficiently improved 
solubility such that each of the remaining substrates could be cyclized efficiently. 
Ultimately we found the N-mesityl tetraamine 3.8 was reluctant to undergo cyclization 
under a variety of conditions. 
 














14a, 77% (R = t-Bu, X = BF4)
14b, 66% (R = Ad, X = BF4)
14c, 64% (R = Ph, X = BF4)
14d, 92% (R = 2-MeOPh, X = Cl)





In summary, we have developed an efficient synthetic and isolation protocol for 
preparing 1,2,4,5-tetrakis(alkyl- and arylamino)benzenes, two elusive classes of electron 
rich arenes. Their structures were unambigously proven using X-ray crystallography and 
compared with their oxidized derivatives. Immediate efforts will concentrate on 
expanding the substrate scope of this reaction and elucidating its unique substitution 
pattern. The tetraamines were successfully cyclized to give the desired bis(azolium) 
compounds in good to excellent yields. Currently we are also investigating applications 
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of the bis(azolium) salts for direct formation of non-chelating bis(carbene)s as well as 
their respective discrete bimetallic complexes. 
 
3.5 Experimental Section 
General Considerations: All reactions were conducted under an atmosphere of 
nitrogen using standard Schlenk techniques or in a nitrogen-filled glove-box. CHCl3 was 
degassed by two freeze-pump-thaw cycles and stored over 4Å molecular sieves and 
K2CO3. Hexanes were distilled from CaH2 and degassed by two freeze-pump-thaw 
cycles. THF and toluene were freshly distilled from Na/benzophenone and degassed by 
two freeze-pump-thaw cycles. All reagents were purchased from Aldrich or Acros and 
were used without further purification. 1H NMR spectra were recorded using a Varian 
Gemini (300 MHz or 400 MHz) spectrometer. Chemical shifts are reported in delta (δ) 
units, expressed in parts per million (ppm) downfield from tetramethylsilane using the 
residual protonated solvent as an internal standard (CDCl3, 7.24 ppm; C6D6, 7.15 ppm). 
13C NMR spectra were recorded using a Varian Gemini (100 MHz) spectrometer. 
Chemical shifts are reported in delta (δ) units, expressed in parts per million (ppm) 
downfield from tetramethylsilane using the solvent as an internal standard (CDCl3, 77.0 
ppm; C6D6, 128 ppm). 13C NMR spectra were routinely run with broadband decoupling. 
High-resolution mass spectra (HRMS) were obtained with a VG analytical ZAB2-E or a 
Karatos MS9 instrument and are reported as m/z (relative intensity).  
 
1,2,4,5-Tetrakis-N-tert-butylaminobenzene (3.4). A catalyst for mediating aryl-
amination coupling reactions was prepared by charging a 20 mL vial with 1,3-bis(2,6-
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diisopropylphenyl)imidazolium chloride (0.127 g, 0.3 mmol), NaOtBu (0.03 g, 0.3 
mmol), Pd(OAc)2 (0.04 g, 0.17 mmol), toluene (5 mL), and a stir bar followed by stirring 
this mixture at 80 ºC for 10 minutes. The catalyst solution was added to a 250 mL flask 
containing 1,2,4,5-tetrabromobenzene (2.22 g, 5.64 mmol) suspended in toluene (100 
mL). tert-Butyl amine (1.73 g, 23.7 mmol) and NaOtBu (2.65 g, 27.6 mmol) were then 
added and the resulting mixture was sealed and stirred at 105 ºC overnight. After cooling 
to ambient temperature, precipitated solids were collected by filtration under a cone of 
nitrogen, dissolved in degassed CHCl3 (100 mL), and filtered to remove residual NaBr 
salts. Solvent was then removed under reduced pressure to afford 1.96 g (96% yield) of 
the desired product as a gray solid. Note: the product slowly oxidizes to the 
corresponding benzoquinonediimine over several days in aerated solutions. As a solid, 
the product is bench stable for >months. 1H NMR (CDCl3): δ 6.53 (s, 2H), 3.73 (br, 4H), 
1.22 (s, 36H); 13C NMR (CDCl3): δ 131.7, 115.5, 52.0, 30.0. HRMS calcd. for C22H42N4: 
362.3409; Found, 362.3406. 
 
N,N’-di(tert-butylamino)-1,4-di(tert-butylamino)-2,5-benzoquinone-diimine (3.5). 
Compound 3.4 was dissolved in CHCl3 and stirred under a ballon of oxygen for 24 hours 
followed by removal of solvent to obtain a yellow powder. Alternatively, oxidation can 
be effected in less than 5 minutes by adding an excess of  H2O2: 1H NMR (CDCl3) δ 5.53 
(s, 2H), 1.35 (s, 36H); 13C NMR (CDCl3) δ (ca 138), 90.8, 52.0, 29.8; HRMS calcd. for 
C24H41N4: 361.3331, found: 361.3326.  
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1,2,4,5-Tetrakis-N-adamantylaminobenzene (3.6). The aryl amination was performed 
in a manner analogous to the synthesis of 3.4. Upon completion, the cool reaction 
mixture was filtered in a drybox to afford a beige solid. The solids were rinsed with 
toluene and extracted with degassed CHCl3 and the extract was concentrated under 
reduced pressure to afford 21.5 g (90% yield) of the desired product as a white powder. 
Note: the product slowly oxidizes to the corresponding benzoquinonediimine over several 
days in aerated solutions. As a solid, the product is bench stable for >months. 1H NMR 
(CDCl3): δ 6.59 (S, 2H), 2.06 (br, 12H), 1.81 (br, 24H), 1.66-1.58 (br, 24H);13C NMR 
(CDCl3): δ 131.3, 117.8, 52.5, 43.7, 36.6, 29.8. HRMS calcd. for C46H66N4: 674.5287; 
Found, 674.5286. 
 
1,2,4,5-Tetrakis-N-phenylbenzene (3.7). The aryl amination was performed in a manner 
analogous to the synthesis of 3.4. Upon completion, the cool reaction mixture was filtered 
in a drybox to afford a beige solid. The solids were rinsed with toluene and extracted with 
degassed CHCl3 and the extract was concentrated under reduced pressure to afford 1.78 g 
(76 %) of the desired product as a light pink powder: 1H NMR (CDCl3): δ 7.24-7.19 (br 
m, 12H), 6.9-6.84 (br, 12H), 5.56 (s, 2H); 13C NMR (CDCl3): δ 144.5, 130.6, 129.3, 
120.2, 116.6, 113.9; HRMS calcd. for C30H25N4: 441.2074; found: 441.2074. 
 
1,2,4,5-Tetrakis(2,4,6-trimethylphenylamino)benzene (3.8): The aryl amination was 
performed in a manner analogous to the synthesis of 3.4. Upon completion, the cool 
reaction mixture was filtered in a drybox to afford a beige solid. The solids were rinsed 
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with toluene and extracted with degassed CHCl3 and the extract was concentrated under 
reduced pressure to afford 2.71 g (94%) of the desired product as a white powder: 1H 
NMR (CDCl3): δ 6.75 (s, 8H), 5.40 (s, 2H), 4.86 (br s, 4H), 2.22 (s, 12H), 2.05 (s, 24 H); 
13C NMR (CDCl3): δ 137.9, 132.6, 132.1, 129.4, 129.0, 105.3, 20.6, 18.2; HRMS m/z 
calcd for C42H49N4: 609.3978, found: 609.3952. 
 
 Mesityl-derived azophenine (3.9):  The tetraamine was stirred in CHCl3 open air for 2 
h. The mixture was concentrated to give an orange-red solid in quantitative yield. 1H 
NMR (CDCl3): δ 6.79 (s, 4H), 6.75 (s, 4H), 5.40 (s, 2H), 4.61 (s, 2H), 2.23 (s, 12H), 2.07 
(s, 12H), 2.05 (s, 12H); 13C NMR (CDCl3): δ 137.9, 132.6, 132.1, 129.4, 129.0, 128.6, 
88.9, 20.8, 20.6, 18.2, 18.0; HRMS m/z calcd for C42H49N4: 609.3956, found: 609.3952. 
 
1,2,4,5-Tetrakis(2-methoxyphenylamino)benzene (3.10): The aryl amination was 
performed in a manner analogous to the synthesis of 3.4. Upon completion, the cool 
reaction mixture was filtered in a drybox to afford a beige solid. The solids were rinsed 
with toluene and extracted with degassed CHCl3 and the extract was concentrated under 
reduced pressure to afford 6.92 g (96%) of the desired product as an off-white powder. 
Alternatively, the cooled reaction mixture was opened under a cone of nitrogen and HCl 
(2 mL) in MeOH (10 mL) was added quickly to produce a deep purple slurry. The 
mixture was poured into H2O (25 mL) and the solids were collected via vacuum 
filtration, rinsed with H2O and Et2O, and dried under vacuum to provide the 
tetrahydrochloride salt as a light purple solid in nearly quantitative yield: 1H NMR 
(CDCl3): δ 7.33 (s, 2H), 7.06-7.04 (m, 4H), 6.86-6.76 (m, 12H), 6.02 (br s, 4H), 3.82 (s, 
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12 H); 13C NMR (CDCl3): δ 148.2, 134.4, 130.5, 121.0, 119.1, 114.4, 110.3, 114.2, 55.5; 
HRMS m/z calcd for C34H35N4O4: 563.2606, found 563.2653. 
 
1,2,4,5-Tetrakis(tert-butylamino)-para-xylene (3.11). The aryl amination was 
performed according to the General Procedure. Upon completion, the cool reaction 
mixture was filtered over Celite under a cone of nitrogen with the aid of degassed 
toluene. The filtrate was concentrated under reduced pressure to afford 2.7g (99%) of the 
desired product as a brown solid. It should be noted that the product is bench stable in 
aerated solutions for >months: 1H NMR (CDCl3): δ 3.39 (br, 4H), 2.28 (s, 6H), 1.06 (s, 
36H); 13C NMR (CDCl3): δ 138.1, 128.2, 55.3, 30.7, 18.6; HRMS m/z calcd. for 
C24H46N4: 390.3722, found, 390.3719. 
 
3,3’,4,4’-Tetrakis(2,4,6-trimethylphenylamino)biphenyl (3.13). A catalyst for 
mediating aryl-amination coupling reactions was prepared by charging a 10 mL vial with 
1,3-bis(2,6-diisopropylphenyl)imidazolium chloride (86 mg, 0.02 mmol), NaOtBu (3 mg, 
0.03 mmol), Pd(OAc)2 (30 mg, 0.01 mmol), toluene (3 mL), and a stir bar followed by 
stirring this mixture at 23 ºC for 10 minutes. 2-Bromomesitylene (410 mg, 2.05 mmol) 
was added to the catalyst solution. 3,3’-diaminobenzidine (110 mg, 0.5 mmol) and NaO-
tBu (0.20 g, 2.05 mmol) were then added and the resulting mixture was sealed and stirred 
at 110 ºC overnight. After cooling to ambient temperature, precipitated solids (NaBr) 
were removed by filtration under a cone of nitrogen. Solvent was removed under reduced 
pressure. Analysis of the crude product showed that the reaction was >98% complete. 
Crude product was triturated with hexanes and then dried under reduced pressure to 
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afford 160 mg (47 % yield) of the desired product as a grey solid: 1H NMR (CDCl3): δ 
6.94 (s, 8H), 6.68-6.66 (m, 2H), 6.27-6.24 (m, 4H), 5.18 (br, 2H), 4.99 (br, 2H), 2.36 (br, 
6H), 2.31 (s, 6H), 2.17 (s, 12H), 2.13 (s, 12H); 13C NMR (CDCl3): δ 137.11, 137.06, 
136.7, 135.7, 135.6, 134.0, 133.9, 133.54, 133.48, 133.3, 133.2, 133.1, 129.30, 129.26, 
117.8, 114.7, 112.4, 20.9, 20.8, 18.1, 18.0; HRMS m/z calcd for C48H55N4: 687.4427, 
found: 647.4423. 
 
Tetrakis(tert-butyl) benzobis(imidazolium) tetrafluoroborate (3.14a). A 10 mL flask 
was charged with triethylorthoformate (5 mL), compound 3.4 (300 mg, 0.45 mmol), and 
HBF4 (0.5 ml, 48% aq.). The reaction mixture was heated to 65 °C for 24 hours. Upon 
completion, the product was collected by filtration, washed with hot acetonitrile (3 x 5 
ml) to obtain 270 mg (70%) of the desired product as a light yellow powder: 1H NMR 
(DMSO-d6): δ 9.06 (s, 2H), 8.62 (s, 2H0, 1.91 (s, 36H); 13C (DMSO-d6): δ 142.9, 128.9, 
102.7, 62.0, 28.0, 9.1. 
 
Tetraadamantyl benzobis(imidazolium) tetrafluoroborate (3.14b). In a manner 
analogous to 3.14a, the product was obtained in 80% yield as a light yellow powder. 
Spectroscopic data was in agreement with our previous report: 1H NMR (C6D6): δ 8.37 
(s, 2H), 2.81 (s, 24H), 2.15 (s, 12H), 1.81-1.67 (br, 24H); 13C NMR (C6D6): δ 227.6, 
130.5, 98.5, 58.3, 43.6, 37.2, 30.5. 
 
Tetraphenyl benzobis(imidazolium) tetrafluoroborate (3.14c): In a manor analogous 
to 3.14a, with a reaction temperature of 130 °C and time of 16 hours 162 mg (51%) of 
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the desired product was obtained as a light yellow powder. Purification required rinsing 
with hot MeOH. Spectroscopic data was in agreement with our previous report. 1H NMR 
(DMSO-d6): δ 10.8 (s, 2H), 8.15(s, 2H) 7.9-7.8 (br, 20H); 13C NMR (DMSO-d6): δ 147.3, 
132.9, 131.0, 130.6, 125.6, 99.2; HRMS calcd. for C32H24N4: 464.2001, found: 464.2004. 
 
Tetrakis(2-methoxyphenyl) benzobis(imidazolium) chloride (3.14d): From the 
tetraamine tetrahydrochloride: The tetraamine tetrahydrochloride (5.0 g, 7.06 mmol) was 
dissolved in HC(OEt)3 (60 mL) and conc. HCl (0.2 mL). The deep purple solution was 
stirred at 140 °C for 2 h during which time the homogenous reaction mixture became a 
light red slurry. The reaction mixture was allowed to cool and Et2O (30 mL) was added to 
facilitate precipitation of the product. The solids were collected, rinsed with Et2O and 
recrystallized from hot MeOH/Et2O to give 4.26 g (92%) of the bis(azolium) as a pink-
brown solid: 1H NMR (DMSO-d6): δ 10.79 (s, 2H), 8.00 (dd, J = 7.8, 1.4 Hz, 2H), 7.98 
(s, 2H), 7.73 (t, J = 8.0 Hz, 4H), 7.48 (d, J = 6.8 Hz, 4H), 7.28 (t, J = 7.2 Hz, 4H), 3.87 (s, 
12H); 13C NMR (DMSO-d6): δ 153.7, 148.5, 133.0, 130.8, 128.4, 121.3, 120.6, 113.7, 
100.4, 56.4; HRMS m/z calcd for C36H32N4O4: 584.2462, found: 584.2418. 
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Chapter 4: Synthesis of Benzobis(imidazolium) Salts via Tandem 
Cyclization-Oxidatino of 2,5-Diamino-1,4-benzoquinonediimines 
 
4.1 Introduction 
Azophenines64 and related N,N′,N′′,N′′′-tetraalkyl-2,5-diamino-1,4-
benzoquinonediimines65 are remarkable quinone derivatives which have found utility in 
coordination chemistry,65 function as pH-dependent chromophores,66 and are currently 
scrutinized for interesting π-electron delocalization characteristics.86 Considering they are 
also robust, stable toward oxygen, and available via several synthetic methods,64,66,71 we 
desired an operationally-simple, “one-pot” procedure for transforming these versatile 
substrates to their respective benzobis(imidazolium) salts, a class of compounds that are 
finding increasing utility in organic, organometallic, and materials chemistry.46 
 
4.2 Tandem cyclization-oxidation of 2,5-diamino-1,4-benzoquinonediimines 
As shown in Scheme 4.1, the o-quinoid tautomer (1-o) of 2,5-diamino-1,4-
benzoquinonediimine 4.1 displays 1,2-diamino and 1,2-diimino moieties which are 
independently known for undergoing dehydrative cyclizations. For example, treatment of 
1,2-diimine 4.2 with formaldehyde affords imidazolium salt 4.387 whereas the 
corresponding vicinal diamine 4.4 affords the cyclic N,N′-acetal 4.5.88 With these 
considerations in mind, we envisioned that analogous cyclization reactions with 4.1 
should afford an annulated benzimidazolium/N,N´-acetal hybrid (e.g. 4.6, Scheme 2). 
Oxidation of this intermediate using Thorn’s recently reported89 Pd-mediated process for 
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efficiently generating hydrogen gas from phenylene diamine-derived N,N´-acetals should 
then afford the respective benzobis(imidazolium) salts.90  
 
Scheme 4.1 (TOP) The o-tautomer of 2,5-diamino-1,4-benzoquinonediimine (4.1-o) 
exhibits 1,2-diamino and 1,2-diimino fragments which are (BOTTOM) independently 



































To test this hypothesis, 2,5-diamino-1,4-quinonediimines 4.1a – e were prepared 
via exhaustive Pd-catalyzed aryl amination of 1,2,4,5-tetrabromobenzene followed by 
spontaneous oxidation during an aerobic workup (see Chapter 3).91 Confirmation of the 
2,5-diamino-1,4-quinonediimine structure was determined using 1H NMR spectroscopy 
through identification of the diagnostic chemical shift of the vinylic proton of the quinoid 
ring (δ = 5.5 ppm in CDCl3) and single crystal X-ray analysis for 4.1b. As shown in 
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Scheme 4.2, compounds 4.1 were each reacted with paraformaldehyde in PhCH3 under 
acidic conditions at 110 °C.92 Within 2 – 6 h, the intense colors associated with these 
quinones derivatives had dissipated and the reaction mixtures developed yellow-brown 
solids suggesting hybrid intermediate 4.6 had formed. The reaction temperature was then 
reduced to 50 °C and, to facilitate dissolution of precipitated solids, i-PrOH (10% by 
volume) was added. Upon addition of catalytic amounts of Pd(OAc)2 (1 mol %), slow 
and persistent generation of hydrogen gas was observed. Analysis of the crude reaction 
mixtures by 1H NMR spectroscopy indicated the 2,5-diamino-1,4-benzoquinonediimines 
(diagnostic signals: tetraaminobenzene C-H, δ = 8 ppm and benzimidazolium C-H, δ = 
10 - 11 ppm in DMSO-d6), were cleanly converted to the desired benzobis(imidazolium) 
products 7 in good to excellent yields (48 – 98%).  
 
Scheme 4.2 Conversion of 2,5-diamino-1,4-quinonediimines to their respective 












4.7a, 48% (R = Ph)
4.7b, 98% (R = 2-MeOPh)
4.7c, 85% (R = t-Bu)
4.7d, 95% (R = Ad)





















Although analysis of the products obtained above via 1H NMR spectroscopy were 
strongly indicative of the desired benzobis(imidazolium) structure, they were further 
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characterized using X-ray analysis after quality crystals of benzobis(imidazolium) 
dichloride 4.7b were obtained by slow cooling of a hot saturated DMSO solution. As 
shown in Figure 4.1, the N1-C2-N2 bond angle (110°) was typical of annulated 
imidazolium compounds as were the imidazole bond lengths.23,37 The N-anisidyl rings 
were rotated out-of-plane with respect to the benzobis(imidazolium) core (dihedral angles 
ranged between 35 and 60°) which indicated there was relatively minimal electronic 
overlap between the two moieties. Finally, C-C bond lengths typical of arene rings were 
observed (1.38 to 1.41 Å), which indicated the parent quinone core was successfully 
reduced.  
 
Figure 4.1 ORTEP representation of benzobis(imidazolium) dichloride 4.7b 
(counterions have been removed for clarity)  
 
Selected bond lengths (Å) and angles (degs): N1-C1, 1.3352(19); N2-C1, 1.3398(19); 
N1-C2, 1.4007(18); N2-C3, 1.3986(18); C2-C3, 1.4062(19); C2-C4, 1.384(2); N1-C1-
N2, 110.21(13); C1-N1-C2, 108.55(11); N1-C2-C3, 106.37(12); C4-C2-N1, 130.60(13); 






In summary, we have developed an efficient one-pot synthetic protocol for 
preparing a variety of N-alkyl and N-aryl benzobis(imidazolium) salts from readily 
available 2,5-diamino-1,4-benzoquinonediimines. In particular, the o-quinoid tautomer of 
2,5-diamino-1,4-benzoquinonediimines was cyclized using paraformaldehyde to obtain 
benzimidazolium/N,N´-acetal hybrids which were subsequently oxidized. Finally, a 
comparative solid-state study between an azophenine derivative and its corresponding 
benzobis(imidazolium) salt was also performed which ultimately aided in confirming the 
chemical structures of these compounds. 
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The construction of new organic-inorganic hybrid materials with interesting 
structural features and technologically-useful functions is a vibrant area of research with 
considerable potential. The key to growth in this field is the development of new, tunable 
molecular scaffolds for bridging transition metals. Ideal linkers should be readily 
accessible, exhibit high affinities toward a broad range of transition metals, and possess 
modular features amenable for precisely manipulating their inherent physical and 
electronic characteristics. Stable N-heterocyclic carbenes (NHCs),2 particularly 
imidazolylidenes,93 fall in this category. They have been found to form robust complexes 
with nearly every transition metal3 and the basic N-heterocyclic nucleus as well as its N-
substituents can be acutely modified.94 As such, an impressive amount of attention has 
been devoted toward optimizing and understanding the interaction of carbenes with 
various transition metals to form monometallic complexes.95 However, comparatively 
less attention has been directed toward the development of discrete, multifunctional 
carbenes that are poised to bind multiple transition metals.27,28,29 Herein, we report the 
synthesis and characterization of benzobis(imidazolylidene)s, a new class of Janus96 
bis(carbene)s comprised of two linearly opposed imidazolylidenes annulated to a 




5.2 Synthesis and characterization of free bis(N-heterocyclic carbene)s 
Requisite benzobis(imidazolium) salts possessing a range of N-substituents (5.1) 
were synthesized as described in Chapters 3 and 4. Independent treatment of 5.1a-c with 
2.2 equiv of lithium diisopropylamide (LDA) in THF at RT caused precipitation of 
products 5.2a and 5.2b which were subsequently isolated via filtration in yields of 83 and 
99%, respectively (Scheme 5.1). While 5.2a and 5.2b were only slightly soluble in 
common organic solvents (THF, toluene, benzene, etc.), a highly soluble derivative 
featuring N-t-amyl groups (5.2c) was obtained in 99% yield after LiCl was precipitated 
with excess toluene and removed via filtration. 
 








5.2a (R = Ad), 83%
5.2b (R = tBu), 99%








5.1a (R = Ad, X = BF4)
5.1b (R = tBu, X = BF4)
5.1c (R = tAmyl, X = Cl)
5.1d (R = Ph, X = Cl)







5.3a (R = Ad, MLn = Rh(COD)Cl), 77%
5.3b (R = Ph, MLn = AgCl), 97%
5.3c (R = 2-OMePh, MLn = AgCl), 94%









The 13C NMR spectra of products 5.2a–c in C6D6 each exhibited a single, 
diagnostic signal between δ = 227 – 231  ppm which was indicative of the highly 
symmetric structures shown in Scheme 5.1 and consistent with other known annulated 
imidazolylidenes.19 To confirm, a crystal of 5.2a was obtained by vapor diffusion of 
pentane into a saturated toluene/THF solution (1:1 v/v) and analyzed using X-ray 
diffraction analysis. An ORTEP view of the molecular structure is shown in Figure 5.1 
with selected bond lengths and angles in the caption. Notably, the N-C-N bond angle was 
found to be 104.8(2)° which was similar to saturated imidazolylidenes97 and 
benzimidazolylidenes.19 This promising result strongly suggested that each carbene 
“face” of these Janus ligands should display similar chemistries and affinities toward 
transition metals as their monofunctional analogues. 
 
Figure 5.1 ORTEP view of 5.2a 
 
Selected bond lengths (Å) and angles (°): C1-N1, 1.369(3); C1-N2, 1.368(3); N1-C3, 





5.3 Synthesis and characterization of bimetallic complexes of bis(N-heterocyclic 
carbene)s 
Addition of an equimolar amount of [Rh(cod)Cl]2 to a THF solution of 5.2a at RT 
resulted in the precipitation of Rh complex 5.3a as a yellow solid, which was isolated in 
77% yield. Analysis of this complex by NMR spectroscopy confirmed the stoichiometry 
between the Rh centers and bis(carbene) nucleus was 2:1. A single 13C resonance 
appeared at δ = 198 ppm and two distinct sets of olefinic 1H signals were observed at 3.0 
(cis to the carbene) and 5.0 ppm (trans), which was suggestive of a square planar 
geometry for each of the metal centers.98 The structure of 5.3a was confirmed by X-ray 
diffraction analysis after a suitable crystal was obtained by slow cooling of a hot CHCl3 
solution (see Figure 5.2). Although key bond lengths were in accord with known NHC-
Rh complexes,98 a notable exception was the positions of Rh atoms which were displaced 
perpendicularly from the plane of the benzobis(imidazolylidene) by 0.75 Å. This unusual 
structural feature was attributed to the substantial steric bulk of the N-adamantyl groups 










Figure 5.2 ORTEP view of 5.3a 
 
Selected bond lengths (Å) and angles (°): Rh1-C1, 2.073(3); Rh1-C25, 2.125(3); Rh1-
C26, 2.131(3); Rh1-C29, 2.184(3); Rh1-C30, 2.197(3); C1-N1, 1.387(4); C1-N2, 
1.406(4); N1-C1-N2, 105.7(2). Hydrogen atoms have been removed for clarity. 
 
In cases where the free bis(carbene)s were not isolable (5.1d-e), an alternative 
method of forming metal complexes was desired. Direction shifted toward Lin’s41 
versatile Ag-mediated carbene transfer protocol for accessing organometallic 
complexes.47 As shown in Scheme 5.1, bis(azolium) salts 5.1d and 5.1e were respectively 
treated with Ag2O (1.0 equiv) in CH2Cl2 (23 °C) or CH3CN (40 °C). Following filtration 
of inorganic salts which precipitated during the reaction, concentration of the resulting 
solutions afforded products 5.3b and 5.3c in excellent yields (97 and 94%, respectively). 
Crystals of 5.3c were obtained from slow diffusion of hexanes into a saturated CH2Cl2 
solution and analyzed using X-ray diffraction analysis. As shown in Figure 5.3, the 
structure was essentially linear along its main axis with a C1-Ag1-Cl1 bond angle of 176° 
and its N-aryl substituents were rotated out of the plane of the benzobis(imidazolylidene) 
with an average dihedral angle = 69°. Interestingly, in the solid-state the complexes 




Figure 5.3 ORTEP view of 5.3c 
 
Selected bond lengths (Å) and angles (°): Ag1-C1, 2.072(11); Ag1-Cl1, 2.236(3); C1-N1, 
1.352(12); C1-N2, 1.360(11); N1-C2, 1.409(11); N2-C3, 1.409(12; N1-C1-N2, 106.4(9). 
Ag-Ag, 3.3054(15). Hydrogen atoms have been removed for clarity. 
 
Treatment of complex 5.3b with an equimolar amount of [Rh(cod)Cl]2 in CH2Cl2 
at 50 °C for 24 h afforded bimetallic Rh complex 5.3d as an orange-brown powder in 
40% yield. Although solution and solid-state structural analyses indicated 5.3d was 
superficially similar to 5.3a, a key difference was the Rh atoms were now coplanar with 
the benzobis(imidazolylidene). Considering the N-phenyl groups were rotated by an 
average of 63° relative to this same plane (minimizing any electronic contributions) and 
both complexes showed a similar trans effect (average Rh-olefin bond distances: 5.3a: 
2.20 Å vs. 5.3d: 2.19 Å), the size of the N-substituents appeared to dominate structural 
features about the metals centers. 
Finally, we focused on the synthesis of bis(azolium) 5.4, a desymmetrized 
precursor that was envisioned to provide a Janus bis(carbene) with differential 
characteristics at each carbene “face.” The dissimilar environments of the 1,3-dimethyl- 
and 1,3-di-t-butylimidazolium fragments were manifested in the 1H NMR spectrum 
(DMSO-d6) of 5.4 which exhibited signals at δ = 9.9 and 9.0 ppm, respectively. 
Deprotonation of 5.4 using 2.1 equiv of NaH (and catalytic KOtBu) in toluene at 120 °C 
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resulted in selective dimerization to afford enetetraamine 5.5 which was subsequently 
isolated in 94% yield. Crystals suitable for X-ray analysis were obtained by slow cooling 
of a saturated toluene solution of 5.5 and an ORTEP view of the structure of this 
compound is shown in Figure 5.4. Key bond lengths and angles of the 
benzimidazolylidene fragments were in accord with 5.2b, and the torsion angle about the 
enetetraamine was found to be 15.2°, consistent with the dimer of 1,3-
dimethylbenzimidazolylidene.98a The solution structure of 5.5 was confirmed by 
treatment with O2 which rapidly and selectively oxidized the enetetramine moiety to 
afford urea 5.6.44 
 












































Figure 5.4. ORTEP view of 5.5 
 
Selected bond lengths (Å) and angles (°): C5-N3, 1.366(3); C5-N2, 1.371(3); N3-C6, 
1.406(2); N2-C4, 1.404(3); C1-N1, 1.426(3); C1-N4, 1.424(3); N4-C8, 1.416(3); N1-C2, 
1.408(2); C1-C1*, 1.349(4); C1-N4-C18, 117.79(18); N2-C5-N3, 104.00(17); N1-C1-N4, 




In summary, we report the first Janus bis(carbene)s with facially opposed 
imidazolylidenes annulated to a common arene core. Solid-state analysis was performed 
for various intermediate and combine, the X-ray analyses suggest a sterically-governed 
binding arrangement. Synthetic routes employed to obtain these compounds were 
modular, high yielding, and permitted access to derivatives with N-alkyl or N-aryl 
substituents as well as a desymmetrized variant. Their promise as ligands was borne out 
through synthesis of new bimetallic complexes, and efforts toward heterobimetallic 
complexes are currently underway. 
 
5.5 Experimental Section 
General Considerations. All reactions were conducted under an atmosphere of 
dry nitrogen using standard Schlenk techniques or in a nitrogen filled glove-box. CH2Cl2 
was distilled from CaH2 under nitrogen and degassed by three freeze-pump-thaw cycles. 
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THF and toluene were distilled from Na/benzophenone under nitrogen and degassed by 
three freeze-pump-thaw cycles. [Rh(cod)Cl]2 and 1,3-bis(2,6-
diisopropylphenyl)imidazolium chloride were purchased from Strem and used without 
further purification. All other reagents were purchased from Aldrich or Acros and were 
used without further purification. 1H NMR spectra were recorded using a Varian Gemini 
(300 MHz or 400 MHz) spectrometer. Chemical shifts are reported in delta () units, 
expressed in parts per million (ppm) downfield from tetramethylsilane using the residual 
protonated solvent as an internal standard (CDCl3, 7.24 ppm; C6D6, 7.15 ppm, DMSO-d6, 
2.49 ppm). 13C NMR spectra were recorded using a Varian Gemini (100 MHz) 
spectrometer. Chemical shifts are reported in delta (δ) units, expressed in parts per 
million (ppm) downfield from tetramethylsilane using the solvent as an internal standard 
(CDCl3, 77.0 ppm; C6D6, 128.0 ppm, DMSO-d6, 39.5 ppm). 13C NMR spectra were 
routinely run with broadband decoupling. High-resolution mass spectra (HRMS) were 
obtained with a VG analytical ZAB2-E or a Karatos MS9 instrument and are reported as 
m/z (relative intensity). 
 
Tetrakis-N-adamantylbenzobis(imidazolylidene) (5.2a). In a nitrogen-filled drybox, a 
20 mL flask was charged with bis(azolium) salt 5.1a (680 mg, 0.78 mmol), THF (10 mL), 
LDA (1.83 M in hexanes, 0.93 mL, 1.70 mmol), and a stir bar. The flask was sealed and 
the resulting slurry was stirred for 10 h at RT. Precipitated solids were collected by 
filtration, washed with THF (5 mL) and dried under reduced pressure to afford 450 mg 
(83%) of the desired product as a white solid. Crystals suitable for X-ray analysis were 
obtained by solvent diffusion of pentane into a saturated solution of 5.2a in toluene/THF 
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(1:1 v/v). 1H NMR (C6D6): δ 8.37 (s, 2H), 2.81 (s, 24H), 2.15 (s, 12H), 1.81-1.67 (br, 
24H); 13C NMR (C6D6): δ 227.6, 130.5, 98.5, 58.3, 43.6, 37.2, 30.5.  
 
Tetrakis-N-t-butylbenzobis(imidazolylidene) (5.2b). In a nitrogen-filled drybox, a 20 
mL flask was charged with bis(azolium) salt 5.1b (1.27 g, 2.3 mmol), THF (10 mL), 
LDA (1.80 M in hexanes, 2.8 mL, 5.05 mmol), and a stir bar. The flask was sealed and 
the resulting slurry was stirred for 10 h at RT. Precipitated solids were collected by 
filtration, washed with THF (5 mL) and dried under vacuum to afford 870 mg (99%) of 
the desired product as a light gray solid. Crystals suitable for X-ray analysis were 
obtained by slow cooling of a hot, saturated toluene solution. 1H NMR (C6D6): δ 7.79 (s, 
2H), 1.78 (s, 36H); 13C NMR (C6D6): δ 228.3, 130.9, 97.5, 57.2, 30.5; HRMS calcd. for 
C24H34N4 [M+H+]: 383.3175, found: 383.3177. 
 
Tetrakis-N-t-amylbenzobis(imidazolylidene) (5.2c). In a nitrogen-filled drybox, a 10 
mL flask was charged with bis(azolium) salt 5.1c (50 mg, 0.098 mmol), LDA (0.41 M in 
THF, 0.48 mL, 0.195 mmol), and a stir bar. The resulting slurry was stirred for 15 
minutes at RT, then toluene (1 mL) was added. The reaction mixture was filtered through 
Celite and the solvent was removed under reduced pressure to afford 22 mg (99%) of the 
desired product as a white solid. 1H NMR (C6D6): δ 7.89 (s, 2H), 2.14 (q, J = 7.2 Hz, 
8H), 1.85 (s, 24H), 0.76 (t, J = 7.2 Hz, 12H); 13C NMR (C6D6): δ 230.2, 131.1, 96.9, 
60.1, 33.7, 29.0, 8.5; HRMS calcd. for C26H46N4 [M+H+]: 438.3722, found: 438.3722. 
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Bimetallic Rhodium Complex 5.3a. In a nitrogen-filled drybox, a 10 mL flask was 
charged with bis(carbene) 5.2a (70 mg, 0.1 mmol), [(COD)RhCl]2 (50 mg, 0.1 mmol), 
THF (2 mL), and a stir bar. The resulting slurry became homogeneous after stirring for 5 
min at RT. Product precipitation began within 30 min and the reaction was stirred for an 
additional 2 h. Precipitated solids were collected by filtration, washed with THF (3 mL), 
and dried under vacuum to afford 100 mg (77%) of the desired product as a yellow 
powder. Crystals suitable for X-ray analysis were obtained by slow evaporation of a 
saturated CHCl3 solution. 1H NMR (CDCl3): δ 8.20 (s, 2H),  4.98 (s, 2H), 3.50-3.47 (m, 
12H), 3.00-2.97 (m, 16H), 2.47-2.41 (m, 22H), 1.67-1.61 (m, 36H); 13C NMR (CDCl3): δ 
198 (d), 129.5, 109.7, 99.9, 92.5 (d, J = 6.9 Hz), 67.7 (d, J = 14.8 Hz), 62.2, 43.2, 36.6, 
32.3, 30.4, 28.8.  
 
Diargento Complex 5.3b. Bis(azolium) salt 5.1d (535 mg, 1.0 mmol) was dissolved in 
CH3CN (10 mL) and Ag2O (243 mg, 1.05 mmol) was added. The resulting suspension 
was stirred at 40 °C for 2 h. The cooled reaction mixture was filtered through Celite and 
concentrated to give 726 mg (97%) of 5.3b as a brown powder. 1H and 13C NMR analysis 
revealed broad peaks indicative of aggregation/oligomerization. 1H NMR (DMSO-d6) δ 
7.82-7.78 (m, 8H), 7.73-7.60 (m, 12H), 7.45 (s, 2H). 
 
Diargento Complex 5.3c. Bis(azolium) salt 5.1e (1.20 g, 1.82 mmol) was suspended in 
CH2Cl2 (100 mL). To the mixture was added Ag2O (423 mg, 1.82 mmol) and the flask 
was protected from light using Al foil. After stirring for 2 h at room RT, a brown 
 83
suspension formed which was filtered over Celite and concentrated to a brown glassy 
solid (1.49 g, 94%). 1H and 13C NMR analysis revealed broad peaks indicative of 
aggregation/oligomerization. Crystals suitable for X-ray analysis were obtained by 
diffusion of hexanes into a solution of 3c in CH2Cl2.  
 
Bimetallic Rhodium Complex 5.3d. From bis(azolium) salt 5.1d·BF4: The bis(azolium) 
salt (100 mg, 0.157 mmol) was added to THF (3 mL) followed by NaHMDS (0.16 mL, 
0.32 mmol, 2.0 M in THF). The slurry was stirred for 1 h, then [(COD)RhCl]2 (77 mg, 
0.157 mmol) was added and the solution was heated to 50 °C in a sealed vial for 10 h. 
The cooled reaction mixture was diluted with hexanes (6 mL) and solids were collected 
by filtration, washed with toluene (5 mL) and hexanes (5 mL). Solvent was removed 
under reduced pressure. Residual inorganic salts were removed by treating the crude solid 
with chloroform and filtering through a 0.45 μm PTFE filter, followed by removal of 
solvent under reduced pressure to obtain the product as a tan solid (51 mg, 34%).  
 
From diargento complex 5.3b: The diargento complex 5.3b (373 mg, 0.50 mmol) and 
[(COD)RhCl]2 (258 mg, 0.52 mmol) were partially dissolved in CH2Cl2 (12 mL) in a 
screw-cap vial under an atmosphere of dry nitrogen. The vial was sealed with a Teflon-
coated cap and stirred at 50 °C for 20 h protected from light with Al foil. The cooled 
reaction mixture was then filtered through Celite and concentrated to give 191 mg (40%) 
of the desired product. Crystals suitable for X-ray analysis were obtained by slow 
diffusion of hexanes into a saturated CH2Cl2 solution. 1H NMR (CDCl3): δ 8.13 (br, 8H), 
7.64-7.52 (br, 12H), 7.13 (s, 2H), 4.89 (br, 4H), 2.73 (br, 4H), 1.8-1.46 (br, 16H); 13C 
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NMR (CDCl3): δ 137.7, 132.7, 129.3, 128.9, 127.8, 127.4, 109.7, 99.3, 91.9, 68.5 (d, J = 
13.9  Hz), 32.0, 28.2. 
 
5,6-Bis(t-butylamino)-1-methylbenzimidazole. Under an atmosphere of nitrogen, a 10 
mL vial was charged with 1,3-bis(2,6-diisopropylphenyl)imidazolium chloride (17 mg, 
0.04 mmol), NaOtBu (2 mg, 0.02 mmol), Pd(OAc)2 (5 mg, 0.02 mmol), toluene (5 mL), 
and a stir bar. The resulting mixture was stirred at 80 °C for 5 minutes. Then, 5,6-
dichloro-1-methylbenzimidazole[99] (101 mg, 0.50 mmol) was added, followed by t-butyl 
amine (146 mg, 2.0 mmol) and NaOtBu (101 mg, 1.05 mmol). The resulting mixture was 
sealed and stirred at 150 °C for 24 h. After cooling to RT, precipitated solids were 
removed by filtration and solvent was removed to obtain a brown solid which was used in 
the next step without additional purification. 1H NMR (CDCl3): δ 7.57 (s, 1H), 7.32 (s, 
1H), 6.70 (s, 1H), 3.70 (s, 3H), 1.34 (s, 9H), 1.21 (s, 9H); 13C NMR (CDCl3): δ 141.2, 
140.0, 136.1, 131.9, 131.4, 115.6, 95.6, 52.8, 51.3, 38.5, 29.8, 29.7. 
 
Desymmetrized Benzimidazolium Salt. Crude 5,6-bis(t-butylamino)-1-
methylbenzimidazole was partially dissolved in  HC(OEt)3 and  HBr (48%). The 
resulting slurry was stirred for 3 h at 65 °C. After cooling to RT, the solids were collected 
by vacuum filtration. The crude product was then dissolved in iPrOH and stirred with 
excess Na2CO3 for 2 h. Filtration through Celite followed by removal of solvent under 
reduced pressure provided the desired product as a golden solid in 65% yield from 5,6-
dichloro-1-methylbenzimidazole. 1H NMR (DMSO-d6): δ 8.83 (s, 1H), 8.53 (s, 1H), 8.5 
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(s, 1H), 8.39 (s, 1H). 4.0 (s, 3H), 1.88 (s, 9H), 1.85 (s, 9H); 13C NMR (DMSO-d6): δ 
148.8, 141.8, 139.1, 133.5, 127.5, 127.0, 105.4, 96.9, 60.72, 60.68, 31.4, 27.9, 27.8; 
HRMS calcd for C17H25N4: 285.2079, found: 285.2079. 
 
Desymmetrized Benzobisbis(imidazolium) Salt 5.4. The asymmetric benzimidazolium 
salt (3.00 g, 8.21 mmol) was dissolved in CH3CN (100 mL) and MeI (5 mL, 78.0 mmol) 
was added. The solution was stirred in a sealed vessel at 60 °C for 3 h. The cooled 
reaction mixture was then concentrated under vaccum to obtain 4.17 g (99%) of 5.4 as a 
brown powder. 1H NMR (DMSO-d6): δ 9.96 (s, 2H), 9.05 (s, 2H), 8.85 (s, 2H), 4.24 (s, 
6H), 1.93 (s, 18H); 13C NMR (DMSO-d6): δ 147.0, 142.4, 130.0, 129.4, 100.9, 61.8, 34.1, 
27.7. 
 
Enetetraamine 5.5. A 10 mL vial was charged with asymmetric salt 5.4 (100 mg 0.197 
mmol), NaH (12 mg 0.48 mmol), a catalytic amount of KOtBu (ca. 1 mg) and toluene (2 
mL). The vial was then sealed and the reaction mixture was heated to 120 °C for 2 h. The 
cooled solution was then filtered through a 0.2 µm PTFE filter and solvent was removed 
under vacuum to obtain 55 mg (94%) of the desired product as a dark red powder. 
Crystals suitable for X-ray analysis were obtained by slowly cooling of a saturated 
toluene solution. 1H NMR (C6D6): δ 6.84 (s, 2H), 2.84 (s, 6H), 1.82 (s, 18H); 13C NMR 
(C6D6): δ 221.2, 138.7, 130.8, 125.9, 94.7, 57.0, 36.9, 30.7. 
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Urea 5.6. Enetetraamine 5.5 (0.05 g, 0.168 mmol) was dissolved in benzene and exposed 
to an atmosphere of oxygen for < 1 minute. After the color of the solution changed from 
red to brown, the solvent was removed under vacuum to obtain 51 mg (99%) of product 
as a brown powder. 1H NMR (C6D6): δ 6.83 (s, 2H), 2.91 (s, 6H), 1.79 (s, 18H); 13C 
NMR (C6D6): δ 223.0, 155.0, 130.6, 125.8, 92.7, 57.2, 20.5, 26.5; HRMS calcd. for 
C18H28N4O [M+H+]: 315.2185; found, 315.2185. 
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Chapter 6: Ionic Liquids via Efficient, Solvent-Free Anion Metathesis 
 
6.1 Introduction 
The impact of ionic liquids (ILs) continues to spread unimpeded as their 
applications and utility transcend many areas of chemistry.100 These neoteric solvents 
provide many desirable features for facilitating chemical reactions, including: 1) non-
volatility, 2) commercial availability, 3) high polarity, 4) high thermal stability, 5) broad 
miscibility, and 6) facile recyclability. The particular combination of low vapor pressure, 
high stability, and reusability have earned ILs recognition as environmentally benign 
alternatives to traditional organic solvents.101 Recently, room-temperature ILs (RTILs) 
have found extraordinary utility in a number of synthetic applications,100 and the anionic 
component is credited with strongly influencing their physical properties.102  
 Obtaining RTILs with non-coordinating counteranions is typically accomplished 
from the corresponding halide salt. Common methods to exchange halides for non-
coordinating anions are based on either metathesis (e.g., with a silver(I), alkali, or 
ammonium salt), or acid-base neutralization reactions.100 The halide-containing 
byproduct salt resulting from these reactions is then removed by precipitation and 
filtration, or extraction. 
 Seeking alternatives to precipitation- or extraction-based halide removal, we 
considered capitalizing on the nucleophilic nature of the halide in such a way that would 
generate volatile reagents as the sole byproducts. Inspired by solution-based studies 
involving the nucleophilicity of halides in polar media,103 we focused our attention on 
using stoichiometric amounts of organic halide salts in combination with alkyl sulfates, 
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sulfonates, phosphates, and phosphonates under solvent-free conditions. Herein, we 
report the scope and utility of a anion metathesis (AM) protocol that does not rely on 
extensive purification protocols, metal reagents, or organic solvents, and effective offers 
a “cleaner,” general approach104 to exchanging anions in ILs. Key data are summarized in 
Table 6.1.  
 
6.2 Solvent-free anion metathesis 
Initial experiments focused on using 1-butyl-3-methylimidazolium (BMIM) 
halides with Me2SO4 to generate the corresponding [BMIM][MeSO4] and MeX (X = Cl, 
Br, I). Treatment of [BMIM]Cl with an equimolar amount of Me2SO4 at amibent 
temperature immediately resulted in rapid gas evolution, leaving a clear liquid product 
(entry 1). After stirring the mixture for ca 5 min, analysis of the remaining material by 1H 
and 13C NMR spectroscopy revealed [BMIM][MeSO4] as the sole product. The MeSO4- 
provided a useful and convenient handle for confirming the progress of halide removal 
(diagnostic signal at δ = 3.75 ppm in CDCl3). Importantly, no residual Me2SO4 was 
present (δ = 3.96 ppm) which indicated the reaction had reached high conversion and was 
consistent with the high yield obtained (>99% yield). Similarly, treatment of [BMIM]Br 
with Me2SO4 also resulted in immediate gas evolution to provide [BMIM][MeSO4] in 
quantitative yield (entry 2). In the case of [BMIM]I, MeI resulting from the AM reaction 
was removed under vacuum, and ultimately provided the desired product in high purity 
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 aPurchased from commercial suppliers and stored in a desiccator until use. bProducts 
were analyzed by 1H and 13C NMR, and compared with authentic samples from 
commercial sources where applicable. All reactions were gravimetrically determined to 
be quantitative. Complete removal of alkyl halides was facilitated under vacuum. cSee 
Experimental Section 6.4 for product characterization. BMIM = 1-butyl-3-
methylimidazolium, BPY = 1-butylpyridinium, Hx3PC14 = 
trihexyl(tetradecyl)phosphonium. 
  
 Encouraged by these results, we shifted focus toward using Me2SO4 to effect AM 
in other classes of ILs. Treatment of 1-butylpyridinium (BPY) halides, [BPY]Cl and 
[BPY]I, with Me2SO4 afforded [BPY][MeSO4] with equal success as the imidazolium-
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based salts (entries 4 and 5, respectively). Phosphonium salts based on 
trihexyl(tetradecyl)phosphonium (Hx3PC14) cation were also investigated. Independently 
treating [Hx3PC14]Cl and [Hx3PC14]Br with a stoichiometric amount of Me2SO4 provided 
[Hx3PC14][MeSO4] in quantitative yields (entries 6 and 7, respectively). 
 Considering the tosylate (OTs) counterion has been incorporated into many ILs, 
we investigated solvent-free AM using MeOTs in lieu of Me2SO4. Independently treating 
[BMIM]Br and [BMIM]I with MeOTs rapidly afforded [BMIM][OTs] in quantitative 
yield and high purity (entries 8 and 9, respectively). As before, removal of MeI was 
facilitated under vacuum. Interestingly, [BPY]Cl (melting point = 162 °C) required 
heating to 120 °C before a relatively rapid reaction would occur (entry 10). Optimal 
conditions involved heating [BPY]Cl prior to addition of MeOTs, which provided the 
desired product rapidly (< 5 min) and in quantitative yield. A key difference in this 
reaction when compared to those described above is that neither the starting IL, nor the 
[BPY][OTs] product are RTILs.105 Use of [BPY]I, a RTIL, resulted in rapid reaction at 
room temperature (entry 11). Complete conversion with this substrate may be facilitated 
by partial solvation from MeI produced during the exchange.  
  Finally, attention was directed toward broadening the aforementioned 
methodology to access ILs containing other classes of non-nucleophilic, non-coordinating 
anions. Treatment of [BPY]Cl with trimethylphosphate afforded corresponding dimethyl 
phosphate salt in 100% yield (entry 12). This reaction required higher temperature (120 
°C) and an extended reaction time (90 min) to reach completion. This is believed to be 
related to the high melting points of the corresponding starting and product salts, in 
addition to the reduced electrophilicity of the phosphate. Importantly, de-alkylation of the 
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phosphate reagent was found to be highly selective, even in the presence of excess halide 
salt. Thus, this method offers a convenient means for obtaining mono-basic phosphonate 
and phosphate counterions. Notably, reactions involving diethyl phosphonates were met 
with limited success, identifying one boundary limit of this methodology. 
  
6.3 Conclusions 
In summary, we have developed an efficient “no workup” protocol for conducting 
concomitant halide-trapping/anion metathesis reactions in a range of widely used ILs. In 
particular, a variety of non-nucleophilic, non-coordinating anions were incorporated into 
ILs, including sulfates, sulfonates, phosphates, and phosphonates. The efficiency of the 
reaction was found to be dependent on a combination of factors, including the melting 
points of the starting and product salts, as well as the electrophilicity of the trapping 
reagent. Considering the practical and environmental benefits, the described methodology 
offers a new, general route for preparing non-coordinating, non-nucleophilic ILs and 
helps to minimize solvent dependency, metal waste byproducts, and purification 
protocols in accessing these important materials.  
 
6.4 Experimental Section 
General Considerations: NMR spectra were recorded using a Varian Unity Plus 
300 or 400 spectrometer. Chemical shifts are reported in delta (δ) units, expressed in 
parts per million (ppm) downfield from tetramethylsilane using the residual protonated 
solvent as an internal standard (CDCl3, 1H: 7.26 ppm; 13C: 77.0 ppm). 13C NMR spectra 
were routinely run with broadband decoupling. 1-Butyl-3-methylimidazolium ([BMIM]) 
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halides were prepared via the reaction of 1-methylimidazole (1.0 equiv) and butyl halide 
(1.05 equiv) in a sealed vessel at 130 °C for 24 h, followed by removal of volatile 
components. 1-Butylpyridinium ([BPY]) halides were prepared in an analogous fashion 
from pyridine and the corresponding 1-haloalkane. All other reagents were purchased 
from commercial suppliers and used as received.  All organic halide salts were stored in a 
desiccator prior to use. Iodide salts were protected from light using aluminum foil.  Due 
to the hygroscopic nature of these salts, reactions were routinely protected with a drying 
tube containing Drierite, unless otherwise noted. All reactions were conducted in a 
ventilated fume hood. Note: For solvent-free reactions involving solid azolium halides 
and trialkyloxonium salts, gradual liquefaction occurs over time. For comparative 
analyses, [BMIM][MeSO4], [BPY][MeSO4], [BMIM][OTs], [BMIM]BF4, [BMIM]PF6, 
[BPY]BF4, trihexyl(tetradecyl)phosphonium tetrafluoroborate ([Hx3PC14]BF4), and 1,3-












Table 6.2 Summary of anion metathesis reactions correlated with respective 
experimental procedures 
 
Entry Trapping Agent Organic Halide Salt Product
1 Me2SO4 [BMIM]Cl [BMIM][MeSO4]
2 Me2SO4 [BMIM]Br [BMIM][MeSO4]
3 Me2SO4 [BMIM]I [BMIM][MeSO4]
4 Me2SO4 [BPY]Cl [BPY][MeSO4]
5 Me2SO4 [BPY]I [BPY][MeSO4]
6 Me2SO4 [Hx3PC14]Cl [Hx3PC14][MeSO4]
7 Me2SO4 [Hx3PC14]Br [Hx3PC14][MeSO4]
8 MeOTs [BMIM]Br [BMIM][OTs]
9 MeOTs [BMIM]I [BMIM][OTs]
10 MeOTs [BPY]Cl [BPY][OTs]
11 MeOTs [BPY]I [BPY][OTs]
12 Me3PO4 [BPY]Cl [BPY][Me2PO4]
13 Me3O·BF4 [BMIM]Cl [BMIM]BF4
14 Me3O·BF4 [BMIM]Br [BMIM]BF4
15 Me3O·BF4 [BMIM]I [BMIM]BF4
16 Et3O·BF4 [BMIM]Br [BMIM]BF4
17 Et3O·PF6 [BMIM]Cl [BMIM]PF6
18 Et3O·BF4 [BPY]Cl [BPY]BF4
19 Et3O·BF4 [Hx3PC14]Cl [Hx3PC14]BF4
20 Et3O·BF4 [Hx3PC14]Br [Hx3PC14]BF4
21 Et3O·BF4 [IMes]Cl [IMes]BF4
22 Et3O·BF4 [BMIM]Br [BMIM]BF4
23 Et3O·BF4 [HPMIM]Br [HPMIM]BF4  
 
Entry 1.  A flask was charged with a magnetic stirbar and 1-butyl-3-methylimidazolium 
chloride (521 mg, 2.98 mmol), and then sealed with a rubber septum. A drying tube 
containing Drierite was fitted with a needle and inserted through the septum. Dimethyl 
sulfate (0.28 mL, 2.98 mmol) was then injected via syringe through the septum. The 
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mixture was then vigorously stirred for 1 min, then placed under vacuum to provide 747 
mg (100% yield) of the desired product. 
 
Entry 2.  A flask was charged with a magnetic stirbar and 1-butyl-3-methylimidazolium 
bromide (639 mg, 2.90 mmol), and then sealed with a rubber septum. A drying tube 
containing Drierite was fitted with a needle and inserted through the septum. Dimethyl 
sulfate (0.28 mL, 2.90 mmol) was then injected via syringe through the septum. The 
mixture was then vigorously stirred for 1 min, then placed under vacuum to provide 727 
mg (100% yield) of the desired product.   
 
Entry 3.  A flask was charged with a magnetic stirbar and 1-butyl-3-methylimidazolium 
iodide (540.5 mg, 2.0158 mmol), and then sealed with a rubber septum. A drying tube 
containing Drierite was fitted with a needle and inserted through the septum. Dimethyl 
sulfate (0.19 mL, 2.02 mmol) was then injected via syringe through the septum. The 
mixture was then vigorously stirred for 1 min, then placed under vacuum to provide 509 
mg (100% yield) of the desired product. 
 
Entry 4.  A flask was charged with a magnetic stirbar and 1-butylpyridinium chloride 
(603 mg, 3.51 mmol), and then sealed with a rubber septum. A drying tube containing 
Drierite was fitted with a needle and inserted through the septum. Dimethyl sulfate (0.33 
mL, 3.51 mmol) was then injected via syringe through the septum. The mixture was then 
vigorously stirred for 1 min, then placed under vacuum to provide 868 mg (100% yield) 
of the desired product. 
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Entry 5.  A flask was charged with a magnetic stirbar and 1-butylpyridinium iodide (528 
mg, 2.01 mmol), and then sealed with a rubber septum. A drying tube containing Drierite 
was fitted with a needle and inserted through the septum. Dimethyl sulfate (0.19 mL, 2.01 
mmol) was then injected via syringe through the septum. The mixture was then 
vigorously stirred for 1 min, then placed under vacuum to provide 496 mg (100% yield) 
of the desired product. 
 
Entry 6.  A flask was charged with a magnetic stirbar and 
trihexyl(tetradecyl)phosphonium chloride (141 mg, 0.27 mmol), and then sealed with a 
rubber septum. A drying tube containing Drierite was fitted with a needle and inserted 
through the septum. Dimethyl sulfate (0.03 mL, 0.27 mmol) was then injected via syringe 
through the septum. The mixture was then vigorously stirred for 1 min, then placed under 
vacuum to provide 162 mg (100% yield) of the desired product as a clear viscous liquid. 
 
Entry 7.  A flask was charged with a magnetic stirbar and 
trihexyl(tetradecyl)phosphonium bromide (152 mg, 0.27 mmol), and then sealed with a 
rubber septum. A drying tube containing Drierite was fitted with a needle and inserted 
through the septum. Dimethyl sulfate (0.03 mL, 0.27 mmol) was then injected via syringe 
through the septum. The mixture was then vigorously stirred for 1 min, then placed under 
vacuum to provide 162 mg (100% yield) of the desired product as a clear viscous liquid. 
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Entry 8.  A flask was charged with a magnetic stirbar and 1-butyl-3-methylimidazolium 
bromide (534 mg, 2.43 mmol), methyl tosylate (452 mg, 2.43 mmol), and then sealed 
with a rubber septum. A drying tube containing Drierite was fitted with a needle and 
inserted through the septum.  The mixture was then placed in an oil bath at 50 °C and 
vigorously stirred for 3 min, then placed under vacuum to provide 753 mg (100% yield) 
of the desired product. 
 
Entry 9.  A flask was charged with a magnetic stirbar and 1-butyl-3-methylimidazolium 
iodide (548 mg, 2.04 mmol), methyl tosylate (381 mg, 2.04 mmol), and then sealed with 
a rubber septum. A drying tube containing Drierite was fitted with a needle and inserted 
through the septum. The mixture was then vigorously stirred for 3 min, then placed under 
vacuum to provide 635 mg (100% yield) of the desired product. 
 
Entry 10.  A flask was charged with a magnetic stirbar and 1-butylpyridinium chloride 
(556 mg, 3.24 mmol), and then sealed with a rubber septum. A drying tube containing 
Drierite was fitted with a needle and inserted through the septum. The flask was then 
placed in an oil bath at 120 °C and methyl tosylate (608 mg, 3.27 mmol) was injected via 
syringe through the septum. The mixture was then vigorously stirred for 3 min, then 
placed under vacuum to provide 1.00 g (100% yield) of the desired product as a beige 
solid. 
 
Entry 11.  A flask was charged with a magnetic stirbar and 1-butylpyridinium iodide 
(699 mg, 2.66 mmol), methyl tosylate (495 mg, 2.66 mmol), and then sealed with a 
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rubber septum. A drying tube containing Drierite was fitted with a needle and inserted 
through the septum. The mixture was then vigorously stirred for 3 min, then placed under 
vacuum to provide 817 mg (100% yield) of the desired product as a beige solid. 
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Conjugated organic salts are a versatile class of molecules that have found utility 
in a range of applications,100,106 including ion-conductive membranes for fuel cells, 
photovoltaics, ionic organic light-emitting diodes, and ionic liquid crystals (ILCs). A 
nascent area of fundamental research, that may significantly advance the aforementioned 
applications, focuses on enhancing the photoluminescent properties of liquid organic salts 
(i.e., fluorescent ionic liquids). Current efforts in this area have been centered on 
traditional imidazolium-based ionic liquids (ILs).106f-h,107,108 Unfortunately, due to their 
relatively small chromophores, such ILs typically display stiflingly low emission 
intensities in the visible region (Фf < 0.05) which not only complicates analytical 
measurements but also limits their utilities.106f,g Further exploration in this field has been 
thwarted by inherent barriers associated with imparting fluidic properties to rigid 
polycyclic aromatic systems. Herein, we report a general, modular route to fluorescent, 
conjugated organic salts with tunable phase characteristics including room-temperature 
fluidity and mesomorphic (i.e., liquid-crystalline (LC)) behavior at higher temperatures. 
As summarized in Figure 7.1, benzobis(imidazolium) (BBI) salts are poised for finely 
tuning the phase characteristics of fluorescent conjugated organic salts. They feature: (1) 
robust imidazolium components for dually providing phase control and high thermal 
stabilities, (2) fluorogenic heteroaromatic cores which should enable efficient 
luminescence, and (3) modular N-substituents to tailor LC phase properties. Overall, 
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BBIs should provide phase-tunability as well as increased emission relative to traditional 
imidazolium-based ILs.                       
 
7.2 Synthesis of benzobis(imidazolium) salts with low Tgs 
Initially, we investigated BBIs 7.1 and 7.2, which possess N-alkyl and N-aryl 
groups, respectively (Figure 7.1). Not only was each salt found to display a high Фf, their 
disparate λmax values suggested a straightforward means to tune their electronic 
characteristics (Table 7.1) through N-substitution. Since 7.1 and 7.2 decomposed prior to 
melting, subsequent efforts shifted toward capitalizing on the structural features shown in 
Figure 7.1 to tune phase characteristics. 
Systematic structural optimization was guided by knowledge of related ILs,106d as 
well as solid-state analysis of select crystalline compounds. An advancement was made 
with BBI 7.3 which exhibited a relatively low glass transition temperature (Tg) of 89 °C 
due to its reduced molecular symmetry and non-coordinating counterions (c.f., 7.1 and 
7.2). Building from these results, BBI 7.4•MeSO4 (Tg = 43 °C) was synthesized, which 
takes advantage of dissimilar imidazolium rings to reduce its molecular symmetry even 
further. Surveying other counterions associated with the same BBI core (c.f., 7.4•BF4 and 
7.4•I) confirmed that MeSO4 was ideal for lowering the Tgs of these salts.109 By 
incorporating N-substituents that not only disrupted π-π interactions but also imparted π-
facial asymmetry (7.5 – 7.7), a BBI with a Tg < 0 °C was ultimately synthesized. Notably, 
high Tds were observed from each of the BBIs, typically exceeding 270 °C.   
As mentioned above, desirable photoluminescence properties were a key 
objective of our study. The absorption, excitation, and emission properties of 7.3 – 7.7 
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were initially investigated in MeOH. As summarized in Table 7.1, the absorption and 
emission spectra for 7.4 – 7.7 remained fairly consistent, which demonstrated an ability 
to selectively manipulate their physical properties without compromising control over 
electronic features. Importantly, each of the BBIs exhibited high Фfs (0.41–0.91), which 
should facilitate their application as functional, solution-based fluorophores. 
 








BBI R R' R" X Yield (%)a
7.1 Bu Bu Bu Br 93
7.2 Ph Ph Ph Cl 48
3 Me Ph Ph MeSO4 86
7.4•MeSO4 Me i -Bu 4-BuPh MeSO4 89
7.4•BF4 Me i -Bu 4-BuPh BF4 85
7.4•I Me i -Bu 4-BuPh I 88
7.5 Me i -Bu 3-MePh MeSO4 90
7.6 Et Me 3-MePh MeSO4 91
7.7 Et Me 4-OctPh MeSO4 89
7.8a C12H25 C12H25 C12H25 BF4 99










c Log (ε)c λem (nm)
c Φf
d
7.1 e 271 288 4.29 330 0.64
7.2 e 325 352 3.94 474 0.41
3 89 267 345 3.31 447 0.91
7.4•MeSO4 43 273 287 4.04 410 0.53
7.4•BF4 84 338 288 4.27 408 0.51
7.4•I 113 218 288 4.20 408 0.47
7.5 35 270 286 4.19 402 0.52
7.6 0.8 272 289 4.01 403 0.63
7.7 -0.3 274 289 4.13 408 0.57
7.8a f 338 291 4.14 332 0.85
7.8b f 341 348 4.03 451 0.72  aGlass transition temperature (Tg) obtained from the second heating run using DSC under 
N2, rate = 5 °C/min. bDecomposition temperature (Td) was defined as the temperature at 
which 10% weight loss occurred as determined by TGA under N2, rate = 10 °C/min. cIn 
MeOH under ambient conditions. dQuantum efficiencies (Φf) were determined relative to 
E-stilbene or anthracene. eNo transitions observed by DSC up to the Td. fMesomorphic, 
see text. 
 
Central to our primary objective, however, was the ability of the BBI 
chromophore to avoid self-quenching mechanisms and maintain intense emission in 
condensed phases. Photoluminescence was qualitatively observed from each of the glassy 
BBI fluorophores (i.e., 7.3 – 7.7) at temperatures above and below their Tgs. For 
example, as depicted in Figure 2, bright blue emission obtained from a bulk sample of 
7.4•MeSO4 was found to persist at 200 °C, a temperature well above its Tg. Excitation of 
an annealed thin film of this material (obtained via melt-casting) produced a bright blue 
emission with a λem of 423 nm, consistent with the λem in solution (Figure 7.2). 
Collectively, these results indicated that BBI-based IL fluorophores maintained efficient 
luminescent properties in solution, solid-state, and as flowing liquids. 
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Figure 7.2 Left: Photoluminescence spectrum of 7.4•MeSO4 in MeOH (solid line) 
and as a thin film (dotted line), each under ambient conditions. Right: Picture of 
7.4•MeSO4 heated at ca 80 °C under irradiation from a 365 nm lamp (5 W). 
               
 
















    
 
7.3 Synthesis of liquid crystalline benzobis(imidazolium) salts 
Having obtained room-temperature fluorescent ILs, we focused next on fine-
tuning phase control to obtain mesomorphic fluorophores based on BBIs. This was 
motivated largely by the observation that imparting LC behavior to neutral organic 
fluorophores can greatly improve their performance in electronic applications.110 
Furthermore, the BBI architecture would introduce a unique structural class of ILCs 
featuring rigid, polycyclic cationic cores106i,j similar to dye-based chromonic LCs but 
photoluminescent in nature.111 
Two BBI-based mesogens, 7.8a and 7.8b (see Figure 7.1), were synthesized and 
each was analyzed by differential scanning calorimetry (DSC), polarized light 
microscopy (PLM), and variable-temperature powder X-ray diffraction (VT-PXRD). 
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Investigation of the DSC cooling cycles of 7.8a suggested a broad LC temperature range 
that began at 53 °C and extended to 194 °C, at which point the material became isotropic. 
Upon cooling from the isotropic melt, PLM of 7.8a showed dendritic growth and 
domains characteristic of columnar LC phases (see Figure 7.3). Low-angle VT-PXRD, 
however, revealed reflections at intervals consistent with a smectic phase. DSC analysis 
of 7.8b revealed a narrower and higher temperature LC range (188 – 238 °C). As shown 
in Figure 3, PLM of this mesogenic material revealed textures that were suggestive of a 
cubic mesophase, which was further confirmed by VT-PXRD.112,113 
 
Figure 7.3 PLM images (left: ILC 7.8a, right: ILC 7.8b) were obtained at 130 and 
215 °C, respectively, on cooling from the isotropic melt. Mag = 100x 
 
          
 
7.4 Conclusions 
In conclusion, unprecedented phase-tunable fluorophores based upon a series of 
highly photoluminescent BBI salts have been synthesized. A key structural feature of 
these fluorophores is that they incorporate imidazolium moieties, whereupon annulation 
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leads to desirable luminescent properties. Through judicious choice of N-substituents and 
counterions, BBI salts with Tds as high as 338 °C were obtained for materials that were 
fluidic below 0 °C.  This feature also enabled access to two BBI-based mesogens, thus 
introducing a new platform for fluorescent ILC design. Collectively, these organic salts 
produced constant blue emission from solution to cooled glassy states to free flowing 
liquids. Considering their high thermal stability, amphiphilic properties, and structural 
modularity, BBI salts effectively form a new class of emissive chromophores with 
promise as processable fluorophores, sensory materials, and models for fundamental 
photophysical investigations.  
 
7.5 Experimental Section 
General Considerations:  1H and 13C NMR spectra were recorded using a Varian 
Unity Plus 300 or 400 spectrometer. Chemical shifts (δ) are expressed in ppm downfield 
from tetramethylsilane using the residual protio solvent as an internal standard (CDCl3, 
1H: 7.26 ppm and 13C: 77.0 ppm; DMSO-d6, 1H: 2.49 ppm and 13C: 39.5 ppm). Coupling 
constants are expressed in hertz (Hz). HRMS (ESI, CI) were obtained with a VG 
analytical ZAB2-E instrument. UV-vis spectra were recorded using a Perkin Elmer 
Instruments Lambda 35 spectrometer. Emission spectra were recorded using a 
QuantaMaster Photon Technology International fluorometer. Differential scanning 
calorimetry (DSC) data was recorded using a TA Instruments DSC-Q100. 
Thermogravimetric analysis (TGA) was performed using a TA Instruments TGA-Q500 
under nitrogen atmosphere. The decomposition temperature (Td) was defined as the 
temperature at which 10% weight loss occurred. Samples were dried under vacuum for ≥ 
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8 h immediately prior to DSC and TGA experiments. Polarized light microscopy studies 
were performed with a Leica DMRXP polarizing light microscope equipped with an 
Optronics digital camera assembly. Powder X-ray diffraction spectra were obtained with 
an Inel CPS 120 diffraction system using monochromated Cu Kα X-ray radiation. Unless 
otherwise noted, reactions were conducted under ambient atmosphere. All starting 
materials and solvents were of reagent quality and used as received from commercial 
suppliers. 
 


































4,6-Dinitro-N,N'-diphenyl-benzene-1,3-diamine (7.1). A flask was charged with a 
magnetic stirbar, EtOH (25 mL), and aniline (7.5 mL, 82.3 mmol). After 1,5-dichloro-
2,4-dinitrobenzene (4.87 g, 20.6 mmol) was added to the reaction mixture, the flask was 
fitted with a H2O-jacketed condenser. The mixture was then stirred in an oil bath at 80 °C 
for 36 h during which time a thick orange slurry developed. The mixture was then 
allowed to cool and poured into H2O (100 mL). Precipitated solids were collected via 
vacuum filtration, rinsed with H2O, and dried under vacuum to give 7.15 g (99% yield) of 
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the desired product as an orange-red powder. 1H NMR (300 MHz, CDCl3): δ 9.74 (br s, 
2H), 9.32 (s, 1H), 7.37-7.32 (m, 4H), 7.23-7.14 (m, 6H), 6.53 (s, 1H); 13C NMR (75 
MHz, CDCl3): δ 146.8, 137.1, 129.6, 129.3, 126.6, 125.3, 124.7, 95.2; HRMS m/z calcd 
for C18H15N4O4 [M+H+] 351.1093, found 351.1090. 
 
1,7-Diphenylbenzobis(imidazole) (7.2). A flask was charged with a magentic stirbar and 
HCO2H (100 mL, 88%). NaHCO3 (15.3 g, 183 mmol) was added portionwise with 
vigorous stirring. To the mixture was added Pd/C (1.94 g, 5 wt % Pd, 0.91 mmol Pd) and 
dinitroarene 7.1 (3.20 g, 9.13 mmol). After the flask was fitted with a H2O-jacketed 
condenser, the reaction mixture was stirred in an oil bath at 110 °C for 48 h. The mixture 
was then allowed to cool and filtered through Celite with the aid of 50 mL H2O. After the 
filtrate volume was reduced to approximately 50 mL under reduced pressure, the 
resulting mixture was added to a vigorously stirred solution of saturated aqueous K2CO3. 
Precipitated solids were collected via vacuum filtration, rinsed with H2O and dried under 
vacuum to provide 2.70 g (95% yield) of the desired product as a beige powder. 1H NMR 
(400 MHz, CDCl3): δ 8.34 (s, 1H), 8.16 (s, 2H), 7.60-7.51 (m, 9H), 7.48-7.44 (m, 2H); 
13C NMR (100 MHz, CDCl3): δ 143.3, 141.3, 136.4, 132.1, 130.1, 127.9, 123.9, 110.6, 
90.1; HRMS m/z calcd for C20H15N4 [M+H+] 311.1297, found 311.1293. 
 
1,7-Dimethyl-3,5-diphenylbenzobis(imidazolium) bis(methyl sulfate) (7.3). 
Diphenylbenzobis(imidazole) 7.2 (660 mg, 2.13 mmol) was dissolved in CH3CN (4 mL). 
After dimethyl sulfate (0.41 mL, 4.37 mmol) was added to the solution, the resulting 
mixture was stirred at 70 °C for 4 h. The mixture was then concentrated under vacuum. 
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After rinsing the residual solids several times with excess EtOAc, they were dried under 
vacuum to give 1.10 g (91% yield) of the desired benzobis(imidazolium) salt as a beige 
powder. Crystals suitable for X-ray analysis were obtained by slow evaporation of a 
MeOH/Et2O solution. 1H NMR (400 MHz, DMSO-d6): δ 10.37 (s, 2H), 9.07 (s, 1H), 8.04 
(s, 1H), 7.88-7.85 (m, 4H), 7.77-7.68 (m, 6H), 4.28 (s, 6H), 3.35 (s, 6H); 13C NMR (100 
MHz, DMSO-d6): δ 147.1, 133.0, 131.2, 130.7, 130.6, 130.1, 125.3, 99.6, 98.0, 52.9, 
32.1; HRMS m/z calcd for C22H19N4 [M-H+] 339.1610, found 339.1606; Td = 267 °C; Tg 
= 89 °C.  
 































X = I, BF4, MeSO4
7.4  
 
N-(5-Chloro-2,4-dinitrophenyl)-4-butylaniline (7.3). 1,5-Dichloro-2,4-dinitrobenzene 
(100.0 g, 422 mmol) was suspended in EtOH (1.3 L) and 4-butylaniline (81.8 mL, 844 
mmol) was added. After the resulting orange-red slurry was stirred for 24 h, it was 
poured into excess H2O (200 mL). Precipitated solids were collected via vacuum 
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filtration, rinsed with H2O, and dried under vacuum to provide 145.2 g (98% yield) of the 
desired product as a red powder. 1H NMR (400 MHz, CDCl3): δ 9.80 (br s, 1H), 9.08 (s, 
1H), 7.32 (d, J = 8.2 Hz, 2H), 7.19 (d, J = 8.2 Hz, 2H), 7.14 (s, 1H), 2.68 (t, J = 7.8 Hz, 
2H), 1.68-1.61 (m, 2H), 1.44-1.35 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 145.9, 143.2, 135.8, 135.6, 133.6, 130.3, 129.3, 126.7, 125.4, 117.9, 35.2, 33.4, 
22.3, 13.9; HRMS m/z calcd for C16H17N3O4Cl [M+H+] 350.0908, found 350.0906. 
 
1-(4-Butylphenyl)amino-5-(2-methylpropyl)amino-2,4-dinitrobenzene (7.4). 
Chloroarene 7.3 (1.35 g, 3.86 mmol) was treated with iso-butylamine (0.76 mL, 7.72 
mmol) in EtOH (4 mL) at 80 °C for 24 h. The mixture was then allowed to cool and 
poured into H2O (50 mL). Precipitated solids were collected via vacuum filtration, rinsed 
with H2O, and dried under vacuum to provide 1.42 g (95% yield) of the desired product 
as an orange powder. 1H NMR (400 MHz, CDCl3): δ 9.73 (br s, 1H), 9.29 (s, 1H), 8.36 
(br t, 1H), 7.28 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 6.04 (s, 1H), 2.88-2.86 (m, 
2H), 2.67 (t, J = 7.8 Hz, 2H), 1.93-1.83 (m, 1H), 1.67-1.59 (m, 2H), 1.42-1.33 (m, 2H), 
0.95 (t, J = 7.2 Hz, 3H), 0.94 (d, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 148.5, 
147.6, 142.0, 134.9, 129.8, 129.5, 125.3, 124.9, 124.2, 92.6, 50.6, 35.1, 33.5, 27.5, 22.2, 
20.2, 13.9; HRMS m/z calcd for C20H27N4O4 [M+H+] 387.2032, found 387.2030. 
 
1-(4-Butylphenyl)-7-(2-methylpropyl)benzobis(imidazole) (7.5). This compound was 
prepared analogously to 7.2 from dinitroarene 7.4 (5.00 g, 12.93 mmol). The crude 
material was recrystallized from Et2O and hexanes to provide 4.31 g (96% yield) of the 
desired product as a tan solid. 1H NMR (400 MHz, CDCl3): δ 8.24 (s, 1H), 8.08 (s, 1H), 
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7.89 (s, 1H), 7.44 (d, J = 8.2 Hz, 2H), 7.40 (d, J = 8.2 Hz, 2H), 7.33 (s, 1H), 3.94 (d, J = 
7.2 Hz, 2H), 2.72 (t, J = 7.6 Hz, 2H), 2.27-2.17 (m, 1H), 1.72-1.64 (m, 2H), 1.45-1.37 
(m, 2H), 0.96 (t, J = 7.4 Hz, 3H), 0.92 (d, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3): 
δ 144.3, 143.1, 142.9, 141.2, 141.0, 134.2, 132.5, 131.9, 130.0, 123.9, 110.3, 89.3, 52.6, 




(7.4•I). A vial was charged with benzobis(imidazole) 7.5 (3.21 g, 9.26 mmol), CH3CN (6 
mL), and MeI (2.0 mL, 32.1 mmol). The vial was sealed with a Teflon-lined cap and the 
mixture was stirred in an oil bath at 60 °C for 8 h. The mixture was then allowed to cool, 
transferred to a round-bottom flask, and concentrated to provide 5.69 g (97% yield) of the 
desired product as a beige powder. 1H NMR (400 MHz, DMSO-d6): δ 10.36 (s, 1H), 
10.07 (s, 1H), 9.03 (s, 1H), 8.61 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.4 Hz, 
2H), 4.48 (d, J = 7.6 Hz, 2H), 4.26 (s, 3H), 4.24 (s, 3H), 2.76 (t, J = 7.8 Hz, 2H), 2.33-
2.23 (m, 1H), 1.70-1.62 (m, 2H), 1.43-1.34 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H), 0.93 (d, J = 
6.8 Hz, 6H); 13C NMR (100 MHz, DMSO-d6): δ 146.7, 146.4, 145.2, 130.9, 130.68, 
130.66, 130.0, 125.2, 99.2, 98.5, 53.3, 34.4, 34.3, 32.8, 28.1, 21.8, 19.3, 13.8; HRMS m/z 
calcd for C24H31N4 [M-H+] 375.2549, found 375.2543; Td = 218 °C; Tg = 113 °C. 
 
1-(4-Butylphenyl)-7-(2-methylpropyl)-3,5-dimethylbenzobis(imidazolium) 
bis(tetrafluoroborate) (7.4•BF4). Bis(imidazolium) diiodide 7.4•I (1.23 g, 1.95 mmol) 
was dissolved in dry CH2Cl2 (8 mL) under an atmosphere of dry N2 and triethyloxonium 
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tetrafluoroborate (741 mg, 3.90 mmol) was added. The reaction was monitored by 1H 
NMR spectroscopy and upon completion (≤ 10 min) the mixture was concentrated to 
provide 1.02 g (95% yield) of the desired product as a beige powder.  1H NMR (300 
MHz, DMSO-d6): δ 10.31 (s, 1H), 9.99 (s, 1H), 8.94 (s, 1H), 8.64 (s, 1H), 7.80 (d, J = 8.4 
Hz, 2H), 7.66 (d, J = 8.4 Hz, 2H), 4.49 (d, J = 7.5 Hz, 2H), 4.27 (s, 3H), 4.24 (s, 3H), 
2.80 (t, J = 7.6 Hz, 2H), 2.34-2.25 (m, 1H), 1.75-1.65 (m, 2H), 1.48-1.36 (m, 2H), 0.98 (t, 
J = 7.2 Hz, 3H), 0.96 (d, J = 6.6 Hz, 6H); 13C NMR (75 MHz, DMSO-d6): δ 146.8, 146.6, 
145.4, 131.1, 131.0, 130.8, 130.3, 130.2, 125.2, 99.0, 98.6, 53.3, 34.5, 34.0, 32.9, 28.2, 
21.9, 19.3, 13.8; HRMS m/z calcd for C24H31N4 [M-H+] 375.2549, found 375.2543; Td = 
338 °C; Tg = 84 °C.   
 
1-(4-Butylphenyl)-7-(2-methylpropyl)-3,5-dimethylbenzobis(imidazolium) 
bis(methyl sulfate) (7.4•MeSO4). Bis(imidazolium) diiodide 7.4•I (833 mg, 1.32 mmol) 
was dissolved in CH2Cl2 (2 mL) and dimethyl sulfate (0.25 mL, 2.64 mmol) was added. 
The reaction was monitored 1H NMR spectroscopy. Upon completion (approximately 3 
h), the mixture was concentrated to provide 788 mg (100% yield) of the desired product 
as a beige powder. 1H NMR (400 MHz, DMSO-d6): δ 10.29 (s, 1H), 9.99 (s, 1H), 8.95 (s, 
1H), 8.61 (s, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.4 Hz, 2H), 4.45 (d, J = 7.6 Hz, 
2H), 4.24 (s, 3H), 4.21 (s, 3H), 3.35 (s, 6H), 2.76 (t, J = 7.8 Hz, 2H), 2.31-2.20 (m, 1H), 
1.70-1.62 (m, 2H), 1.43-1.34 (m, 2H), 0.95 (t, J = 8.2 Hz, 3H), 0.91 (d, J = 6.8 Hz, 6H); 
13C NMR (100 MHz, DMSO-d6): δ 146.8, 146.6, 145.3, 131.0, 130.8, 130.7, 130.3, 
130.1, 125.2, 99.1, 98.6, 53.3, 52.8, 34.5, 34.0, 32.9, 28.1, 21.9, 19.3, 13.8; HRMS m/z 
calcd for C24H31N4 [M-H+] 375.2549, found 375.2543; Td = 273 °C; Tg = 43 °C. 
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 N-(5-chloro-2,4-dinitrophenyl)-3-methylaniline (7.6). This compound was prepared 
analogously to 7.3 from 1,5-dichloro-2,4-dinitrobenzene (2.04 g, 8.61 mmol) and m-
toluidine (1.88 mL, 17.2 mmol) in EtOH (10 mL) to provide 2.51 g (95% yield) of the 
desired product as an orange powder. 1H NMR (400 MHz, CDCl3): δ 9.81 (br s, 1H), 
9.07 (s, 1H), 7.42-7.38 (m, 1H), 7.23-7.21 (m 1H), 7.16 (s, 1H), 7.11-7.10 (m, 2H), 2.43 
(s, 3H); 13C NMR (100 MHz, CDCl3): δ 145.7, 140.7, 136.1, 135.8, 135.6, 130.1, 129.4, 
128.9, 126.6, 126.1, 122.4, 118.0, 21.4; HRMS m/z calcd for C13H11N3O4Cl [M+H+] 
308.0438, found 308.0442. 
 
 1-(3-Methylphenyl)amino-5-(2-methylpropyl)amino-2,4-dinitrobenzene (7.7).  This 
compound was prepared analogously to 7.4 from chloroarene 7.6 (11.0 g, 35.8 mmol) and 
iso-butylamine (7.1 mL, 71.5 mmol) in EtOH (70 mL) at 80 °C to provide 12.3 g (>99% 
yield) of the desired product as an orange powder. 1H NMR (400 MHz, CDCl3): δ 9.76 
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(br s, 1H), 9.29 (s, 1H), 8.37 (br t, 1H), 7.37-7.33 (m, 1H), 7.15-7.11 (m, 3H), 6.13 (s, 
1H), 2.90-2.87 (m, 2H), 2.40 (s, 3H), 1.95-1.84 (m, 1H), 0.95 (d, J = 6.8 Hz, 6H); 13C 
NMR (75 MHz, CDCl3): δ 148.6, 147.3, 140.1, 137.4, 129.6, 129.5, 127.6, 125.8, 125.0, 
124.3, 122.1, 92.7, 50.7, 27.6, 21.3, 20.2; HRMS m/z calcd for C17H21N4O4 [M+H+] 
345.1563, found 345.1561. 
 
1-(3-Methylphenyl)-7-(2-methylpropyl)benzobis(imidazole) (7.8). This compound was 
prepared analogously to 7.2 from dinitroarene 7.7 (12.7 g, 34.8 mmol). The crude 
material was recrystallized from Et2O and hexanes to provide 10.27 g (97% yield) of the 
desired product as a tan solid. 1H NMR (400 MHz, CDCl3): δ 8.25 (s, 1H), 8.12 (s, 1H), 
7.93 (s, 1H), 7.50 (t, J = 8.0 Hz, 1H), 7.38-7.35 (m, 2H), 7.35 (s, 1H), 7.32-7.30 (m, 1H), 
3.96 (d, J = 7.2 Hz, 2H), 2.49 (s, 3H), 2.28-2.18 (m, 1H), 0.94 (d, J = 6.4 Hz, 6H); 13C 
NMR (100 MHz, CDCl3): δ 144.4, 143.0, 141.3, 141.0, 140.3, 136.6, 132.5, 131.7, 129.8, 
128.6, 124.7, 121.0, 110.3, 89.3, 52.6, 28.6, 21.4, 20.1; HRMS m/z calcd for C19H21N4 
[M-H+] 305.1764, found 305.1761. 
 
1-(3-Methylphenyl)-7-(2-methylpropyl)-3,5-dimethylbenzobis(imidazolium) 
bis(methyl sulfate) (7.5). This compound was prepared analogously to 7.3 from 
benzobis(imidazole) 7.7 (758 mg, 2.49 mmol) to provide 1.37 g (99% yield) of the 
desired product as a brown foam.  1H NMR (400 MHz, DMSO-d6): δ 10.31 (s, 1H), 10.00 
(s, 1H), 8.96 (s, 1H), 8.60 (s, 1H), 7.72-7.66 (m, 3H), 7.59-7.57 (m, 1H), 4.45 (d, J = 7.2 
Hz, 2H), 4.25 (s, 3H), 4.21 (s, 3H), 3.34 (s, 6H), 2.29-2.22 (m, 1H), 0.92 (d, J = 6.4 Hz, 
6H); 13C NMR (75 MHz, DMSO-d6): δ 146.8, 146.7, 140.4, 133.0, 131.3, 131.00, 130.96, 
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130.8, 130.4, 130.1, 125.8, 122.5, 99.1, 98.6, 53.3, 52.8, 34.0, 28.2, 21.0, 19.3; HRMS 
m/z calcd for C21H25N4 [M-H+] 333.2078, found 333.2074; Td = 270 °C; Tg = 35 °C. 
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 1-Methylamino-5-(3-methylphenyl)amino-2,4-dinitrobenzene (7.8). Chloroarene 7.6 
(2.00 g, 6.50 mmol), methylamine (40 wt% in H2O, 2.02 g, 26.0 mmol), and EtOH (15 
mL) were combined in a vial, which was later sealed with a Teflon-lined screw-cap. The 
mixture was vigorously stirred at 70 °C for 24 h. After pouring the cooled reaction 
mixture into H2O (50 mL), precipitated solids were collected by vacuum filtration, rinsed 
with H2O, and dried under vacuum to provide 1.89 g (96% yield) of the desired product 
as a yellow powder. 1H NMR (300 MHz, CDCl3): δ 9.80 (br s, 1H), 9.29 (s, 1H), 8.25 (br 
s, 1H), 7.38-7.33 (m, 1H), 7.15-7.13 (m, 3H), 6.14 (s, 1H), 2.84 (d, J = 5.1 Hz, 3H), 2.41 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 149.3, 147.5, 140.1, 137.4, 129.7, 129.4, 127.7, 
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125.8, 122.1, 92.4, 29.8, 21.3; HRMS m/z calcd for C14H15N4O4 [M+H+] 303.1084, 
found 303.1088. 
 
1-Methyl-7-(3-methylphenyl)benzobis(imidazole) (7.9). Dinitroarene 7.8 (1.78 g, 5.89 
mmol) was suspended in HC(OEt)3 (45 mL) in a 100 mL high-pressure, Schlenk flask. 
To the suspension was added HCO2H (5 mL, 88%), HCO2Na (8.03 g, 118 mmol), and 
Pd/C (2.50 g, 5 wt%, 1.18 mmol Pd). The Schlenk flask was sealed and the mixture was 
stirred at 100 °C for 36 h. After cooling to ambient temperature, the Schlenk flask was 
carefully opened to slowly release pressure. The mixture was then filtered through a pad 
of Celite. The filtrate was treated with 5% aqueous HCl (100 mL) and stirred for 10 min. 
The solution was then made alkaline using 10% aqueous NaOH and allowed to stand for 
approximately 1 h. The resulting solids were collected via vacuum filtration, rinsed with 
H2O, and dried under vacuum to give 1.48 g (96% yield) of the desired product as a beige 
powder. 1H NMR (400 MHz, CDCl3): δ 8.23 (s, 1H), 8.13 (s, 1H), 7.92 (s, 1H), 7.52-7.48 
(m, 1H), 7.40-7.37 (m, 2H), 7.38 (s, 1H), 7.32-7.30 (m, 1H), 3.85 (s, 3H), 2.50 (s, 3H); 
13C NMR (75 MHz, CDCl3): δ 144.5, 143.0, 141.1, 140.4, 136.6, 133.1, 131.9, 129.9, 
128.7, 124.8, 121.2, 110.4, 89.0, 31.2, 21.4; HRMS m/z calcd for C16H15N4 [M+H+] 
263.1297, found 263.1299. 
 
1,7-Diethyl-3-methyl-5-(3-methylphenyl)benzobis(imidazolium) bis(methylsulfate) 
(7.6). A vial was charged with benzobis(imidazole) 7.9 (131 mg, 0.50 mmol), CH3CN (5 
mL), and EtI (0.12 mL, 1.50 mmol). The vial was sealed with a Teflon-lined cap and the 
mixture was stirred in an oil bath at 70 °C for 8 h. The mixture was then allowed to cool 
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and concentrated under vacuum. To the resulting brown foam was added CH2Cl2 (4 mL) 
and Me2SO4 (95 μL, 1.00 mmol). The solution was stirred for 6 h and then concentrated 
under vacuum. The thick tan oil was rinsed with Et2O and dried under vacuum to provide 
287 mg (100% yield) of the desired product. X-ray quality crystals were obtained by slow 
evaporation of a CH2Cl2/EtOAc/Et2O solution. 1H NMR (400 MHz, DMSO-d6): δ 10.35 
(s, 1H), 9.96 (s, 1H), 9.02 (s, 1H), 8.50 (s, 1H), 7.71-7.68 (m, 3H), 7.58-7.57 (m, 1H), 
4.68 (quart, J = 7.2 Hz, 2H), 4.63 (quart, J = 7.2 Hz, 2H), 4.14 (s, 3H), 3.34 (s, 6H), 2.49 
(s, 3H), 1.68 (t, J = 7.2 Hz, 3H), 1.61 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, DMSO-d6): 
δ 146.3, 145.8, 140.4, 133.0, 131.30, 131.25, 130.3, 130.04, 129.98, 129.9, 125.8, 122.5, 
98.92, 98.86, 52.8, 43.1, 42.6, 34.0, 20.9, 14.1, 13.8; HRMS m/z calcd for C20H23N4 [M-
H+] 319.1925, found 319.1917; Td = 272 °C; Tg = 0.8 °C.   
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 N-(5-chloro-2,4-dinitrophenyl)-4-octylaniline (7.10). This compound was prepared 
analogously to 7.3 from 1,5-dichloro-2,4-dinitrobenzene (1.52 g, 6.40 mmol) and 4-
octylaniline (2.85 mL, 12.8 mmol) to provide 2.49 g (96% yield) of the desired product 
as an orange powder. 1H NMR (300 MHz, CDCl3): δ 9.81 (br s, 1H), 9.07 (s, 1H), 7.32 
(d, J = 8.1 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 7.14 (s, 1H), 2.67 (t, J = 7.8 Hz, 2H), 1.68-
1.63 (m, 2H), 1.34-1.28 (m, 10H), 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): 
δ 145.9, 143.3, 135.5, 133.6, 130.3, 129.8, 129.3, 126.7, 125.4, 117.9, 35.5, 31.8, 31.3, 
29.4, 29.3, 29.2, 22.6, 14.1; HRMS m/z calcd for C20H25N3O4Cl [M+H+] 406.1534, found 
406.1529. 
 
 1-(4-Butylphenyl)-5-methylamino-2,4-dinitrobenzene (7.11). This compound was 
prepared analogously to 7.8 from chloroarene 7.10 (1.05 g, 2.59 mmol) and methylamine 
(40 wt% in H2O, 804 mg, 10.4 mmol) to provide 1.02 g (98% yield) of the desired 
product as an orange powder. 1H NMR (300 MHz, CDCl3): δ 9.79 (br s, 1H), 9.29 (s, 
1H), 8.24 (br s, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.23 (d, J = 8.8 Hz, 2H), 6.08 (s, 1H), 2.82 
(d, J = 4.8 Hz, 3H), 2.65 (t, J = 7.7 Hz, 2H), 1.67-1.62 (m, 2H), 1.33-1.28 (m, 10H), 0.88 
(t, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 149.3, 147.7, 142.0, 134.9, 129.8, 
129.4, 125.2, 124.9, 124.3, 92.2, 35.5, 31.8, 31.3, 29.7, 29.4, 29.2, 22.6, 14.1; HRMS m/z 
calcd for C21H29N4O4 [M+H+] 401.2186, found 401.2183. 
 
1-(4-Butylphenyl)-7-methylbenzobis(imidazole) (7.12). This compound was prepared 
analogously to 7.9 from dinitroarene 7.11 (801 mg, 2.00 mmol) to provide 694 mg (96% 
yield) of the desired product as a tan solid. 1H NMR (400 MHz, CDCl3): δ 8.26 (s, 1H), 
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8.12 (s, 1H), 7.90 (s, 1H), 7.47 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 7.37 (s, 1H), 
3.84 (s, 3H), 2.72 (t, J = 7.8 Hz, 2H), 1.74-1.66 (m, 2H), 1.40-1.26 (m, 10H), 0.89 (t, J = 
7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 144.5, 143.1, 141.2, 141.1, 134.3, 133.1, 
132.1, 130.0, 124.1, 113.0, 110.4, 89.0, 35.6, 31.9, 31.5, 31.2, 29.4, 29.3, 29.2, 22.7, 
14.1; HRMS m/z calcd for C23H29N4 [M+H+] 361.2392, found 361.2390. 
 
1-(4-Butylphenyl)-3,5-diethyl-7-methylbenzobis(imidazolium) bis(methyl sulfate) 
(7.7). A vial was charged with benzobis(imidazole) 7.12 (180 mg, 0.50 mmol), CH3CN 
(5 mL), and EtI (0.12 mL, 1.50 mmol). The vial was sealed with a Teflon-lined cap and 
the mixture was stirred in an oil bath at 70 °C for 8 h. The mixture was then allowed to 
cool and concentrated under vacuum. To the resulting brown foam was added CH2Cl2 (4 
mL) and Me2SO4 (95 μL, 1.00 mmol). The solution was stirred for 6 h, then concentrated 
under vacuum. The thick tan oil was rinsed with Et2O and dried under vacuum to provide 
320 mg (>99% yield) of the desired product. 1H NMR (400 MHz, DMSO-d6): δ 10.33 (s, 
1H), 9.96 (s, 1H), 9.02 (s, 1H), 8.51 (s, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.4 Hz, 
2H), 4.68 (quart, J = 7.2 Hz, 2H), 4.64 (quart, J = 7.2 Hz, 2H), 4.14 (s, 3H), 3.34 (s, 6H), 
2.75 (t, J = 7.6 Hz, 2H), 1.68 (t, J = 7.2 Hz, 3H), 1.65 (br, 2H), 1.61 (t, J = 7.2 Hz, 3H), 
1.33-1.27 (m, 10H), 0.86 (t, J = 6.8 Hz); 13C NMR (75 MHz, DMSO-d6): δ 146.3, 145.8, 
145.4, 138.0, 131.2, 130.8, 130.2, 130.1, 130.0, 129.9, 125.2, 98.8, 52.8, 43.0, 42.6, 34.8, 
33.9, 31.3, 30.9, 28.8, 28.71, 28.69, 22.1, 14.03, 13.97, 13.8; HRMS m/z calcd for 






















































1,3,5,7-Tetradodecylbenzobis(imidazolium) bis(tetrafluoroborate) (7.8a). 
Benzobis(imidazole) (208 mg,  1.32 mmol) was suspended in CH3CN (15 mL), and 1-
bromododecane (1.6 mL, 6.58 mmol). NaHCO3 (1.11 g, 13.15 mmol) was added and the 
mixture was stirred in an oil bath at 80 °C for 72 h. The cooled solution was then filtered 
through Celite and concentrated under vacuum. The waxy residue was triturated with 
hexanes and the resulting tan powder was collected via vacuum filtration. The resulting 
1,3,5,7-tetradodecylbenzobis(imidazolium) dibromide was then subjected to anion 
metathesis analogously to 4•BF4 using triethyloxonium tetrafluoroborate to obtain 1.32 g 
(99% yield) of the desired product. 1H NMR (300 MHz, CDCl3): δ 9.28 (s, 2H), 8.52 (s, 
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2H), 4.61 (br t, 8H), 1.97 (br, 8H), 1.34-1.24 (m, 72H), 0.87 (t, J = 6.6 Hz, 12H); 13C 
NMR (75 MHz, CDCl3): δ 144.2, 130.6, 99.5, 48.1, 31.9, 29.7, 29.63, 29.56, 29.5, 29.3, 
29.0, 26.4, 22.7, 14.1; HRMS m/z calcd for C56H105N4 [M+H] 833.8339, found 833.8336. 
 
4,6-Dinitro-N,N'-bis(4-octylphenyl)-benzene-1,3-diamine (7.13). This compound was 
prepared analogously to 7.1 from 1,5-dichloro-2,4-dinitrobenzene (1.53 g, 6.48 mmol) 
and 4-octylaniline (5.32 g, 25.9 mmol) in EtOH (20 mL) to obtain 3.65 g (98% yield) of 
the desired product as an orange-red powder. 1H NMR (300 MHz, CDCl3): δ 9.68 (br s, 
2H), 9.31 (s, 1H), 7.13 (d, J = 8.2 Hz, 4H), 7.04 (d, J = 8.2 Hz, 4H), 6.47 (s, 1H), 2.57 (t, 
J = 7.7 Hz, 4H)), 1.61-1.53 (m, 4H), 1.33-1.29 (m, 20H), 0.90 (t, J = 6.6 Hz, 6H); 13C 
NMR (75 MHz, CDCl3): δ 147.0, 141.6, 134.7, 129.4, 129.3, 125.2, 124.7, 95.1, 35.5, 
31.9, 31.6, 29.5, 29.33, 29.28, 22.7, 14.1; HRMS m/z calcd for C34H47N4O4 [M+H+] 
575.3597, found 575.3602. 
 
1,7-Bis(4-octylphenyl)benzobis(imidazole) (7.14). This compound was prepared 
analogously to 7.9 from dinitroarene 7.13 (1.30 g, 2.26 mmol) to provide 972 mg (80% 
yield) of the desired product as a tan powder. 1H NMR (400 MHz, CDCl3): δ 8.32 (s, 
1H), 8.13 (s, 2H), 7.53 (s, 1H), 7.41 (br d, 4H), 7.37 (br d, 4H), 2.69 (t, J = 6.4 Hz, 4H), 
1.67 (br, 4H), 1.28 (br, 20H), 0.89 (br, 6H); 13C NMR (75 MHz, CDCl3): δ 143.4, 143.0, 
141.4, 134.1, 132.3, 129.9, 123.9, 110.6, 90.2, 35.5, 31.8, 31.4, 29.4, 29.3, 29.2, 22.6, 




(7.8b). The corresponding diiodide salt was obtained analogously to 7.4•I from 
benzobis(imidazole) 7.14 (348 mg,  0.65 mmol), and was subjected to anion metathesis 
analogously to 7.4•BF4 using triethyloxonium tetrafluoroborate to provide 476 mg (99% 
yield) of the desired product. 1H NMR (400 MHz, CDCl3): δ 9.10 (s, 2H), 8.74 (s, 1H), 
7.57 (s, 1H), 7.54 (d, J = 8.4 Hz, 4H), 7.29 (d, J = 8.4 Hz, 4H), 4.19 (s, 6H), 2.58 (t, J = 
7.6 Hz, 4H), 1.60-1.53 (m, 4H), 1.29-1.21 (m, 20H), 0.87 (t, J = 6.8 Hz, 6H); 13C NMR 
(100 MHz, CDCl3): δ 146.2, 145.3, 131.8, 131.3, 130.5, 130.2, 125.4, 99.9, 97.7, 35.6, 
34.4, 31.8, 31.2, 29.5, 29.4, 29.2, 22.6, 14.1; HRMS m/z calcd for C38H51N4 [M-H+] 















Figure 7.4 Top: Crystal packing diagram of 7.3. Bottom: Crystal packing diagram of 
7.6. Counterions, hydrogen atoms, and solvent molecules have been removed for clarity.  
Molecules of 7.3 arranged such that the chromophores were stacked (intermolecular 
distance ~ 4.0 Å) with the methyl groups pointing inward. No π-π interactions were 











Figure 7.5 UV-Vis (black), excitation (red, 415 nm emission), and emission (blue, 
350 nm excitation) spectra for 7.4•BF4 in MeOH under ambient conditions. BBIs 7.4 – 
7.7 gave similar spectra. 




















Determination of quantum efficiencies. Solutions of BBIs 7.1 – 7.8 were prepared in 
MeOH and passed through a 0.2 μm PTFE filter. Concentrations were adjusted such that 
the absorbance at the excitation wavelength was between 0.01 and 0.10 AU. The 
fluorescence spectrum was then collected for each sample. Plots of integrated 
fluorescence intensity versus absorbance were prepared (see below) for each compound, 
and a linear regression was performed using Microsoft Excel. Y-intercepts were set to 
zero. The procedure was repeated for E-stilbene and anthracene, in hexane and 
cyclohexane solvent, respectively. The literature quantum efficiencies for the standards 
(Фstd),114 gradients from the plots (GradBBI = gradient of BBI fluorophore, Gradstd = 
gradient of standard fluorophore), and refractive index for each solvent (ηMeOH = 
refractive index of MeOH, ηstd = refractive index of the solvent used for the standard) 
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were used in the following equation to determine the quantum efficiency of the BBI 
fluorophore (ФBBI): 
 
ФBBI = Фstd(GradBBI/Gradstd)( ηMeOH/ηstd)2 
 
Figure 7.6 Integrated fluorescence intensity versus absorbance for solutions of 7.8b 
in MeOH (black), 7.4•MeSO4 in MeOH (red), anthracene in cyclohexane (green), and E-













































Figure 7.7 VT-PXRD data for 7.8a (left) and 7.8b (right) at 130 °C and 205 °C, 
respectively 
        
 
 
Figure 7.8 DSC scans of 7.8a (black) and 7.8b (blue). Data collected from the third 
cooling cycle at a rate of 5 °C/min. 


















The discovery and development of novel organic emissive materials is essential 
for advancement in a multitude of areas of chemical research.115 Fluorescent organic salts 
are an emerging sub-class of emissive materials that are receiving considerable attention 
due to their unique attributes. They not only exhibit tunable electronic and physical 
characteristics, including solution-based and solid-state fluorescence, but also offer other 
advantages ascribed specifically to their charged nature. For example, the incorporation 
of ionic moieties in emissive salts have been credited with imparting high thermal 
stabilities, phase tunabilities, water-solubility, chemoselective sensing via electrostatic 
interactions, and strengthened solid-state intermolecular interactions. These features have 
already inspired research in a number of areas including fundamental photophysical 
investigations,106,116 sensory materials,117,118,119 novel materials for display 
applications,106b,c multi-photon excitation (MPE),120 and nanoscopic fluorescent ionic 
liquids.107 Overall, these materials encompass a tremendous breadth of structural 
diversity, each targeting a specific application or area of study. 
To complement these systems, we sought a single, modular platform from which 
task-specific fluorophores could be obtained rapidly and efficiently. 
Benzobis(imidazolium) (BBI) salts are one class of such compounds that feature a 
number of attributes poised for achieving this goal (see Figure 8.1). The BBI architecture 
features two imidazolium moieties annulated to a common arene linker. An important 
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consequence of this arrangement is that the charged moieties are embodied within the 
system’s chromophore, which distinguishes these materials from common types of 
fluorescent organic salts. In addition, BBIs feature four N-substituents, two C1-
substituents, and two counterions which can be independently varied.  As such, the 
physical, electronic, and chemical properties exhibited by these materials may be finely 
tuned. Combined, these features may synergistically open new opportunities for 
fluorescent organic salts that not only display versatile photoluminescence characteristics, 
but also may be used in a broad array of applications. 
 


















As described in previous chapters, our preliminary interest in annulated 
bis(imidazolium) salts was as precursors to facially-opposed bis(N-heterocyclic 
carbene)s. As such, syntheses were designed to provide predominantly symmetric, and 
exclusively C1-unsubstituted systems (i.e., R = H, Figure 8.1). Initial efforts focused on 
two primary variants exemplified in Scheme 8.1: one featuring four N-alkyl groups (e.g. 
8.2•Br) and the other containing four N-aryl groups (e.g., 8.4). 
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Scheme 8.1 Synthesis and photoluminescence properties of tetrabutyl BBI salt 8.2•Br 
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During our initial studies, we observed that systems such as 8.2•Br and 8.4 were 
highly photoluminescent with λem of 330 and 474 nm, respectively. In addition, high 
photoluminescence efficiencies (Фf) were observed from each BBI, with Фf = 0.64 and 
0.41 for 8.2•Br and 8.4, respectively. This inspired the design and synthesis of new 
subclasses of phase-tunable (i.e., ionic liquid and ionic liquid crystal) BBI salts, as 
described in Chapter 7.  These materials also displayed high Фfs, and their emission 
maxima (λem) suggested an ability to tune the electronic properties of BBIs via judicious 
control of the N-substituents. To further investigate the photophysics and applications of 
fluorescent BBI salts, a systematic series of these materials were prepared and studied. 
Syntheses and analyses were aimed at understanding the electronic delocalization 




8.2 Syntheses of benzobis(imidazolium) salts 
To develop comprehensive structure-property relationships based on BBI salts, 
focus was placed on controlling four areas of structural modulation: 1) counterions, 2) 
regioisomers, 3) N-aryl electronics, and 4) C1-aryl electronics. Photophysical studies and 
applications of BBI salts are described in subsequent sections. General syntheses utilized 
one of four strategies, summarized in Schemes 8.2 – 8.5 below. Tetra-N-butyl (8.2•Br) 
and tetra-N-phenyl (8.4) BBIs were prepared as previously described (see Chapters 1, 3, 
and 4). Overall, syntheses of the BBIs in this Chapter required a maximum of four steps, 
were chromatography-free, and afforded products in yields ranging from 40 – 97% from 
commercial starting materials. 
A unique feature of organic salts is that in principle both their cation and anion 
constituents may be independently tuned. While the anion has been shown to play a key 
role in controlling physical properties,100,102,106 photophysical anion-dependencies have 
not been studied in detail.121 This is likely due to the fact that for emissive organic salts, 
focus is placed primarily on cationic chromophores. Alternatively, ion-pairing 
interactions may greatly influence the photophysical characteristics of an organic salt 
under specific conditions. For example, red-edge effects from charged compounds, have 
been attributed to different orientations of associated species.106,116 Accordingly, one 
might expect that the counterion would influence a fluorescent salt’s response to red-edge 
excitation. 
To facilitate a comparative study involving counterion effects on photophysical 
properties of BBIs, compounds with simple, highly symmetric dicationic cores and either 
Br, BF4 or MeSO4 counterions were investigated. Capitalizing on the nucleophilic nature 
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of halides, 8.2•Br was treated with either Et3O•BF4 or Me2SO4 to produce anion 
metathesis products 8.2•BF4 and 8.2•MeSO4, respectively, as shown in Scheme 8.2. 
Subsequent removal of residual, volatile byproducts afforded each of the desired BBIs in 
excellent isolated yields (≥ 95%). As will be discussed below, the counterions had little 
effect on the λem, provided excitation was performed at the λabs; however, analysis of 
these compounds ultimately revealed counterion-dependent REEs in dilute solutions.   
 

































Incorporation of distinct functional groups around the BBI core was expected to 
provide additional degree of control over the λem of the resulting BBIs. Prior to engaging 
in the synthesis of compounds bearing substituents with different electronic properties, 
however, we investigated the effects of site-specific N-arylation. Hence, BBI 
regioisomers bearing two N-phenyl and two N-methyl groups in various substitution 
patterns were synthesized as shown in Scheme 8.3. Benzobis(imidazole) 8.1 underwent 
Cu-catalyzed cross coupling with PhI to provide a 1:1 mixture of 1,7-diphenyl- (8.5syn) 
and 1,5-diphenylbenzobis(imidazole)s  (8.5anti) in 95% combined yield.122 Separation of 
the two isomers was accomplished via recrystallization from hot DMSO. Subsequent 
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alkylation with MeI afforded BBIs 8.6syn and 8.6anti, respectively. As shown in Scheme 
8.3, the other possible regioisomer (8.9) was obtained from 5,6-dichloro-1-
methylbenzimidazole (8.7).123 Aryl amination with PhNH2, followed by formylative 
cyclization of the resulting diamine with HC(OEt)3, afforded benzimidazolium chloride 
8.8 in 86% yield. Treatment of 8.8 with 2.0 equiv of Me2SO4 not only resulted in N-
methylation but also effectively removed the Cl anion (as gaseous CH3Cl), affording the 
desired bis(methyl sulfate) salt (8.9) in 85% overall yield from 8.7. As will be discussed 
below, BBI 8.6syn  displayed longer λem than 8.6anti and 8.9. Hence, further structural 
modulation focused on 1,7-diaryl BBIs.  
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As stated previously, the photophysics of BBI salts were found to be dependent 
on the nature of the N-substituent (c.f., 8.2•Br and 8.4 in Scheme 8.1). Thus, BBIs 
bearing electron-donating and withdrawing N-aryl groups (Scheme 8.4) were synthesized 
to further explore the effects of differential N-aryl electronic factors. This was 
accomplished from 2,4-dinitro-1,5-dichlorobenzene (8.10), which underwent SNAr 
reactions with benzocaine and p-anisidine to provide dinitroarenes 8.11 and 8.12, 
respectively. Reduction followed by in situ formylative cyclization afforded the 
corresponding benzobis(imidazole)s 8.13 and 8.14. Finally, alkylation with MeI afforded 
the BBI salts 8.15 and 8.16 in 95 and 74% overall yield, respectively from 8.10. As will 
be discussed below, incorporation of electron-rich N-arenes bathochromically shifted the 
λem of these compounds by as much as 61 nm. In contrast, electron-poor N-arenes 
resulted in significant hypsochromic shifts in the λem. 
 





















8.10 8.11, Ar = 4-(CO2Et)Ph, 98%








8.13, Ar = 4-(CO2Et)Ph, 96%
8.14, Ar = 4-MeOPh, 78%
8.15, Ar = 4-(CO2Et)Ph, >99%
8.16, Ar = 4-MeOPh, 99%  
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As stated previously, the ability to independently-substitute the N- and C1-
positions of the BBI structure provides an additional handle for precisely tuning their 
photophysical properties. To obtain systems comprising both N- and C1-aryl substituents, 
we employed dinitroarenes 8.12 (Scheme 8.4) and 8.17 (Scheme 8.5), which were each 
obtained from SNAr reaction of 8.10 with the appropriate aryl amine. While the 4-MeOPh 
groups of 8.12 ultimately provided longer wavelength λem, the 4-BuPh groups of 8.17 
lead to increased solubilities  
 
























8.17, Ar = 4-BuPh
8.12, Ar = 4-MeOPh
1) RC(O)Cl
    Na2CO3
    THF, RT
2) AcOH
    110 °C
8.20, Ar = 4-BuPh, R = Ph, 96%
8.21, Ar = 4-BuPh, R = 4-CNPh, 93%
8.22, Ar = 4-BuPh, R = 4-MeOPh, 91%
8.23, Ar = 4-BuPh, R = 2-Th, 78%
8.24, Ar = 4-MeOPh, R = 4-PhPh, 88%
8.25,  Ar = 4-MeOPh, R = 4-CNPh, 99%
8.18, Ar = 4-BuPh
8.19, Ar = 4-MeOPh
R R
8.26, Ar = 4-BuPh, R = Ph, >99%
8.27, Ar = 4-BuPh, R = 4-CNPh, >99%
8.28, Ar = 4-BuPh, R = 4-MeOPh, 95%
8.29, Ar = 4-BuPh, R = 2-Th, 93%
8.30, Ar = 4-MeOPh, R = 4-PhPh, 94%










To complete the syntheses, the nitro groups of 8.12 and 8.17 were first reduced 
using Pd/C and hydrazine under acidic conditions to afford the corresponding 
tetraaminobenzenes 8.18 and 8.19, as their hydrochloride salts. Reaction of these 
tetraamines with various aroyl chlorides afforded diamide intermediates (structures not 
shown), which underwent dehydrocyclization in AcOH to give benzobis(imidazole)s 8.20 
– 8.25.124 The aroyl chlorides chosen for study were commercially-available and 
encompassed both electron-withdrawing (e.g., R = 4-CNPh) and donating functional 
groups (e.g., R= 4-MeOPh, 2-thienyl, 4-biphenyl). Subsequent alkylation of 
bis(imidazole)s 8.20 – 8.25 with MeI provided a series of highly functionalized BBI salts  
(8.26 – 8.31) in overall yields of 72 – 93% based on 8.10. As discussed below, the 
different electron-donating and withdrawing capabilities of the C1-substituents lead to 
λem tunability over a broad range of wavelengths. Ultimately, we observed that optimal 
combinations of N- and C1-aryl groups were able to bathochromically shift λem by up to 
227 nm, relative to BBI 8.2•Br; specific details are discussed in the following section. 
 
8.3 Photophysical analyses   
With a systematic series of BBI salts in hand, attention turned toward studying the 
electronic and physical characteristics of these materials; a summary of key results is 
shown in Table 8.1. Collectively, these BBI salts displayed good Фfs and molar 
absorptivities as well as a broad range of λem. The following sections discuss a 
combination of structural, substituent, and solvent effects on the photophysical properties 
of BBI fluorophores, as well as their utility in specific applications. 
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 As stated previously, the emission properties of the BBI salts are strongly 
influenced by the nature of the N-substituents. In particular, comparing 8.2•Br versus 8.4 
revealed a relatively large Δλem (124 nm).  Hence, we aimed to better understand the 
impact of systematically placing N-aryl groups at different positions on the BBI core. 
Comparison of the emission spectra of diphenyl BBIs 8.6syn, 8.6anti, and 8.9 (see Figure 
8.2) indicated that the longest wavelength λem were obtained when N-phenyl groups were 
placed on opposite imidazolium rings; however, the two possible regioisomers displayed 
nearly identical absorption and emission characteristics characteristics. Specifically, BBIs 
8.6syn and 8.6anti exhibited identical λabs = 345 nm with slightly different λem = 447 and 
442 nm, respectively. In contrast, BBI 8.9, which bears two N-phenyl substituents on the 
same imidazolium ring, showed hypsochromically shifted λem at 403 nm. Considering 
BBI 8.6syn displayed the longest λem values, and was straightfoward to synthesize, 
subsequent efforts focused on derivatizing this compound to further tune λem values (see 
below).125 
 



























8.4 Effects of incorporating functional N-aryl groups 
To compare the effects of electronic tuning the N-aryl substituents, we compared 
BBIs 8.6syn, 8.15, and 8.16 (see Figure 8.3). Whereas BBI 8.6syn showed a λem at 447 nm, 
incorporation of electron-withdrawing groups on the N-aryl substituents (8.15) resulted in 
a hypsochromically shifted λem at 408 nm. In contrast, BBI 8.16, which has electron-
donating groups on the N-aryl substituents, showed a λem at 469 nm. Thus, from this 
series of BBIs it is apparent that increased electron density at the N-substituent is 
advantageous for increasing λem values. 
 
Figure 8.3 BBI salts used to evaluate N-aryl electronic effects on λem. Values shown 

























 To better study the electronic communication within the BBI chromophore and 
ability to further tune λem, we prepared an N-to-N′ “donor-acceptor” BBI (8.32) featuring 
N-(4-MeOPh) and N′-(4-CO2EtPh) groups. Stepwise treatment of 1,5-dichloro-2,4-
dinitrobenzene (8.10) with benzocaine (to afford intermediate 8.33) followed by p-
anisidine provided dinitroarene 8.34 in 93% yield over the two steps. Following reductive 
cyclization, the intermediate benzobis(imidazole) 8.35 was alkylated with MeI to provide 
BBI 8.32 (see Figure 8.3) in 78% overall yield from 8.10. Analysis of the emission 
spectra of this compound revealed a λem at 472 nm, representing a slight bathochromic 
shift relative to 8.16. Overall, comparison of the BBIs in Figure 8.3 emphasize the ability 
to tune the emission characteristics through variation of N-aryl electronics, and establish 
a means to increase λem, primarily via incorporation of electron-rich N-arenes. 
Next, we turned our attention toward evaluating the feasibility of tuning 
fluorescence properties through C1-substitution. Analysis of BBIs 8.26 – 8.31 (see Figure 
8.4) revealed a strong dependence of the λem on the nature of the C1-substituent. Since 
C1-substituted BBI fluorophores were essentially unexplored, we initially investigated 
the effects of placement of phenyl groups at these positions. Thus, we compared BBI 
8.6syn, which is unsubstituted at C1, with C1-Ph substituted BBI 8.26. The λem of the 
latter appeared at a considerably longer wavelength (507 nm) than the former (447 nm). 
Having revealed a strong dependence of the λem on the C1-substituent, we considered 




Figure 8.4 Photoluminescence spectra of C1-aryl BBI salts in MeOH, excited at the 
absorption maximum, under ambient conditions. Concentration ca 5 μM, signal 






8.26, R = Bu, Ar = Ph
8.27, R = Bu, Ar = 4-CNPh
8.28, R = Bu, Ar = 4-MeOPh
8.29, R = Bu, Ar = 2-Th
8.30, R = MeO, Ar = 4-PhPh
8.31, R = MeO, Ar = 4-CNPh
R R  























Installation of electron-donating C1-aryl groups such as 4-MeOPh (8.28), 2-
thienyl (8.29), or 4-biphenyl (8.30) resulted in hypsochromic shifts in the λem relative to 
BBI 8.26. The magnitudes of these shifts were consistent with the relative electron-
donating abilities of the respective C1-arenes (i.e., 4-MeOPh > 2-thienyl > 4-biphenyl). 
In other words, increased electron density at C1 was consistently accompanied by a 
decrease in λem. Interestingly, the increased electron density at C1 in BBIs 8.29 and 8.30 
was significant enough to cause the λem of these BBIs to appear at lower wavelengths 
than even C1-unsubstituted BBI 8.6syn. 
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Electron-withdrawing C1-substituents, on the other hand, increased λem relative to 
BBI 8.26. For example, installation of 4-CNPh groups at C1 (8.27) resulted in a λem at 
551 nm, which is bathochromically shifted by 44 nm relative to 8.26. Overall, it appeared 
that electronic influences from the N- and C1-substituents were complementary in that 
increased electron density at the N-positions, and decreased electron density at C1 each 
resulted in longer λem. Considering these two factors, we envisioned it should be possible 
to take advantage of a donor-acceptor functionalized BBI featuring electron-donating N-
aryl groups in combination with electron-withdrawing C1-aryl groups. Such a system was 
expected to display electronic communication as depicted in Figure 8.5.  
 
Figure 8.5 Proposed diagram of the major electronic communication pathways 










To investigate, we synthesized BBI 8.31 which features 4-MeOPh groups at the 1- 
and 7-positions, and 4-CNPh groups at C1. The λem of BBI 8.31 appeared at 561 nm, 
which is the longest λem of all the BBIs described herein. The discernable increase in the 
λem relative to BBI 8.27 (see Table 8.1) confirmed a synergistic electronic impact 
resulting from judicious control of both the N- and C1-substituents. Notably, both BBI 
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8.27 and 8.31 undergo efficient excitation in the visible region, as the absorption cutoff of 
each appeared at approximately 450 nm. 
 











BBI R1 R2 R3 R4 R5 X λabs (nm)
a λem (nm)
a,b Yield (%)c
8.2•Br H Bu Bu Bu Bu Br 288 (4.29) 330 (0.64) 97
8.2•BF4 H Bu Bu Bu Bu BF4 290 (4.25) 329 (0.55) 92
8.2•MeSO4 H Bu Bu Bu Bu MeSO4 289 (4.26) 331 (0.63) 92
8.4 H Ph Ph Ph Ph Cl 352 (3.94) 474 (0.41) 64
8.6syn H Me Me Ph Ph MeSO4 345 (3.31) 447 (0.91) 86
8.6anti H Ph Me Me Ph MeSO4 345 (4.05) 442 (0.38) 40
8.9 H Ph Me Ph Me MeSO4 330 (3.92) 425 (0.31) 83
d
8.15 H Me Me 4-MeOPh 4-MeOPh I 343 (3.93) 469 (0.05) 74
8.16 H Me Me 4-(CO2Et)Ph 4-(CO2Et)Ph I 360 (4.13) 408 (0.02) 95
8.32 H Me Me 4-MeOPh 4-(CO2Et)Ph I 362 (3.60) 472 (0.01) 78
8.26 Ph Me Me 4-BuPh 4-BuPh I 322 (4.54) 507 (0.14) 94
8.27 4-CNPh Me Me 4-BuPh 4-BuPh I 388 (4.94) 551 (0.43) 93
8.28 4-MeOPh Me Me 4-BuPh 4-BuPh I 332 (4.51) 393 (0.55) 89
8.29 2-Th Me Me 4-BuPh 4-BuPh I 349 (4.00) 400 (0.18) 72
8.3 4-PhPh Me Me 4-MeOPh 4-MeOPh I 331 (4.61) 461 (0.05) 82
8.31 4-CNPh Me Me 4-MeOPh 4-MeOPh I 389 (4.91) 561 (0.06) 97  aData taken in MeOH under ambient conditions; log(ε) given in parantheses. bQuantum 
efficiencies (Фf) are given in parantheses and were determined relative to E-stilbene, 
anthracene, or 9,10-bis(phenylethynyl)anthracene. cIsolated overall yield from 
commercial material. dIsolated overall yield from 5,6-dichloro-1-methylbenzimidazole 
(8.7). 
 
8.5 Solvent effects on absorption and emission properties 
Many classes of molecules exhibit solvent-dependent photophysical 
properties.126,127,128 Most commonly, the λabs and λem respond to changes in solvent 
dielectric in a manner consistent with changes in the polarity of the chromophore as it 
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transitions from the ground to excited state. Other factors such as solvent reorganization 
energies, solvent donor and acceptor abilities, and chemical reactions taking place in the 
excited state can each alter the Stokes shift, and thus the λem, as the solvent is 
varied.129,130 Regardless of the origins, it is important to note that solvent-dependency can 
offer an excellent handle for tuning the photophysical characteristics of a solute.131 
To probe the effects of different solvents on the photophysical properties of BBI 
salts, the absorption and emission spectra of BBI 8.27 (see Figure 8.6) were analyzed in 
CH3CN, (MeO)3PO, DMF, and DMSO; limited solubilities precluded analysis in less 
polar solvents (i.e., PhCH3, THF, CH2Cl2, dioxane, etc.) As shown in Table 8.2, the λabs 
of 8.27 remained fairly constant upon increasing solvent polarity. The λem of this 
compound, however, was found to be strongly dependent on the nature of the solvent, 
displaying positive solvatofluorochromism with λem ranging from 437 – 557 nm.132  
 






8.26, R  = H
8.27, R  = CN









Table 8.2 Solvent effects on the photophysical properties of various BBI salts 
          Absorption and Emission Maxima (nm)
BBI CH3CN (MeO)3PO DMF DMSO
8.27 312 / 437 313 / 439 315 / 551 315 / 557
8.27•BF4 312 / 446 313 / 436 315 / 550 316 / 561
8.26 310 / 420 310 / 412 312 / 412 314 / 438
8.28 331 / 392 331 / 390 332 / 394 333 / 395
8.21 350 / 436 336 / 438 358 / 439 354 / 442  aData taken under ambient conditions. Concentration ca 5 μM. Solvent donor numbers 
and dielectric constants are: CH3CN = 14.1, 38.0; (MeO)3PO = 23.0, 20.6; DMF = 26.6, 
38.3; DMSO = 29.8, 45.0.133 
 
One possible explanation for the large, solvent-induced shifts in the λem may be 
significant structural reorganizations of the BBI solute that are unique to the excited state. 
The Stokes shifts exhibited by BBI 8.27 were also consistent with large structural 
changes in the excited state (see Table 8.3). For BBI 8.27, the Stokes shifts increased 
with solvent DN, ranging from 9118 to 13597 cm-1.  These values are in the range of 
unusually large Stokes shifts (5000 – 15000 cm-1), commonly ascribed to structural 
reorganization of the fluorophore or excited state reactions.134 Furthermore, consistent 
with the trend in λem (see below), the magnitudes of the Stokes shifts decreased with 
increasing electron density of the BBI core. For example, BBI 8.27 exhibited Stokes 
shifts ranging from 9168 – 13793 cm-1, whereas the increased electron density from the 







Table 8.3 Stokes shifts of various BBIs in different solvents 
Stokes Shift (cm-1)
BBI CH3CN (MeO)3PO DMF DMSO
27 9168 9170 13597 13793
26 8449 7986 7779 9016
28 4701 4570 4740 4714  
 aStokes shifts, in various solvents, given in cm-1 by 107(1/λem – 1/λabs). Solvents are listed 
in order of increasing donor number (DN). 
 
As described in Scheme 8.6, one plausible reorganization may involve 
nucleophilic attack at one of the electrophilic C1-positions. Such an event would result in 
a strongly dipolar system capable of extended delocalization, features commonly 
manifested in large positive solvatofluorochromism.126,127 The most likely nucleophilic 
species (Nuc) are either an iodide counterion or a solvent molecule. To exclude the 
former from consideration, we prepared 8.27•BF4 from 8.27, using the anion metathesis 
method previously described in Chapter 6. As shown in Table 8.2, nearly identical 
spectroscopic signals were observed in each of the aforementioned solvents suggesting 



































We next considered the solvent as a possible nucleophile in the mechanism 
described in Scheme 8.6 above.  An interesting relationship was realized after comparing 
the solvatofluorochromic shifts with solvent donor numbers (DN) and dielectric constants 
(κ).133 The λem for BBI 8.27 correlated better with increasing solvent DN than with κ. For 
example, CH3CN and DMF have nearly identical κ (38.0 and 38.3, respectively), but 
different DN (14.1 and 26.6, respectively). The λem of 8.27 appeared at 409 nm in 
CH3CN, but was shifted to 555 nm in DMF. This strong dependence on solvent DN,133 
further supported the proposed excited state reaction described in Scheme 8.6. To further 
investigate the existence of a nucleophile-electrophile interaction as the cause of the 
solvatofluorochromism, we compared the λem solvent-dependency of less electrophilic 
BBIs 8.26 and 8.28, as well as neutral benzobis(imidazole) 8.21 (see Table 8.2). BBI 8.26 
showed only very small changes in λem upon increasing solvent DN as did electron-rich 
BBI 8.28 and benzobis(imidazole) 8.21. Collectively, comparing chromophores of 
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different electrophilicities suggested that the dicationic nature of BBI 8.27, in 
combination with the electron-withdrawing C1-substituents, were responsible for the 
large solvatochromic shifts. Encouraged by the sensitivity of the observed 
solvatofluorochromism to the nature of the BBI core, we compared various solutions of 
BBIs 8.27 and 8.31. As can be seen in Figure 8.7, marked differences were visually 
observed upon irradiation of the two dicyano BBIs.   
 
Figure 8.7 Solutions of BBIs 8.28 (left) and 8.33 (right) irradiated with a 365 nm (5 
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8.6 Red-edge effects 
A red-edge effect (REE) refers to shifting of the λem to longer wavelengths in 
response to an increase in the excitation wavelength, along the red-edge of the absorption 
band.116,135 Multiple polar organic fluorophores have been found to display a REE, and 
this phenomenon has found application in a number of areas.106,116 Particularly interesting 
to our studies were recent reports of REEs from imidazolium-based ionic liquids.106 The 
specific cause of the REE in imidazolium species is not entirely understood, but it has 
been speculated that its origins involve different ground state orientations of associated 
species.106,136 Considering the BBI structure comprises two imidazolium moieties, we 
envisioned a REE may be observable from these materials. In addition, differential ion-
pairing interactions of BBIs 8.2•Br, 8.2•BF4, and 8.2•MeSO4 may manifest in 
counterion-dependent REEs. 
Since REEs of BBI-type fluorophores were unexplored, we began our 
investigations with a simple BBI structure (8.2) that would also be amenable to probing 
counterion effects. To determine if a REE was observable from BBI solutions, and 
explore any resulting counterion dependency, MeOH solutions (ca. 1 μM) of BBIs  
8.2•Br, 8.2•BF4, and 8.2•MeSO4 were each excited at various wavelengths along the red-
edge of their excitation spectra. As shown in Table 8.1, the absorption and emission 
spectra (excitation at the λabs) for 8.2 in MeOH were independent of the counterion; a 
representative set of spectra for 8.2•MeSO4 is shown in Figure 8.8.   
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Figure 8.8 Electronic absorption (solid line), excitation (dashed line, emission 
intensity monitored at 330 nm), and emission (dotted line, excitation at 290 nm) spectra 
of 8.2•MeSO4 in MeOH under ambient conditions. For aesthetic purposes, signal 
intensities have been adjusted. 












Both 8.2•Br and 8.2•BF4 gave nearly identical spectra upon red-edge excitation; 
the resulting spectra for 8.2•Br are depicted in Figure 8.9. Excitation at 330 nm resulted 
in a shoulder protruding at ca. 410 nm, which becomes the only apparent peak at λex ≥ 
340 nm. Notably, a mixture of 8.2•Br and 8.2•BF4 (1:1 molar ratio) also gave the same 
response. In contrast, red-edge excitation of 8.2•MeSO4 gave bimodal emission spectra 
that continued to shift bathochromically when excited at 330, 340, and 350 nm (see 
Figure 8.10). The difference in fine structure and overall response to REE between 
8.2•MeSO4 and 8.2•Br/BF4 strongly suggested that the counterion plays a decisive role 
in dictating the photophysical properties under these conditions. These results 
demonstrate, for the first time, REEs in extended, highly photoluminescent imidazolium-
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based chromophores and support the contention that REE may be influenced by cation-
anion interactions. 
 
Figure 8.9 Emission spectra of 8.2•Br in MeOH under ambient conditions excited at 
330 (solid line), 340 (dashed line) and 350 nm (dotted line). Concentration = 1 μM. 
 















Figure 8.10 Emission spectra of 8.2•MeSO4 (1 μM) in MeOH under ambient 
conditions excited at 330 (solid line), 340 (dashed line) and 350 nm (dotted line). 

















8.7 pH stability of benzobis(imidazolium) salts 
It has been previously demonstrated that BBI salts can be deprotonated137 under 
strongly basic conditions to generate bis(N-heterocyclic carbene)s.46 When the N-
substituents were small, such as 1°-alkyl groups (e.g., 8.2•Br), carbene dimerization 
occurred resulting in the formation of poly(enetetraamine)s as depicted in Scheme 8.7. 
Enetetraamines are well-known to be extremely oxygen sensitive and rapidly convert to 
ureas upon exposure to air.44 Alternatively, one may envision hydrolysis of the BBI to 
generate a diamide, which upon further hydrolysis and oxidation would result in a 
diamino-benzoquinonediimine. These reactivities to strong base prompted us to explore 
the pH stability of a simple BBI chromophore (8.2•Br) in aqueous solutions; key data are 
summarized in Table 8.4. 
 












































In neutral H2O, BBI 8.2•Br showed absorption and emission characteristics 
nearly identical to those observed in MeOH solvent. After 30 min in H2O (pH 7), 
emission intensity of BBI 8.2•Br was at 93% of its initial value (see Table 8.4). After 2 h, 
85% of the emission intensity persisted. To investigate the emission properties of 8.2•Br 
under more basic conditions, a fresh sample was dissolved in aqueous media buffered to 
pH 9. Under these conditions, the emission intensity remained essentially unchanged 
from that at pH 7, and did not diminish significantly even after 2 h. At pH 11, the 
photoluminescence disappeared almost instantly, and was not returned upon acidification 
to pH 7. Thus, the upper limit of tolerable pH levels appeared to be approximate 9. 
Furthermore, the irreversibility of the fluorescence loss suggested that the BBI 
chromophore was in fact destroyed via hydrolysis or oxidation, as described in Scheme 
8.7. 
  
Table 8.4. Total emission intensity observed from BBI 8.2•Br at various pH values and 
durationsa 
Ix/I7 at time n         In/Io at pH X
pH 0 min 30 min 120 min 30 min 120 min
1 0.09 0.09 0.10 0.94 0.93
3 0.87 0.92 1.00 0.98 0.98
5 0.87 0.89 1.04 0.95 1.02
7 1.00 1.00 1.00 0.93 0.85
9 0.86 0.91 0.98 0.98 0.97
11 0.01 0.01 0.01 0.98 1.03  
aEmission data collected under ambient conditions. Excitation at 290 nm. Ix = total 
integrated emission intensity at pH = X, and time indicated. I7 = total integrated emission 
intensity at pH = 7, and time indicated. Io = total integrated emission intensity at time 0 
for the pH indicated. 
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To elucidate the degradation pathway of BBI 8.2•Br under basic aqueous 
conditions, we performed NMR-scale experiments in D2O/NaOH (pH = 11). Analysis of 
the products after 2 h at room temperature revealed complete loss of the C1-proton 
signals (δ = 9.57 in D2O). Mass-spectral analysis confirmed hydrolysis products 
consistent with the bis(formamide) shown in Scheme 8.7. 
Next, we explored the stability of 8.2•Br under acidic aqueous conditions. At pH 
levels of 5 and 3, the emission intensities remained essentially unchanged after 2 h, and 
were similar to the emission intensity observed at pH 7. Upon further acidification (pH 
1), however, photoluminescence was lost immediately and was not regained upon 
neutralization to pH 7. Overall, despite reactive imidazolium moieties, BBI 8.2•Br 
showed excellent stability in aqueous solutions ranging in pH from 3 – 9. Outside of 
these limits, degradation was observed consistent with the formation of a diamino-
benzoquinonediimine/bis(urea), depending on pH. 
 
8.8 Conclusions 
 In summary, a new series of ionic fluorophores based upon 
benzobis(imidazolium) salts has been developed. A variety of characteristics and 
applications of this new class of fluorophores have been studied, including emission 
wavelength tunability, pH stability, solvatochromism and solvatofluorochromism, and 
red-edge excitation. The scope of potential applications of these materials was facilitated 
by a modular synthetic design. Each of the fluorophores described herein was synthesized 
in at most four steps without the need for  chromatographic purification. 
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 Installation of functional groups at various sites on the BBI core allowed for 
emission wavelength tunability. Ultimately it was found that longer λem were obtained 
when electron-rich N-substituents and electron-deficient C1-substituents were in place. 
Furthermore, evidence for N-to-C1 electronic communication was observed. Overall, the 
emission wavelengths were tunable over a broad range, extending from the ultraviolet 
(330 nm) into the visible region (up to 561 nm), and Фfs were generally good, reaching a 
maximum of 0.91. 
Fundamental studies regarding the solution photophysics were carried out with 
focus on solvatochromism, solvatofluorochromism, and red-edge excitation. The λem 
solvent-dependency was found to be strongly influenced by the nature of the BBI core as 
well as solvent, and independent of the nature of the counterions. Collectively, the 
response to changes in solvent DN, and the magnitude of the Stokes shifts suggested a 
nucleophilic attack from solvent molecules as the cause of the solvatofluorochromism. 
REE was observed from solutions of BBIs with varying counterions. The REE was found 
to be counterion dependent, even in dilute MeOH solutions. Importantly, these resulted 
not only demonstrated for the first time REE of extended imidazolium-based 
fluorophores, but also unveiled the influence of cation-anion pairing in addition to solvate 
interactions. 
 
8.9 Experimental Section 
 
General Considerations. 1H and 13C NMR spectra were recorded using a Varian 
Unity Plus 300 or 400 spectrometer. Chemical shifts (δ) are expressed in ppm downfield 
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from tetramethylsilane using the residual protio solvent as an internal standard (CDCl3, 
1H: 7.26 ppm and 13C: 77.0 ppm; DMSO-d6, 1H: 2.49 ppm and 13C: 39.5 ppm). Coupling 
constants are expressed in hertz (Hz). HRMS (ESI, CI) were obtained with a VG 
analytical ZAB2-E instrument. UV-vis spectra were recorded using a Perkin Elmer 
Instruments Lambda 35 spectrometer. Emission spectra were recorded using a 
QuantaMaster Photon Technology International fluorometer. Unless otherwise noted, all 
reactions were performed under ambient atmosphere. All starting materials and solvents 
were of reagent quality and used as received from commercial suppliers. 
 
1,3,5,7-Tetrabutylbenzobis(imidazolium) bis(tetrafluoroborate) (8.2•BF4): After 
suspending BBI 8.2•Br (992 mg, 1.82 mmol) in dry CH2Cl2, Et3O•BF4 (692 mg, 3.64 
mmol) was added in a single portion. The reaction progress was monitored by 1H NMR 
spectroscopy and upon completion (ca 10 min), the solution was concentrated to provide 
969 mg (95% yield) of the desired product as a white powder. 1H NMR (400 MHz, 
DMSO-d6): δ 10.10 (s, 2H), 8.97 (s, 2H), 4.59 (t, J = 7.2 Hz, 8H), 2.00-1.93 (m, 8H), 
1.42-1.33 (m, 8H), 0.94 (t, J = 7.2 Hz, 12H); 13C NMR (75 MHz, DMSO-d6): δ 145.5, 
130.2, 98.8, 47.1, 30.2, 19.1, 13.4. HRMS m/z calcd for BF4 87.0029, found 87.0026. 
 
1,3,5,7-Tetrabutylbenzobis(imidazolium) bis(methyl sulfate) (8.2•MeSO4): After 
suspending BBI 8.2•Br (488 mg, 0.90 mmol) in dry CH2Cl2, Me2SO4 (0.17 mL, 1.80 
mmol) was added in a single portion. The reaction progress was monitored by 1H NMR 
spectroscopy and upon completion (ca 4 h), the solution was concentrated to provide 542 
mg (99% yield) of the desired product as a beige powder. 1H NMR (400 MHz, CDCl3): δ 
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9.94 (s, 2H), 8.84 (s, 2H), 4.72, (t, J = 7.0 Hz, 8H), 3.76 (s, 6H), 1.96-1.89 (m, 8H), 1.42-
1.32 (m, 8H), 0.93 (t, J = 7.2 Hz, 12H); 13C NMR (100 MHz, CDCl3+DMSO-d6): δ 
145.3, 130.3, 99.7, 54.5, 47.8, 31.1, 19.5, 13.4. 
 
1,5-Diphenylbenzobis(imidazole) (8.5anti): Benzobis(imidazole) 8.1 (500 mg, 3.16 
mmol) was dissolved in dry DMF (15 mL) in a screw-cap vial. Under nitrogen 
atmosphere, PhI (1.42 mL, 12.6 mmol), CuI (60 mg, 0.32 mmol), 1,10-phenanthroline 
(114 mg, 0.63 mmol) and K2CO3 (1.75 g, 12.6 mmol) were added. The vial was then 
sealed with a Teflon-lined cap and the mixture was stirred at 130 °C for 17 h. Upon 
completion, the mixture was poured into H2O (30 mL).  Collection of the precipitated 
solids via vacuum filtration afforded 932 mg (95% yield) as a 1:1 mixture of two 
regioisomers 8.5syn and 8.5anti. Recrystallization of the mixture from hot DMSO provided 
392 mg (40% yield based on 8.1) of 8.5syn. Spectral data for 8.5syn were consistent with 
those previously reported (see Chapter 7). Data for 8.5anti: 1H NMR (300 MHz, CDCl3): δ 
8.20 (s, 2H), 8.00 (s, 2H), 7.63-7.62 (m, 8H), 7.52-7.45 (m, 2H); 13C NMR (75 MHz, 
CDCl3): δ 143.7, 142.2, 136.6, 131.5, 130.1, 128.0, 123.9, 100.4; HRMS m/z calcd for 
C20H15N4 [M+H+] 311.1297, found 311.1299. 
 
1,5-Dimethyl-3,7-diphenylbenzobis(imidazolium) bis(methyl sulfate) (8.6anti): After 
dissolving diphenylbenzobis(imidazole) 8.5anti (50 mg, 0.15 mmol) in CH3CN (1.0 mL) 
in a screw-cap vial, Me2SO4 (29 μL, 0.31 mmol) was added in a single portion. The vial 
was sealed with a Teflon-lined cap and placed in an oil bath at 80 °C for 4 h. The reaction 
mixture was then cooled and concentrated to afford 84 mg (> 99% yield) of the desired 
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product as a beige wax. 1H NMR (400 MHz, DMSO-d6): δ 10.35 (s, 2H), 8.64 (s, 2H), 
7.92 (d, J = 7.6 Hz, 4H), 7.85-7.78 (m, 6H), 4.24 (s, 6H), 3.34 (s, 6H); 13C NMR (75 
MHz, DMSO-d6): δ 147.4, 146.3, 132.9, 131.2, 130.9, 130.5, 130.1, 125.7, 99.1, 52.9, 
34.0; HRMS m/z calcd for. 
 
Benzimidazolium chloride 8.8: In a nitrogen-filled drybox, a screw-cap vial was 
charged with 5,6-dichloro-1-methylbenzimidazole 8.7 (375 mg, 1.87 mmol) and PhCH3 
(10 mL). To the solution was added Pd(OAc)2 (4 mg, 0.02 mmol), 1,3-bis(2,6-
diisopropylphenyl)imidazolium chloride (16 mg, 0.04 mmol), NaOtBu (368 mg, 3.83 
mmol), and PhNH2 (869 mg, 9.33 mmol). The vial was then sealed with a Teflon-lined 
cap and placed in an oil bath at 120 °C for 12 h. After cooling the reaction mixture to 
ambient temperature, it was poured into a solution of HC(OEt)3 (50 mL) and conc. HCl 
(1.0 mL). The resulting mixture was then stirred in an oil bath at 150 °C for 12 h, allowed 
to cool, and then poured into Et2O (100 mL). The precipitated solids were collected via 
vacuum filtration, rinsed with Et2O, and redissolved in a saturated solution of Na2CO3 in 
iPrOH. After standing for 1 h, the mixture was filtered through Celite and the filtrate was 
concentrated to provide 523 mg (86% yield) of the desired product as a light brown 
powder. 1H NMR (400 MHz, DMSO-d6): δ 10.58 (s, 1H), 8.57 (s, 1H), 8.13 (s, 1H), 8.09 
(s, 1H), 8.05-8.02 (m, 4H), 7.83-7.72 (m, 6H); 13C NMR (75 MHz, DMSO-d6): δ 149.2, 
143.2, 143.0, 134.9, 133.5, 133.4, 130.5, 130.4, 128.1, 127.7, 125.6, 125.4, 102.6, 94.6, 
31.5; HRMS m/z calcd for C21H17N4 [M+] 325.1453, found 325.1454. 
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1,3-Dimethyl-5,7-diphenylbenzobis(imidazolium) bis(methyl sulfate) (8.9): After 
dissolving benzimidazolium chloride 8.8 (50 mg, 0.15 mmol) in CH3CN (1.0 mL), 
Me2SO4 (39 mg, 0.31 mmol) was added in a single portion. After stirring the solution at 
80 °C for 2 h, it was concentrated to afford 84 mg (>99% yield) of the desired product as 
a tan solid. 1H NMR (400 MHz, CDCl3): δ 10.81 (s, 1H), 10.04, (s, 1H), 8.60 (s, 2H), 
8.04 (d, J = 7.2 Hz, 4H), 7.85-7.78 (m, 6H), 4.18 (s, 6H), 3.35 (s, 6H); 13C NMR (75 
MHz, DMSO-d6): δ 147.4, 146.3, 132.9, 131.2, 130.9, 130.5, 130.1, 125.7, 99.1, 52.9, 
34.0;  HRMS m/z calcd for C22H19N4 [M-H+] 339.1610, found 339.1607. 
 
1,5-Bis(4-carboethoxyphenyl)amino-3,4-dinitrobenzene (8.11): A screw-cap vial was 
charged with 1,5-dichloro-3,4-dinitrobenzene (8.10) (413 mg, 1.74 mmol), benzocaine 
(1.44 g, 8.71 mmol), iPrOH (15 mL), and a stir bar. The vial was sealed with a Teflon-
lined cap, placed in an oil bath at 120 °C and stirred for 48 h. After pouring the mixture 
into 5% HCl (50 mL), the precipitated solids were collected via vacuum filtration, rinsed 
with H2O and dried under vacuum to provide 1.66 g (98% yield) of the desired product as 
a yellow powder. 1H NMR (400 MHz, CDCl3): δ 9.92 (br s, 2H), 9.32 (s, 1H), 8.05 (d, J 
= 8.4 Hz, 4H), 7.25 (d, J = 8.4 Hz, 4H), 6.83 (s, 1H), 4.38 (quart, J = 7.2 Hz, 4H), 1.41 (t, 
J = 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 165.4, 145.6, 141.2, 131.3, 129.2, 
128.2, 126.1, 123.0, 96.7, 61.2, 14.3; HRMS m/z calcd for C24H23N4O8 [M+H+] 
495.1516, found 495.1517. 
 
1,5-Bis(4-methoxyphenyl)amino-3,4-dinitrobenzene (8.12): After dissolving 1,5-
dichloro-3,4-dinitrobenzene (8.10) (1.00 g, 4.22 mmol) in EtOH (75 mL), p-anisidine 
 156
(2.08 g, 16.9 mmol) was added in a single portion. The mixture was then placed in an oil 
bath at 80 °C and stirred for 48 h. The mixture was then poured into H2O (200 mL) which 
caused solids to precipitate.  The solids were collected via vacuum filtration, rinsed with 
H2O and dried under vacuum to provide 1.42 g (96% yield) of the desired product as a 
red-orange powder. 1H NMR (300 MHz, CDCl3): δ 9.57 (br s, 2H), 9.31 (s, 1H), 7.05 (d, 
J = 8.9 Hz, 4H), 6.84 (d, J = 8.9 Hz, 4H), 6.18 (s, 1H), 3.80 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 158.2, 1147.7, 129.8, 129.4, 126.7, 125.0, 114.8, 94.9, 55.5; HRMS m/z calcd 
for C20H19N4O6 [M+H+] 411.1305, found 411.1301. 
 
1,7-Bis(4-carboethoxyphenyl)benzobis(imidazole) (8.13): Dinitroarene 8.11 (400 mg, 
0.81 mmol) was dissolved in HC(OEt3) (10 mL) in a screw-cap vial. To the solution was 
added HCO2H (88%, 1 mL), HCO2Na (1.65 g, 24.3 mmol) and Pd/C (172 mg, 5 wt%, 
0.08 mmol Pd). The vial was then sealed with a Teflon-lined cap and the mixture was 
heated in an oil bath at 110 °C for 48 h. Upon cooling the mixture to ambient 
temperature, it was filtered through Celite. The filtrate was treated with 5% HCl, stirred 
for ca 30 min, and then brought to pH 9 using saturated aqueous Na2CO3. Precipated 
solids were subsequently collected via vacuum filtration, rinsed with H2O, and dried 
under vacuum to provide 352 mg (96% yield) of the desired product as a tan powder. 1H 
NMR (400 MHz, CDCl3): δ 8.38 (s, 1H), 8.26 (d, J = 8.4 Hz, 4H), 8.21 (s, 2H), 7.63 (s, 
1H), 7.61 (d, J = 8.4 Hz, 4H), 4.43 (quart, J = 7.2 Hz, 4H), 1.43 (t, J = 7.2 Hz, 6H); 13C 
NMR (75 MHz, CDCl3): δ 165.5, 143.1, 141.8, 140.1, 131.8, 131.7, 129.9, 123.3, 111.6, 
90.4, 61.4, 14.3; HRMS m/z calcd for C26H23N4O4 [M+H+] 455.1719, found 455.1716. 
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1,7-Bis(4-methoxyphenyl)benzobis(imidazole) (8.14): Dinitroarene 8.12 (1.00 g, 2.44 
mmol) was suspended in HCO2H (88%, 100 mL). To the suspension was added HCO2Na 
(1.99 mg, 29.2 mmol) and Pd/C (103 mg, 5 wt%, 0.05 mmol Pd). The mixture was heated 
in an oil bath at 110 °C for 48 h. Upon completion, the cooled reaction mixture was 
filtered through Celite and the filtrate volume was reduced to ca 25 mL under vacuum. 
The solution was then added slowly into a vigorously stirred saturated solution of 
aqueous Na2CO3 (150 mL). Precipitated solids were collected via vacuum filtration, 
rinsed with H2O, and dried under vacuum to provide 705 mg (78% yield) of the desired 
product as a tan powder. 1H NMR (300 MHz, CDCl3): δ 8.31 (s, 1H), 8.08 (s, 2H), 7.41 
(d, J = 8.8 Hz, 4H), 7.35 (s, 1H), 7.06 (d, J = 8.8 Hz, 4H), 3.88 (s, 6H); 13C NMR (75 
MHz, CDCl3): δ 159.2, 143.6, 141.2, 132.8, 129.3, 125.9, 115.2, 110.5, 89.8, 55.6; 
HRMS m/z calcd for C22H19N4O2 [M+H+] 371.1508, found 371.1511. 
 
1,7-Bis(4-carboethoxyphenyl)-3,5-dimethylbenzobis(imidazolium) diiodide (8.15): 
Benzobis(imidazole) 8.13 (300 mg, 0.66 mmol) was dissolved in CH3CN (10 mL) and 
MeI (1.0 mL) in a screw-cap vial. The vial was sealed with a Teflon lined cap and the 
mixture was heated at 80 °C for 8 h. Upon completion, the mixture was concentrated 
under vacuum to provide 485 mg (>99% yield) of the desired product as a dark brown 
powder. 1H NMR (400 MHz, DMSO-d6): δ 10.48 (s, 2H), 9.12 (s, 1H), 8.27 (d, J = 8.2 
Hz, 4H), 8.24 (s, 1H), 8.03 (d, J = 8.2 Hz, 4H), 4.38 (quart, J = 7.2 Hz, 4H), 4.30 (s, 6H), 
1.35 (t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, DMSO-d6): δ 164.7, 147.4, 136.6, 131.6, 
131.3, 131.2, 129.9, 125.7, 107.3, 99.9, 98.5, 61.4, 34.4, 14.2; HRMS m/z calcd for 
C28H27N4O4 [M-H+] 483.2032, found 483.2033. 
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1,7-Bis(4-methoxyphenyl)-3,5-dimethylbenzobis(imidazolium) diiodide (8.16): 
Benzobis(imidazole) 8.14 (500 mg, 1.35 mmol) was dissolved in CH3CN (10 mL) and 
MeI (1.0 mL) in a screw-cap vial. The vial was sealed with a Teflon lined cap and the 
mixture was heated at 80 °C for 8 h. Upon completion, the mixture was concentrated 
under vacuum to provide 877 mg (99% yield) of the desired product as a dark brown 
powder. 1H NMR (400 MHz, DMSO-d6): δ 10.30 (s, 2H), 9.06 (s, 1H), 7.87 (s, 1H), 7.76 
(d, J = 8.8 Hz, 4H), 7.25 (d, J = 8.8 Hz, 4H), 4.27 (s, 6H), 3.86 (s, 6H); 13C NMR (100 
MHz, DMSO-d6): δ 160.7, 147.1, 130.9, 130.6, 127.0, 125.4, 115.5, 99.4, 97.8, 55.8, 
34.2; HRMS m/z calcd for C24H23N4O2 [M-H+] 399.1821, found 399.1817. 
 
1,5-Bis(4-butylphenyl)amino-3,4-dinitrobenzene (8.17): Following a similar procedure 
used to prepare 8.12, 1,5-dichloro-3,4-dinitrobenzene (8.10) (1.00 g, 4.22 mmol) and 4-
butylaniline (2.52 g, 16.88 mmol) afforded 1.83 g (94% yield) of the desired product as a 
burnt orange powder. 1H NMR (400 MHz, CDCl3): δ 9.68 (br s, 2H), 9.30 (s, 1H), 7.14 
(d, J = 8.2 Hz, 4H), 7.05 (d, J = 8.2 Hz, 4H), 6.48 (s, 1H), 2.58 (t, J = 7.6 Hz, 4H), 1.61-
1.53 (m, 4H), 1.40-1.31 (m, 4H), 0.95 (t, J = 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3): 
δ 147.0, 141.5, 134.6, 129.4, 129.3, 125.1, 124.6, 95.1, 35.1, 33.6, 22.2, 13.9; HRMS m/z 
calcd for C26H31N4O4 [M+H+] 463.2345, found 463.2343. 
 
General procedure for the reduction of dinitroarenes 8.11 and 8.17. The dinitroarene 
(1.0 mmol, 1.0 equiv) was dissolved in EtOH (20 mL) in a 100 mL flask. Pd/C (5 wt%, 
0.10 mmol Pd, 0.10 equiv) was added. The flask was fitted with a H2O-jacketed 
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condenser and H2NNH2•H2O (80%, 16 mmol, 16 equiv) was added dropwise followed by 
1.2 N HCl (7 mL, 8.0 mmol, 8.0 equiv). The solution was stirred in an oild bath at 80 °C 
for 4 h. The cooled reaction mixture was filtered through Celite and concentrated under 
vacuum to provide the corresponding tetraamines as their di-hydrochloride salts. These 
products were used directly in subsequent steps without further purification. Note: these 
materials were found to decompose upon prolonged standing under ambient atmosphere 
and thus were stored in a nitrogen-filled desiccator prior to use. 
 
General procedure for the synthesis of C1-aryl benzobis(imidazole)s 8.20 – 8.25. 
Under an atmosphere of dry nitrogen, the corresponding tetraaminobenzene (1.0 mmol, 
1.0 equiv) was suspended in THF (10 mL). The aroyl chloride (2.0 mmol, 2.0 equiv) was 
added, followed by Na2CO3 (10.0 mmol, 10.0 equiv). After stirring the solution for 12 h 
at ambient temperature, it was slowly poured into AcOH (30 mL). The resulting 
suspension was heated open-air in an oil bath at 110 °C for 24 h, during which time 
AcOH was added in portions to maintain the solution volume at what?. Upon completion, 
the solution volume was reduced to ca 10 mL under reduced pressure, and the resulting 
solution was slowly poured into a vigorously stirred solution of 10% NaOH containing an 
equal mass of crushed ice. The resulting solids were collected via vacuum filtration, 
rinsed with 10% NaOH, then H2O, and dried under vacuum.  
 
1,7-Bis(4-butylphenyl)-2,6-diphenylbenzobis(imidazole) (8.20): Yield: 580 mg (96%). 
1H NMR (300 MHz, CDCl3): δ 8.36 (s, 1H), 7.58 (dd, J = 6.3, 1.8 Hz, 4H), 7.37-7.26 (m, 
10H), 7.20 (d, J = 8.7 Hz, 4H), 6.97 (s, 1H), 2.68 (t, J = 2.68 Hz, 4H), 1.70-1.60 (m, 4H), 
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1.45-1.32 (m, 4H), 0.96 (t, J = 7.3 Hz, 6H) ; 13C NMR (75 MHz, CDCl3): δ 153.1, 143.4, 
135.8, 134.8, 130.1, 129.8, 129.4, 129.3, 128.2, 127.3, 109.0, 90.2, 35.3, 33.3, 22.3, 13.9; 
HRMS m/z calcd for C40H39N4 [M+H+] 575.3175, found 575.3176. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(4-cyanophenyl)benzobis(imidazole) (8.21): Yield: 308 
mg (93%). 1H NMR (300 MHz, CDCl3): δ 8.37 (s, 1H), 7.69 (d, J = 8.7 Hz, 4H), 7.58 (d, 
J = 8.7 Hz, 4H), 7.32 (d, J = 8.4 Hz, 4H), 7.19 (d, J = 8.4 Hz, 4H), 6.96 (s, 1H), 2.71 (t, J 
= 7.7 Hz, 4H), 1.72-1.61 (m, 4H), 1.46-1.34 (m, 4H), 0.97 (t, J = 7.2 Hz, 6H); 13C NMR 
(75 MHz, CDCl3): δ 151.2, 144.3, 140.8, 136.5, 134.3, 134.0, 132.0, 130.2, 129.7, 127.1, 
118.4, 112.8, 109.9, 90.5, 35.3, 33.3, 22.4, 13.9; HRMS m/z calcd for C42H37N6 [M+H+] 
625.3080, found 625.3078. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(4-methoxyphenyl)benzobis(imidazole) (8.22): Yield: 
287 mg (91%). 1H NMR (300 MHz, CDCl3): δ 8.28 (s, 1H), 7.50 (d, J = 8.1 Hz, 4H), 
7.27 (d, J = 7.3 Hz, 4H), 7.19 (d, J = 7.3 Hz, 4H), 6.90 (s, 1H), 6.80 (d, J = 8.1 Hz, 4H), 
3.80 (s, 6H), 2.68 (t, J = 7.7 Hz, 4H), 1.70-1.60 (m, 4H), 1.45-1.33 (m, 4H), 0.96 (t, J = 
7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 160.3, 152.9, 143.3, 140.5, 135.6, 135.0, 
130.8, 129.8, 127.3, 122.7, 113.6, 108.4, 89.9, 55.2, 35.3, 33.3, 22.3, 13.9; HRMS m/z 
calcd for C42H43N4O2 [M+H+] 635.3386, found 635.3390. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(2-thienyl)benzobis(imidazole) (8.23): Yield: 200 mg 
(78%). 1H NMR (300 MHz, CDCl3): δ 8.25 (s, 1H), 7.37-7.26 (m, 10H), 6.89 (dd 
appearing as t, J = 4.5 Hz, 2H), 6.77 (d, J = 3.6 Hz, 2H), 6.59 (s, 1H), 2.73 (t, J = 7.7 Hz, 
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4H), 1.74-1.64 (m, 4H), 1.48-1.35 (m, 4H), 0.97 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, 
CDCl3): δ 148.2, 144.6, 140.5, 136.4, 134.0, 132.9, 130.0, 128.25, 128.16, 127.9, 127.4, 
108.4, 89.6, 35.4, 33.3, 22.4, 13.9; HRMS m/z calcd for C36H35N4S2 [M+H+] 587.2303, 
found 587.2307.  
 
2,6-Bis(4-biphenyl)-1,7-bis(4-methoxyphenyl)benzobis(imidazole) (8.24): Yield: 492 
mg (88%). 1H NMR (400 MHz, CDCl3): δ 8.36 (s, 1H), 7.67 (d, J = 8.4 Hz, 4H), 7.59 (d, 
J = 7.2 Hz, 4H), 7.54 (d, J = 8.4 Hz, 4H), 7.45-7.41 (m, 4H), 7.37-7.33 (m, 2H), 7.25 (d, 
J = 6.8 Hz, 4H), 7.01 (d, J = 8.8 Hz, 4H), 6.85 (s, 1H), 3.88 (s, 6H); 13C NMR (75 MHz, 
CDCl3): δ 159.4, 152.9, 141.8, 140.6, 140.1, 136.3, 130.0, 129.7, 129.0, 128.82, 128.8, 
127.7, 127.0, 126.8, 115.2, 108.9, 90.0, 55.5; HRMS m/z calcd for C46H35N4O2 [M+H+] 
675.2760, found 675.2763. 
 
2,6-Bis(4-cyanophenyl)-1,7-bis(4-methoxyphenyl)benzobis(imidazole) (8.25): Yield: 
469 mg (99%). 1H NMR (400 MHz, CDCl3+DMSO-d6): δ 8.29 (s, 1H), 7.68 (d, J = 8.2 
Hz, 4H), 7.55 (d, J = 8.2 Hz, 4H), 7.16 (d, J = 8.4 Hz, 4H), 6.97 (d, J = 8.4 Hz, 4H), 6.80 
(s, 1H), 3.84 (s, 6H), ; 13C NMR (75 MHz, CDCl3+DMSO-d6): δ 159.7, 151.1, 140.6, 
136.8, 134.2, 131.9, 129.5, 128.9, 128.5, 118.2, 115.4, 112.6, 109.6, 90.3, 55.5; HRMS 
m/z calcd for C36H25N6O2 [M+H+] 573.2039, found 573.2038. 
 
General procedure for the alkylation of benzobis(imidazole)s 8.20 – 8.25 to provide 
BBI salts 8.26 – 8.31. The benzobis(imidazole) (1.0 mmol, 1.0 equiv) was dissolved or 
suspended in CH3CN (10 mL) and MeI (5.0 mmol, 5.0 equiv) in a screw-cap vial. The 
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vial was sealed with a Teflon-lined cap and the reaction mixture was stirred in an oil bath 
at 100 °C for 2 – 10 h. The reaction progress was monitored by No-D 1H NMR 
spectroscopyref of aliquots taken periodically over time. Upon completion of the reaction, 
the reaction mixtures were cooled to ambient temperature and concentrated.  Crude 




(8.26): Yield: 149 mg (>99%). 1H NMR (300 MHz, CDCl3): δ 8.44 (s, 1H), 7.88 (d, J = 
7.5 Hz, 4H), 7.65-7.50 (m, 10H), 7.31 (s, 1H), 7.23 (d, J = 8.4 Hz, 4H), 4.27 (s, 6H), 
1.60-1.50 (m, 4H), 1.35-1.23 (m, 4H), 0.89 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, 
CDCl3): δ 153.7, 146.4, 133.1, 132.9, 132.0, 131.4, 130.2, 129.5, 129.3, 127.6, 120.6, 
99.9, 98.0, 35.2, 34.9, 32.9, 22.1, 13.8; HRMS m/z calcd for C42H43N4 [M-H+] 603.3488, 
found 603.3492. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(4-cyanophenyl)benzobis(imidazolium) diiodide (8.27): 
Yield: 255 mg (>99%). 1H NMR (400 MHz, DMSO-d6): δ 9.33 (s, 1H), 8.12 (d, J = 7.8 
Hz, 4H), 8.05 (d, J = 7.8 Hz, 4H), 7.49 (d, J = 8.2 Hz, 4H), 7.38 (s, 1H), 7.36 (d, J = 8.2 
Hz, 4H), 4.19 (s, 3H), 2.59 (t, J = 7.4 Hz, 4H), 1.52-1.48 (m, 4H), 1.25-1.20 (m, 4H), 
0.84 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3+DMSO-d6): δ 151.7, 146.5, 132.6, 
132.3, 132.1, 131.8, 129.9, 128.7, 127.0, 124.8, 116.7, 116.3, 99.8, 97.3, 34.7, 34.3, 32.4, 




bis(tetrafluoroborate) (8.27•BF4): This compound was prepared analogously to 8.2•BF4 
from BBI 8.27 (59 mg, 0.06 mmol) to provide 49 mg (98% yield) of the desired product. 
1H NMR (300 MHz, DMSO-d6): δ 9.30 (s, 1H), 8.15 (d, J = 8.4 Hz, 4H), 7.99 (d, J = 8.4 
Hz, 4H), 7.46 (d, J = 8.1 Hz, 4H), 7.43 (s, 1H), 7.38 (d, J = 8.7 Hz, 4H), 4.20 (s, 6H), 
2.62 (t, J = 7.8 Hz, 4H), 1.57-1.47 (m, 4H), 1.31-1.19 (m, 4H), 0.86 (t, J = 7.2 Hz, 6H); 
13C NMR (75 MHz, DMSO-d6): δ 152.4, 145.8, 132.8, 132.3, 131.9, 131.3, 130.2, 129.5, 
127.4, 125.4, 117.6, 115.5, 99.4, 96.8, 34.3, 3.8, 32.5, 21.6, 13.7. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(4-methoxyphenyl)-3,5-
dimethylbenzobis(imidazolium) diiodide (8.28): Yield: 425 mg (95%). 1H NMR (400 
MHz, DMSO-d6): δ 9.22 (s, 1H), 7.73 (d, J = 8.6 Hz, 4H), 7.48 (d, J = 8.2 Hz, 4H), 7.37 
(d, J = 8.2 Hz, 4H), 7.15 (s, 1H), 7.13 (d, J = 8.6 Hz, 4H), 4.19 (s, 6H), 3.82 (s, 6H), 2.61 
(t, J = 7.6 Hz, 4H), 1.55-1.48 (m, 4H), 1.26-1.21 (m, 4H), 0.85 (t, J = 7.2 Hz, 6H); 13C 
NMR (400 MHz, DMSO-d6): δ 162.5, 153.8, 145.4, 133.4, 131.7, 131.1, 130.14, 130.09, 
127.5, 114.5, 112.5, 55.7, 34.3, 34.0, 32.5, 21.6, 13.7; HRMS m/z calcd for C44H47N4O2 
[M-H+] 663.3699, found 663.3701. 
 
1,7-Bis(4-butylphenyl)-2,6-bis(2-thienyl)-3,5-dimethylbenzobis(imidazolium) 
diiodide (8.29): Yield: 276 mg (93%). 1H NMR (400 MHz, CDCl3): δ 8.48 (s, 1H), 7.80 
(d, J = 3.6 Hz, 2H), 7.78 (d, J = 4.8 Hz, 2H), 7.39 (d, J = 8.2 Hz, 4H), 7.31 (d, J = 8.2 Hz, 
4H), 7.25 (d, J = 4.8 Hz, 2H), 7.11 (s, 1H), 4.32 (s, 6H), 2.67 (t, J = 7.8 Hz, 4H), 1.64-
1.56 (m, 4H), 1.38-1.29 (m, 4H), 0.92 (t, J = 7.4 Hz, 6H); 13C NMR (100 MHz, CDCl3): 
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δ 148.7, 147.1, 137.6, 135.5, 132.8, 132.2, 130.6, 129.5, 128.7, 127.8, 119.0, 98.8, 97.0, 




diiodide (8.30): Yield: 186 mg (94%). 1H NMR (400 MHz, DMSO-d6): δ 9.28 (s, 1H), 
7.95 (d, J = 8.4 Hz, 4H), 7.90 (d, J = 8.4 Hz, 4H), 7.58-7.43 (m, 10H), 7.37 (s, 1H), 7.10 
(d, J = 9.2 Hz, 4H), 4.24 (s, 6H), 3.76 (s, 6H); 13C NMR (75 MHz, DMSO-d6): δ 160.6, 
153.8, 144.1, 138.0, 132.3, 132.0, 131.2, 129.2, 128.8, 127.0, 126.9, 124.7, 119.8, 115.5, 




dimethylbenzobis(imidazolium) diiodide (8.31): Yield: 102 mg (99%). 1H NMR (400 
MHz, DMSO-d6): δ 9.30 (s, 1H), 8.14 (d, J = 8.6 Hz, 4H), 8.04 (d, J = 8.6 Hz, 4H), 7.51 
(d, J = 9.0 Hz, 4H), 7.49 (s, 1H), 7.07 (d, J = 9.0 Hz, 4H), 4.18 (s, 6H), 3.76 (s, 6H); 13C 
NMR (100 MHz, DMSO-d6): δ 160.7, 152.5, 132.8, 132.4, 131.3, 129.1, 125.5, 124.2, 
117.6, 115.5, 115.4, 96.9, 88.0, 55.6, 34.0; HRMS m/z calcd for C38H29N6O2 [M-H+] 
601.2352, found 601.2355. 
 
1-(4-carboethoxyphenyl)-7-(4-methoxyphenyl)-3,5-dimethylbenzobis(imidazolium) 
diiodide (8.32): This compound was prepared analogously to BBI 8.15 from 
benzobis(imidazole) 8.35 (100 mg, 0.24 mmol) to provide 169 mg (>99% yield) of the 
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desired product as a pale yellow powder. 1H NMR (300 MHz, DMSO-d6): δ 10.48 (s, 
1H), 10.33 (s, 1H), 9.1 (s, 1H), 8.27 (d, J = 8.7 Hz, 2H), 8.07 (s, 1H), 8.04 (d, J = 9.0 Hz, 
2H), 7.80 (d, J = 9.0 Hz, 2H), 7.25 (d, J = 9.0 Hz, 2H), 4.38 (quart, J = 6.9 Hz, 2H), 4.30 
(s, 3H), 4.29 (s, 3H), 3.86 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, DMSO-
d6): δ 164.7, 160.6, 147.2, 136.7, 131.6, 131.3, 131.1, 131.0, 130.6, 129.8, 127.0, 125.8, 
125.5, 115.5, 99.7, 98.2, 61.4, 55.8, 34.4, 34.3, 14.1; HRMS m/z calcd for C26H25N4O3 
[M-H+] 441.1927, found 441.1930. 
 
1-(4-carboethoxyphenyl)amino-5-chloro-2,4-dinitrobenzene (8.33): A screw-cap vial 
was charged with 1,5-dichloro-3,4-dinitrobenzene (8.10) (595 mg, 2.51 mmol), 
benzocaine (829 g, 5.02 mmol), EtOH (10 mL), and a stir bar. The vial was then sealed 
with a Teflon-lined cap and the mixture was placed in an oil bath at 50 °C and stirred for 
12 h. Upon completion, the mixture was poured into 5% HCl (50 mL).  Precipitated 
solids were collected via vacuum filtration, rinsed with H2O and dried under vacuum to 
provide 875 mg (95% yield) of the desired product as a yellow powder. 1H NMR (400 
MHz, CDCl3): δ 9.90 (br s, 1H), 9.06 (s, 1H), 8.18 (d, J = 8.8 Hz, 2H), 7.38 (d, J = 8.8 
Hz, 2H), 7.32 (s, 1H), 4.41 (quart, J = 7.2 Hz, 2H), 1.42 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 165.4, 144.2, 140.4, 136.7, 135.8, 131.7, 130.3, 129.4, 126.5, 




(8.34): After dissolving aryl chloride 8.33 (380 mg, 1.04 mmol) in EtOH (10 mL), p-
 166
anisidine (256 mg, 2.08 mmol) was added in a single portion. The mixture was then 
stirred at 80 °C for 24 h. After cooling to ambient temperature, the mixture was poured 
into 5% HCl (50 mL).  Precipitated solids were collected via vacuum filtration, rinsed 
with H2O and dried under vacuum to provide 462 mg (98% yield) of the desired product 
as an orange powder. 1H NMR (300 MHz, CDCl3): δ 9.85 (br s, 1H), 9.65 (br s, 1H), 9.33 
(s, 1H), 7.98 (d, J = 8.7 Hz, 2H), 7.17 (d, J = 8.7 Hz, 2H), 7.12 (d, J = 8.7 Hz, 2H), 6.92 
(d, J = 9.0 Hz, 2H), 6.53 (s, 1H), 4.38 (quart, J = 7.2 Hz, 2H), 3.81 (s, 3H), 1.41 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.6, 158.7, 148.1, 145.1, 141.7, 131.1, 
129.5, 129.3, 127.6, 127.0, 125.64, 125.55, 122.6, 115.1, 96.1, 61.1, 55.5, 14.3; HRMS 
m/z calcd for C22H21N4O7 [M+H+] 453.1410, found 453.1406. 
 
1-(4-carboethoxyphenyl)-7-(4-methoxyphenyl)benzobis(imidazole) (8.35):  This 
compound was prepared analogously to 8.13 from dinitroarene 8.34 (354 mg, 0.78 mmol) 
to provide 272 mg (84% yield) of the desired product as an off-white solid. 1H NMR (300 
MHz, CDCl3): δ 8.33 (s, 1H), 8.24 (d, J = 8.7 Hz, 2H), 8.19 (s, 1H), 8.10 (s, 1H), 7.61 (d, 
J = 9.0 Hz, 2H), 7.49 (s, 1H), 7.41 (d, J = 9.0 Hz, 2H), 7.08 (d, J = 9.0 Hz, 2H), 4.42 
(quart, J = 7.2 Hz, 2H), 3.89 (s, 3H), 1.42 (t, J = 1.42 (t, J = 7.2 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 165.5, 159.4, 143.9, 142.7, 141.6, 141.5, 140.3, 133.1, 131.6, 131.5, 
129.6, 129.1, 125.9, 123.2, 115.3, 111.1, 90.1, 61.4, 55.6, 14.3; HRMS m/z calcd for 
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